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Regulated exocytosis is spatially and temporally regulated by a cascade of protein-protein
interactions. The minimal machinery required for membrane fusion is the SNARE complex,
formed between three membrane proteins: syntaxin, synaptobrevin (VAMP) and SNAP-25.
The conformation of syntaxin la, which exists in 'open' and 'closed' states, is believed to
play a role in SNARE complex assembly in neuronal and neuroendocrine cells, through
regulation of the interconversion between its different conformational states by the
cytoplasmic protein muncl8-l. Recent work has also demonstrated that phosphorylation of
muncl8-l by protein kinase C on serines 306 and 313 weakens its affinity for syntaxin la in
vitro.
To further understand the role of the syntaxin la - muncl8-l complex, the interaction of
these two proteins was studied in vitro and in vivo. These studies utilized muncl8-l and
syntaxin la chimeras containing the fluorescent proteins EGFP and EYFP. Use of
radiolabelled muncl8-l, EGFP-muncl8-l, muncl8-lR39c (mutated in a residue that is
important for interaction with syntaxin la and for maintaining muncl8-ls conformation),
EGFP-muncl8-lR39c, EYFP-muncl8-lS306E:S3i3E(a phosphomimetic mutant) and EYFP-
muncl8-lR39C:S306E:S3i3Ein in vitro binding studies revealed that the addition of the fluorescent
proteins to syntaxin la and muncl8-l had little effect on their interaction in comparison with
wild-type proteins. The muncl8-lR39c and the phosphomimetic muncl8-l mutants had a
reduced affinity for syntaxin la. In order to study protein interaction within cells, using a
cell line with no endogenous protein background, muncl8-l and syntaxin la variants were
expressed in HEK293 cells and imaged using confocal laser scanning microscopy. These
studies showed that phosphorylation ofmuncl8-l reorganised the cellular localisation of the
syntaxin la - muncl8-l complex from the cytoplasm to the plasma membrane. Finally
FRET and FLIM analysis of the interaction between ECFP-syntaxin la and EYFP-muncl8-
1, and its mutants, revealed that the conformation of the syntaxin la- munc 18-1 complex
depended on its cellular location, and that PKC phosphorylation ofmuncl8-l occurred in a
spatially restricted manner in HEK293 cells, altering the intracellular conformation. Also
the syntaxin la - muncl8-l complex can assume at least one other spatially defined
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1.1 The Secretory Pathway
One of the defining features of eukaryotic cells is their compartmentalisation into
membrane-bound organelles. Cellular life and differentiation depend on keeping the
boundaries of a cell and its organelles intact at all times. There is, however, a dynamic flux
of membrane constituents and cargo transported between these organelles and to the plasma
membrane without compromising membrane integrity (Bock and Scheller 1999; Jahn and
Sudhof 1999). With the advent of electron microscopy in the 1960s and 1970s, and
following the development of cell-free systems for the study of protein synthesis, the
hypothesis of the secretory pathway was developed, which posited that proteins to be
secreted were synthesised on ribosomes bound to the endoplasmic reticulum, co-
translationally translocated into the lumen, moved to and through the Golgi apparatus then
packaged into secretory vesicles and finally secreted (Blobel, Walter et al. 1979). This
process is largely mediated by the budding of transport vesicles from a donor compartment
followed by the trafficking to and fusion with an acceptor compartment, and the transfer of
soluble vesicular constituents (Figure 1.1) (Bock and Scheller 1999). Limited progress made
in understanding the secretory pathway was largely due to two approaches: the biochemical
dissection of the secretory machinery of mammalian cells, including vertebrate synapses, and
the genetic dissection of the secretory pathway in yeast. Both approaches revealed that a key
event in intracellular membrane traffic is membrane fusion. This suggested a common
underlying mechanism for all trafficking reactions between intracellular organelles during
constitutive and regulated secretory pathways within cell types ranging from yeast to man,
with some pathways having specialised features (Jahn and Sudhof 1999).
1.2 Exocytosis
Exocytosis forms the basis of intercellular communication in multicellular organisms
through the release of a wide array of signalling molecules. The fusion of secretory vesicles
with the plasma membrane is essential for normal cellular function and occurs in most cells
2
Proteins are translated on bound ribosomes and co-translationally translocated into the
endoplasmic reticulum (ER). The proteins travel through the ER then onto and through the
Golgi apparatus. In the Golgi the proteins are packaged into secretory vesicles that travel to
the plasma membrane, where they fuse releasing their contents into the extracellular space.
Transport between organelles occurs by the budding of vesicles from the donor
compartment followed by the subsequent trafficking and fusion with the appropriate
acceptor compartment
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in the form of constitutive exocytosis, allowing the maintenance of plasma membrane lipids,
proteins and the extracellular environment. In addition, some cells perform more specialised
forms of exocytosis: regulated exocytosis, used to release materials, such as
neurotransmitters, neuropeptides, cytokines, hormones, and also to control levels of different
lipids, receptors and transporters in the plasma membrane, in a highly regulated manner.
Regulated exocytosis occurs in response to a range of physiological signals, which usually
result in an increase in the intracellular free calcium concentration. Although the regulation
differs, the fundamental pathway and the basic machinery involved in constitutive and
regulated exocytosis and for membrane fusion throughout the secretory pathway are similar
(Brunger 2000; Lin and Scheller 2000; Burgoyne and Morgan 2003).
1.3 Types of secretory vesicles
The ability of secretory cells to release material by exocytosis, strictly on demand, is
accomplished by the selective exclusion of regulated secretory proteins from constitutive
secretory vesicles. Therefore an alternative organelle capable of stimulus-induced
exocytosis is used, known as the secretory vesicle. There are different types of secretory
vesicles present in different types of secretory cells (Burgoyne and Morgan 2003).
Neuronal cells contain two types of secretory vesicles, synaptic vesicles (SVs) and large
dense-cored vesicles (LDCVs), also found in neuroendocrine cells. SVs are approximately
spherical with a diameter of 50 nm and store non-peptide transmitters. Within neurons each
synapse is thought to contain 200-250 SVs. LDCVs store peptide hormones and biogenic
amines and have a diameter of 150-300 nm. Exocytosis of SVs and LDCVs is separately
controlled via differences in sensitivity to Ca2+ although probably through a common
mechanism. In addition to SVs and LDCVs, peripheral neurons contain secretory vesicles of




Both SVs and LDCVs are generated from the Golgi apparatus, although with significant
differences. The cargo proteins of LDCVs accumulate in the trans Golgi network (TGN)
forming aggregates, resulting in the deformation of the TGN membrane, condensation of the
granule matrix and membrane budding to form immature secretory granules. Newly formed
LDCVs then mature by fusing with other immature granules, and undergoing membrane
remodelling, with the removal of mis-sorted material via clathrin coated vesicles (Burgoyne
and Morgan 2003; Apps 2004). SVs also bud from the Golgi as immature vesicles with
morphology and protein composition different from mature SVs. They reach synapses by
axonal transport where they undergo processing and remodelling.
The major difference between SVs and LDCVs lies in their fate following fusion with the
plasma membrane. After LDCV fusion, vesicle membrane components are retrieved and
recycled to the Golgi, where they collect new cargo, thus generating vesicles de novo in each
cycle. In contrast SVs are used many times, being locally recycled up to 1-2000 times prior
to degradation, because most central nerve synapses are far from the cell body. Therefore,
de novo generation of SVs after fusion would not produce enough SVs to maintain
prolonged stimulation. Also some transmitters, such as GABA are synthesised in nerve
terminals. SVs use proton-coupled transporters for neurotransmitter uptake. This proton
motive force is generated by a V-type H+-translocating ATPase (Apps 2004).
1.4 Regulated exocytosis
Regulated exocytosis consists of a sequence of functionally defined steps (Figure 1.2).
Before any event at the plasma membrane, secretory vesicles may need to be mobilized by
dissolution of cytoskeletal barriers to movement, and thereafter transported to their site of
fusion (Cheek and Burgoyne 1987; Greengard, Valtorta et al. 1993; Vitale, Seward et al.
1995). The first step in exocytosis proper, membrane attachment, also known as tethering,








Figure 1.2: The steps involved in regulated exocytosis
Secretory vesicles are initially mobilised, move towards the plasma membrane and
associate with it in a process known as tethering. Proteins on the vesicles then undergo
specific interactions with proteins present on the plasma membrane (docking) which is
followed by the priming of the vesicles into a fusion-competent state, through several steps
that require Ca2+ and MgATP. The vesicles then undergofusion with the plasma membrane
through the opening of a fusion pore that either expands, resulting in fullfusion, or closes
again (kiss and run).
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step results in the vesicles becoming "morphologically docked", i.e. closely associated with
the membrane; but docking itself, i.e. direct engagement with the fusion machinery, may be
a separate process. After docking secretory vesicles undergo priming, which probably
contains multiple events and requires both ATP hydrolysis and a low concentration of Ca2+.
The final stage in regulated exocytosis is membrane fusion, the signal for which is invariably
increased free [Ca2+], at a higher concentration than is needed for priming, typically in the 2-
30 pM range for most types of regulated exocytosis. Fusion then proceeds through the
formation of a fusion pore that can open transiently or expand, leading to full fusion. The
molecular nature of the fusion pore is still a matter for debate (Lindau and Alvarez de Toledo
2003) although it has recently been proposed that the pore initially formed contains the
transmembrane domains of several syntaxin molecules (Han, Wang et al. 2004). The
opening of the fusion pore is probably the most tightly regulated step since it mediates the
release of the secretory materials. In the case of neurotransmitter release, acute triggering of
release has to act on the very last step of exocytosis simply because Ca2+-triggered release is
so fast (<100 ps in some synapses) that there is probably insufficient time for it to act on
earlier steps. Based on this speed, it has been argued that synaptic vesicle exocytosis is
arrested at a late step in fusion, i.e. largely completed during priming, and that elevated
[Ca2+] acts at a point in exocytosis at which only fusion pore opening is required for release
(Gerber and Sudhof 2002; Burgoyne and Morgan 2003). Extensive evidence suggests,
however, that the steps prior to fusion are also tightly regulated.
Functional studies of secretion kinetics, in a variety of cells, have led to the proposal of
distinct functional pools of vesicles (Heinemann, Chow et al. 1994; Eliasson, Renstrom et al.
1997; Nelson, Robinson et al. 2002). Only a small fraction of the synaptic vesicles docked at
the plasma membrane, referred to as the readily releasable pool (RRP) are ready/available
for immediate release upon Ca2+ influx. The remaining vesicles belong to a reserve pool
(RP), perhaps retained by a cytoskeletal network, which requires recruitment in an ATP-,
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Ca2+-, and temperature-dependent fashion prior to release (Holz, Bittner et al. 1989; Bittner
and Holz 1992; Barg, Olofsson et al. 2002).
Through studies of membrane trafficking in yeast and in vitro fusion reactions of
intracellular organelles, similarities between all eukaryotic fusion reactions have emerged,
where four protein families play key roles: NSF and its adaptor proteins (a-soluble NSF
attachment protein, a-SNAP), soluble N-ethylmalemide-sensitive factor attachment protein
receptors (SNAREs), Secl/muncl8 (SM Proteins) and Rab proteins (Sudhof 1995; Gerber
and Sudhof 2002; Burgoyne and Morgan 2003).
1.5 NSF and SNAPs
The discovery of NSF followed the development of a cell-free assay for vesicular traffic
between mammalian ER and Golgi (Beckers, Block et al. 1989), the sensitivity of this
process to the alkylating agent N-ethyl maleimide permitting the isolation of its target. NSF
is a hexameric ATPase, homologous to secl8p in yeast, which was independently discovered
by mutational analysis (Wilson, Wilcox et al. 1989; Kaiser and Schekman 1990). The three
SNAPS (a, |3 and y) were then discovered as soluble brain proteins that bound to NSF, as
part of a stoichiometric 20S-complex that contained the SNAREs (see below) a-SNAP,
which stimulates the ATPase activity of NSF, is homologous to the yeast protein secl7p.
1.6 SNARE proteins
SNARE proteins were discovered independently in yeast and neurons and were originally
classified on the basis of their subcellular localisation, either as t-SNAREs (found on the
target membrane) or as v-SNAREs (located on the vesicle membrane) (Figure 1.3A).
Sequence analysis revealed that they all contained a characteristic heptad repeat of -70
residues, known as the SNARE motif, which mediates the association of SNAREs into core
complexes (see below). In addition to the SNARE motifs, SNAREs contain flanking
8
The 0 layer
Figure 1.3: The SNARE proteins
Figure A is a diagrammatic representation of the localisation of the SNARE proteins on either
the vesicle or the plasma membrane (Burgoyne and Morgan. 2002).
Figure B illustrates how the SNARE proteins assemble into the core complex and the sites of
clostridial neurotoxin cleavage (Rizo and Sudhof, 2002)
Figure C shows the coordination of the three glutamine and one arginine residue present in
the ionic layer of the core complex (Burgoyne and Morgan, 2002)
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sequences that attach them to membranes and partake in additional protein-protein
interactions (Sollner, Bennett et al. 1993; Terrian and White 1997; Weimbs, Low et al. 1997;
Weimbs, Mostov et al. 1998; Pelham 1999; Bock, Matern et al. 2001).
SNAREs were divided into families based on whether they contained one or two SNARE
motifs, on the sequences of the SNARE motifs and on the type and sequences of the flanking
domains. Most SNAREs contain a single SNARE motif preceded by a variable N-terminal
domain, followed by a single transmembrane domain as seen in the syntaxin and
synaptobrevin/VAMP families. Other SNAREs do not contain a transmembrane domain, but
interact with the membrane via post-translationally attached lipids, for example SNAP-25 is
attached to the membrane by palmitoylated cysteine residues. SNAREs are also classified as
Q or R SNAREs based on whether they contain a conserved glutamine (Q) or arginine (R) in
the SNARE motif in the so called zero layer (see below) (Hess, Slater et al. 1992; Fasshauer,
Sutton et al. 1998; Pelham 1999; Bock, Matern et al. 2001).
1.6.1 The core complex of SNAREs
The human genome encodes 35 SNAREs compared with 22 in the yeast genome. The
synaptic SNARE complex remains the most intensively studied and is the model for how
other SNARE complexes in the secretory pathway may assemble. It is composed of the
three proteins: VAMP/synaptobrevin, located on the vesicle membrane, and syntaxin la and
SNAP-25, located on the plasma membrane. These assemble into a stable ternary complex
with a 1:1:1 stoichiometry that is referred to as the core complex (Wilson, Whiteheart et al.
1992) (Figure 1.3B). The core complex is formed by the four SNARE motifs (one SNARE
motif each from syntaxin and synaptobrevin and two from SNAP-25) twisted into a parallel
four-helical bundle approximately 12 nm long. The interactions in the core of this bundle
are mainly hydrophobic apart from a central ionic layer (known as the zero layer) that is
constructed from an arginine residue contributed by the SNARE motif of synaptobrevin and
three glutamine residues contributed by each of the three SNARE motifs of syntaxin la and
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SNAP-25 hence the sub-classification into Q and R SNAREs (Figure 1,3C). All SNARE
complexes consist of 1R and 3Q SNARE motifs. This ionic layer is shielded from its
aqueous surroundings by the flanking leucine zipper layers and the polypeptide backbones of
the proteins, greatly increasing the stability of this complex. Furthermore, the asymmetric
ionic layer fixes the positions of the hydrophobic layer in the centre of the bundle, ensuring
that the helices of the SNARE motifs are placed in the correct register during assembly
(Sutton, Fasshauer et al. 1998). Before core complex assembly, the cytoplasmic regions of
synaptobrevin and SNAP-25 are largely unstructured and a binary complex between syntaxin
1 a and SNAP-25 forms before the ternary complex. The formation of the binary complex
induces secondary structure in SNAP-25 and in vitro data has suggested that secondary
structure in synaptobrevin is then induced by its interaction with the binary complex during
formation of the core complex (Fasshauer, Bruns et al. 1997), a process known as
'zippering'. The assembled SNARE complex is unusually stable, with a 'melting'
temperature of 70-90 °C, and is resistant to SDS. It is believed to function in all cellular
fusion reactions, since SNAREs are ubiquitous, and each SNARE exhibits a characteristic
subcellular distribution. The requirement for SNAREs in membrane fusion has been further
proved by genetic studies in the yeast, Saccharomyces cerevisiae, where deletion of
SNAREs is usually lethal (Gerst 1999). Similarly genetic ablation of synaptic SNAREs in
Drosophila melanogaster, Caenorhabditis elegans and Mas musculus abolishes evoked
neurotransmission (Schulze, Broadie et al. 1995; Nonet, Saifee et al. 1998; Schoch, Deak et
al. 2001; Washbourne, Thompson et al. 2002). Furthermore, the identification of the
SNARE proteins as substrates for the Botulinum and Tetanus neurotoxins revealed an
essential role for these proteins in exocytosis. The light chains of these toxins are
metalloproteinases that enter target neurons and inhibit neurotransmission through
degradation of SNAREs. Synaptobrevin is cleaved by Tetanus toxin and Botulinum toxin
types B, D, F and G; SNAP-25 is cleaved by Botulinum toxins A, C and E and syntaxin la is
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cleaved by Botulinum toxin C (Hayashi, McMahon et al. 1994). These results, with the
additional observation that synaptobrevin, syntaxin and SNAP-25 form a stoichiometric
complex (the 20S complex) with NSF and SNAPs, led to a model of intracellular membrane
traffic known as the 'SNARE hypothesis'.
1.6.2 The SNARE hypothesis
The SNARE hypothesis was an early attempt to explain the events leading up to membrane
fusion and postulated that the assembly of the SNARE proteins synaptobrevin, syntaxin la
and SNAP-25 into the stable core complex, bringing the vesicle and plasma membrane into
close proximity, supplied the energy required to overcome the repulsive forces of the two
lipid bilayers resulting in membrane fusion. This was supported by studies of in vitro fusion
reactions in which the SNARE proteins synaptobrevin, syntaxin la and SNAP-25 were
found to be both necessary and sufficient to promote lipid bilayer fusion (Weber, Zemelman
et al. 1998). The fusion of proteoliposomes has also been demonstrated with specific
combinations of core SNAREs (McNew, Parlati et al. 2000; Parlati, McNew et al. 2000).
These in vitro fusion reactions were extremely slow, and the inclusion of synaptotagmin
produced only a modest acceleration of fusion (Tucker, Weber et al. 2004), suggesting that
additional factors might be required; but in recent work (E. Chapman, personal
communication) much faster fusion of SNARE-containing proteoliposomes has been
achieved, by use of much smaller proteindipid ratios and thus avoiding the formation of
refractory SNARE aggregates.
In the original formulation of the SNARE hypothesis, ATP hydrolysis by NSF was supposed
to drive the fusion reaction itself, and for a while NSF was taken to mean 'NEM-sensitive
fusion protein'. This idea, however, was confounded by the observation that the rate of ATP
hydrolysis by NSF, even when stimulated by a-SNAP, was far too slow, and then by the
finding that the rapid phase of LDCV fusion occurred even after removal of ATP (Holz,
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Bittner et al. 1989). It was later suggested that following membrane fusion, SNARE
complex disassembly was catalysed by the binding of a-SNAP and NSF. Following ATP
hydrolysis, NSF and a-SNAP are released and the dissociated individual SNAREs can
participate in further fusion reactions. The study of stage-specific exocytosis in chromaffin
cells and high resolution electrophysiological approaches have suggested, however, that a-
SNAP/NSF acts in an early ATP-dependent priming reaction that precedes the later Ca2+-
dependent fusion step (Chamberlain, Roth et al. 1995; Banerjee, Barry et al. 1996; Xu,
Rammner et al. 1999).
Despite the general agreement that SNARE complex assembly has an essential role in
exocytosis, some studies have suggested it has a pre-fusion role, in which it is not directly
involved in the opening of the fusion pore and the SNARE proteins themselves do not confer
specificity on membrane fusion. In studies of fusion between two populations of vacuoles
that contained either v-SNAREs or t-SNAREs, trans-core complexes were formed and could
be disassembled by Secl8/Secl7 without inhibiting the subsequent mixing of vacuolar
contents (Ungermann, Sato et al. 1998). Also experiments with sea urchin egg secretory
vesicles indicated that core complexes were, in fact disrupted by Ca2+ in a step before
membrane fusion (Tahara, Coorssen et al. 1998). In Drosophila the deletion of
synaptobrevin abolishes evoked neurotransmitter release, but spontaneous miniature release
events (minis) still occurred and C.elegans synaptobrevin mutants still had some movement
and were not totally paralysed (Harter, James et al. 1989; Ferro-Novick and Jahn 1994;
Steyer, Horstmann et al. 1997; Oheim, Loerke et al. 1998; Rizo and Sudhof 2002).
The SNARE hypothesis also stated that the SNARE proteins themselves conferred the
specificity for the different fusion events throughout the secretory pathway ensuring that the
vesicles fused with the correct target membranes. Several yeast SNAREs have, however,
been implicated in multiple SNARE complexes (Gaudin, Ruigrok et al. 1995). In addition,
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synaptic vesicles release neurotransmitters only at active zones, despite the presence of
syntaxin la and SNAP-25 throughout the plasma membrane (Weimbs, Low et al. 1997).
More recently, a model for how SNAREs participate in neurotransmitter release has been
proposed (Figure 1.4). In this model SNARE complex assembly forces synaptic vesicles
into an unstable fusion intermediate that is stabilised by complexin. The two complexins, I
and II, are closely related -15 kDa cytosolic proteins, expressed specifically in the brain.
Double knockout mice studies have suggested complexins positively regulate a late step in
exocytosis by binding to the assembled trimeric SNARE complex. Synaptotagmin (see
below) could then bind in the absence of Ca2+, but switch to the phospholipid membrane as
[Ca2+] concentration increases. Binding of the synaptotagmin C2-domains to the
phospholipids, with partial insertion of synaptotagmin hydrophobic sequences into the
membrane, could then induce a mechanical stress that destabilises the fusion intermediate,
opening the fusion pore. This speculative model, however, is far from proven (Sudhof
2004).
There is little doubt that the role the SNAREs play is specific, but their specificity could
arise from sequences outside of the SNARE motif, or from surface residues of the SNARE
motif that do not participate in core complex assembly as SNARE proteins also differ from
each other in sequences surrounding the SNARE motifs and the membrane attachment
domains. Syntaxin, one of the SNARE proteins, and its homologues contain an N-terminal
domain that plays an important role by interacting with other synaptic proteins, which
regulate membrane fusion.
1.7 Syntaxin
Syntaxin 1 was discovered as a protein that interacts with the synaptic vesicle membrane
protein synaptotagmin and by immunocytochemistry as a surface protein of various neurons
(Bennett, Calakos et al. 1992; Inoue, Obata et al. 1992) and since then many syntaxin 1
homologues have been identified that work at all transport steps throughout the secretory
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Figure 1.4: The role of SNAREs in neurotransmission
In this model SNARE complex assemble forces the synaptic vesicle into an unstable fusion
intermediate, followed by the binding of synaptotagmin to the core complex in the absence
of Ca2+. Upon an increase in [Ca2+] synaptotagmin binds and partially inserts its
hydrophobic sequences into the plasma membrane, inducing a mechanical stress resulting
in the opening of the fusion pore (figure taken from Rizo and Sudhof, 2002).
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pathway. Unlike the other SNARE proteins, syntaxin-null mutants have no evoked and
spontaneous neurotransmission and are paralysed in Drosophila and C.elegans respectively
(Schulze, Broadie et al. 1995; Nonet, Saifee et al. 1998), indicating that the syntaxin family
of proteins are essential for membrane fusion.
In addition to the SNARE motif and a C-terminal transmembrane region, all syntaxins
contain a characteristic N-terminal domain. These domains are conserved between syntaxins
that function at the same trafficking step, but differ between syntaxins that function at
distinct trafficking steps, while the SNARE motifs of all syntaxins are homologous,
suggesting that the N-terminal domains of syntaxins are specific for a given trafficking step
(Weimbs, Low et al. 1997). The presence of an evolutionarily conserved autonomously
folding N-terminal domain in syntaxins suggests that these proteins have additional roles
besides core complex formation, which are thought to be mediated through the interaction of
syntaxins with various other proteins involved in membrane fusion (Jahn and Sudhof 1999).
This idea was further supported when the synaptic syntaxin, syntaxin la, was found to have
more binding partners than any other synaptic protein, interacting with at least nine other
neuronal proteins, including munc 18/n-Sec 1, Ca2+ channels, synaptotagmin, complexins, a-
SNAP, rsec6/rsec8, CIRL/latrophilin, tomosyn and munc 13, in addition to synaptobrevin and
SNAP-25 (Chapman, Hanson et al. 1995; McMahon, Missler et al. 1995; Hsu and Jackson
1996; Krasnoperov, Bittner et al. 1997; Betz, Ashery et al. 1998; Fujita, Shirataki et al.
1998).
1.7.1 Syntaxin 1a
The N-terminal domain of syntaxin la spans two-thirds of its sequence and is composed of a
three- helical bundle called the Habc domain, which is preceded by a short amino-terminal
sequence and is followed by a linker region that separates it from the SNARE motif and the













Figure 1.5: The conformations of syntaxin 1a
Syntaxin la has a large N-terminal domain, consisting of a 3 helical bundle termed the
Habc domain.
Syntaxin la exists in two conformations: 'closed', in which the Habc domain folds back
and interacts with the H3 domain, and 'open', in which the H3 helix can participate in
core complex assembly (adapted from Dulubova et al, 1999).
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conformations, the open conformation, which can interact with the other SNARE proteins in
the core complex, and the closed conformation, in which the Habc domain folds back onto
the SNARE motif and prevents such interactions (Fernandez, Ubach et al. 1998; Dulubova,
Sugita et al. 1999). Isolated syntaxin la was found to switch between the closed and the
open conformation suggesting that regulatory proteins were required to hold it in the closed
inactive conformation (Margittai, Widengren et al. 2003). The SM protein muncl8-l binds
to syntaxin la, stabilising it in the closed conformation and thereby preventing interaction
with the other SNAREs. This finding has led to the theory that regulation of the
conformational state of syntaxin la plays a key role in regulating exocytosis.
1.8 Munc18-1
Muncl8-1 is a member of the Secl/muncl8 (SM) protein family and was first identified by
its ability to bind syntaxin la with nanomolar affinity (Hata, Slaughter et al. 1993) and was
later cloned based on its similarity to Drosophila Rop and C.elegans unc-18 using homology
screening (Halachmi and Lev 1996). In vertebrates three isoforms of muncl8-l have been
discovered; muncl8-l, -2 and -3 (also known as muncl8a, 18b and 18c).
SM proteins are 60-70 kDa hydrophilic soluble proteins with high sequence homology that is
distributed evenly over their entire sequence, suggesting that they have a similar structure.
SM proteins were first discovered during genetic screens in C.elegans for uncoordinated
(unc) phenotypes that were fully or partially paralysed (UNC-18) (Brenner 1974) and as
secretion mutants in S.cerevisiae (Seel) (Novick and Schekman 1979). Since then genetic
studies have established a general requirement for SM proteins in membrane fusion in a wide
variety of organisms, operating throughout the secretory pathway (Jahn 2000), including
yeast, plants, nematodes. Hies and mice (Halachmi and Lev 1996; Verhage, Maia et al.
2000), although their precise role remains elusive. Exocytosis is completely blocked in
S.cerevisiae Seel mutants and Drosophila Rop null mutants suggesting a positive role for
SM proteins in membrane fusion. Over-expression of Drosophila Rop, however, leads to a
18
decrease in neurotransmitter release (Schulze, Littleton et al. 1994), which is representative
of a more negative role for SM proteins. This idea was further supported when muncl8-l
was found to bind to the closed conformation of syntaxin la, preventing it from interacting
with the other SNAREs. Furthermore, in PC12 cells, syntaxin is unable to leave the Golgi in
the absence of muncl8 (Rowe, Calegari et al. 2001).
The action of SM proteins remains controversial, most experimental evidence indicating that
they have multiple functions in vesicle trafficking through their interactions with several
other proteins. Such a notion is supported by observations in yeast, where a genetic
interaction between Slyl and the Rab-like GTPase YPT suggests an involvement in the early
event of vesicle recruitment, whereas Seclp acts at a very late stage in exocytosis,
downstream of SNARE complex assembly (Dascher, Ossig et al. 1991; Ossig, Dascher et al.
1991; Carr, Grote et al. 1999; Grote, Carret al. 2000). An additional role in docking has
been suggested for SM proteins since in C.elegans unc-18 mutant synapses there is a reduced
number of docked vesicles, which was mirrored in muncl8-l knockout mice by a similar
reduction in docked dense core granules in chromaffin cells (Verhage, Maia et al. 2000;
Voets, Moser et al. 2001; Weimer, Richmond et al. 2003). In these mice, although there was
no effect on synaptic vesicle docking, there was a complete block of neurotransmission,
implying an additional post-docking role for muncl8-l in the late stages of exocytosis
(Verhage, Maia et al. 2000; Ciufo, Barclay et al. 2005). Despite the different phenotypes
seen for different SM protein mutants, a conserved function among all SM proteins in
membrane fusion is its interaction with the corresponding syntaxin homologue.
1.8.1 SM Proteins and syntaxin protein interactions
Generally SM proteins interact with their respective syntaxins with high specificity and high
affinity, although the way in which these proteins interact appear to be fundamentally
different among different pairs (Toonen and Verhage 2003). So far at least four binding
modes have been identified (Figure 1.6):
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Figure 1.6: Modes of syntaxin - SM protein interactions
1. SM protein binding to the closed conformation of syntaxin
2. SM protein binding to assembled SNARE complexes
3. SM protein binding to the conserved N-terminus irrespective of syntaxin la
conformation





1. Binding to the closed conformation of syntaxin. This is exemplified by the way in
which muncl8-l interacts with syntaxin la (Misura, Scheller et al. 2000).
2. Binding to assembled SNARE complexes. In the yeast S.cerevisiae the
corresponding SM protein, Seclp, interacts with the assembled SNARE complex,
even though the syntaxin homologue, Ssolp adopts a closed conformation when free
(Carr, Grote et al. 1999).
3. Binding to the conserved N-terminus irrespective of the conformation of syntaxin.
Examples of this have been observed in both yeast and mammals where the SM
protein involved in membrane traffic events to and from the Golgi, Slylp/mSlyl and
Vps45p/mVps45, bind to a conserved N-terminal motif of their respective syntaxins.
This binding mode allows the simultaneous binding of SM protein and SNARE
complex members and seems to represent the most general mode of syntaxin - SM
protein coupling (Bryant and James 2001; Peng and Gallwitz 2002; Rizo and Sudhof
2002).
4. Binding via multiprotein complexes. In S.cerevisiae another yeast SM protein,
Vps33p is part of a complex (C-Vps complex) that functions in Golgi to vacuole
transport and interacts with the Syntaxin homologue Vam3p (Sato, Rehling et al.
2000). The same interactions are observed with homologues of Vps33p and
members of the C-Vps complex in Drosophila (Sevrioukov, He et al. 1999).
These different binding modes might be an evolutionary adaptation to prevent the binding of
SM proteins to non-cognate syntaxins. Since only muncl8/UNC18 bind to monomeric
syntaxins this binding mode might be necessary to meet the specific requirements and
regulation of fast exocytosis of neurotransmitters (Toonen and Verhage 2003). Furthermore
the crystal structure of the syntaxin la - muncl8-l complex has made this interaction of
particular interest since it appears to represent a specialised mode of interaction between SM
proteins and syntaxins (Misura, Scheller et al. 2000).
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1.9 Syntaxinl A - Munc18-1 interaction
The crystal structure of the syntaxin la - muncl8-l complex (Figure 1.7) (Misura, Scheller
et al. 2000) revealed that the interaction between syntaxin la and muncl8-l requires most of
the cytoplasmic domain of syntaxin la, including the Habc and the H3 domains and almost
all of muncl8-l (Hanson 2000; Misura, Scheller et al. 2000). Muncl8-1 is a horseshoe-, or
arch-shaped molecule, containing three domains arranged around a -15 A central cavity that
wraps around syntaxin la (Misura, Scheller et al. 2000). The syntaxin la-muncl8-l
interaction is believed to stabilise the closed conformation of syntaxin la and may help
prevent premature or inappropriate SNARE complex assembly. This structural work led to
the idea that additional factors must be involved in the regulation of this complex, resulting
in conformational changes in either or both syntaxin la and muncl 8-1 to allow SNARE
complex assembly.
1.9.1 Disassembly of the syntaxin 1a - muncl8-1 interaction
To date several candidates for mediating the dissociation of the syntaxin la - muncl 8-1
complex, which is necessary for membrane fusion to occur, have been investigated, such as
phosphorylation, UNC13/muncl3 proteins, Rab and Rab effectors, and Tomosyn.
1.9.1.1 Munc18-1 phosphorylation
Destabilisation of muncl8-1 - syntaxin la interaction could be promoted by
phosphorylation, as muncl8-l has been shown to be phosphorylated by Cyclin-dependent
Kinase 5 (Cdk5) in vitro (Fletcher, Shuang et al. 1999) and by Protein Kinase C (PKC) both
in vitro and in vivo (Fujita, Sasaki et al. 1996; Barclay, Craig et al. 2003; Craig, Evans et al.
2003). PKC has been shown to stimulate Ca2+-dependent exocytosis in various types of
secretory cells and was found to phosphorylate muncl8-1 on Ser306 and Ser313 (Figure 1.8),
the latter being conserved in Drosophila Rop (Fujita, Sasaki et al. 1996). Muncl8-1
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Figure 1.7: Crystal structure of syntaxin 1a - munc18-1 complex
Figure A shows the structures of both syntaxin la and munc 18-1
Figure B is the crystal structure of the syntaxin l a - munc 18-1 bimolecular complex from
two different angles, revealing how munc 18-1 wraps around syntaxin la (Misura et al,
2000)
Munc 18-1 is shown in blue: domain 1, green: domain 2 and yellow: domain 3.
Syntaxin la is shown in red: Habc domain and purple: H3 domain.
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Figure 1.8: Phosphorylation sites on munc18-1
This shows the phosphorylation sites Ser306 and Ser313 on muncl8-l (shown in blue)
and their position in relation to syntaxin la (shown in green).
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phosphorylation has been shown to reduce the affinity of muncl8-l for syntaxin la and
occurs in response to histamine and Ca2+ in permeabilised chromaffin cells, altering the
release kinetics of single vesicles (Barclay, Craig et al. 2003; Craig, Evans et al. 2003).
1.9.1.2 UNC-13/munc13 proteins
C.elegans UNC-13 and its mammalian homologue have been implicated in priming synaptic
vesicles to a fusion competent state. Muncl3-1 has been shown to interact with the N-
terminal domain of syntaxin la in the open conformation, and this interaction and the
interaction of syntaxin la with muncl8-l are mutually exclusive. This idea was reinforced
when C.elegans UNC-13 was shown to displace UNC-18 from its complex with syntaxin in
vitro (Sassa, Haradaet al. 1999). Furthermore, UNC-13 mutations in C.elegans and
Drosophila, and double knockout of muncl3-l and muncl3-2 in mice, completely block
neurotransmitter release, apparently through a defect in synaptic vesicle priming (Rizo and
Sudhof 2002). Finally, the importance of UNC-13 as a priming factor was demonstrated by
the successful rescue of the unc-13 null phenotype by the introduction of syntaxin mutant
that is locked in the open conformation (Richmond, Weimer et al. 2001).
1.9.1.3 Rab and Rab effectors
Rab proteins are small GTPases that are believed to be involved in vesicle docking. This
idea is supported by studies in S.cerevisiae where SEC1 genetically interacts with the Rab-
like GTPase SEC4 and the absence of Rab proteins results in a block in fusion at defined
stages (Jahn and Sudhof 1999). Also, C. elegans mutants in the Rab effector RIM (Rab3
interacting molecule) suffer a severe decrease in neurotransmitter release, which was
restored by the mutant syntaxin with the open conformation. Furthermore RIM has been
found to interact with muncl3 functionally, suggesting that RIM may have a role in
regulating the priming activity ofmuncl3 (Betz, Thakur et al. 2001).
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1.9.1.4 Tomosyn
Tomosyn is a large, neuron-specific SNARE protein regulator that has been shown to bind
syntaxin I a, displacing muncl8-l in vitro (Fujita, Shirataki et al. 1998). Although it is
unknown whether this interaction is physiologically relevant, SR07 and SR077, putative
tomosyn orthologues in yeast, are essential for vesicle exocytosis, suggesting that these
proteins may have conserved roles in regulating SNARE-dependent trafficking (Lehman,
Rossi et al. 1999).
1.9.1.5 Other proteins that interact with munc18
Muncl8 has also been shown to interact with a number of other proteins and whether such
interactions have any effect on the syntaxin la - muncl8-l interaction or whether they
participate in the other multiple roles ofmuncl8 remains unclear. One such group of
proteins are Mints, which contain a muncl8 interacting domain followed by a sequence that
binds to CASK, a cellular junction protein enriched in synapses. Mint 1 and Mint 2 were
detected in brain in a complex with syntaxin la and muncl8-l and may function by
recruiting muncl8-l to neurexin-containing regions of the plasma membrane through its
association with CASK (Okamoto and Sudhof 1997; Biederer and Sudhof 2000).
The second protein family to be identified was that of the Doc2 proteins namely, Doc2a and
Doc2p, which are synaptic proteins that contain two C2 domains thought to associate with
intracellular membranes. Doc2 proteins have been implicated in regulating exocytosis
through their interaction with other exocytotic proteins. In addition, over expression of Doc2
in PC 12 cells enhances exocytosis (Duncan, Apps et al. 2000). As well as muncl8-l, Doc2
has been shown to interact with muncl3 and undergo a munc 13-dependent redistribution
from the cytoplasm to the plasma membrane in response to stimulation of PC 12 cells with
phorbol ester (Duncan, Betz et al. 1999).
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Finally muncl8-l has been shown to interact with granuphilin, a protein identified in
pancreatic beta cells that associates with dense-core granules and also Rab3A and Rab27
(Fukuda, Kanno et al. 2002), providing a potential mechanism for the modulation of
muncl8-l function through Rab activity (Ciufo, Barclay et al. 2005).
1.10 Synaptotagmins as the Ca2+ sensors in regulated exocytosis
Most forms of regulated exocytosis are Ca2+-dependent and this dependence has been most
closely studied for neurotransmitter release, which is extremely rapid, with a steep [Ca2+]
dependence. In contrast, Ca2+-triggered exocytosis of peptidergic vesicles in endocrine cells
is multiphasic and sustained, although a small component of their secretion is through fast
Ca2+-dependent exocytosis. Thus, there are major differences in the time course of Ca2+-
triggered exocytosis between endocrine and synaptic systems, however the Ca2+ dependence
and cooperativity appear to be similar (Gerber and Sudhof 2002).
At present the favoured candidates for the calcium trigger are the synaptotagmins, which in
humans constitute a family of at least 19 proteins, with similar domain organisation. All
synaptotagmins contain an N-terminal glycosylated domain, a single transmembrane
sequence, a central linker sequence and two C-terminal C2-domains referred to as C2A- and
C2B-domains. These C2 domains are the most highly conserved parts of synaptotagmins
(Gerber and Sudhof 2002).
Synaptotagmin 1 and 2, the first synaptotagmins to be purified and cloned, are highly
homologous. These two synaptotagmins are detectable only in the brain and endocrine
tissues where they are expressed in overlapping but distinct sets of cells (Gerber and Sudhof
2002). Furthermore, evidence from genetic studies in mice, Drosophila melanogaster and
Caenorhabditis elegans as well as microinjection studies in squid giant synapses indicated
that synaptotagmin 1 plays an essential role in fast Ca2+-triggered synaptic vesicle
exocytosis. The C2A-domain of synaptotagmin 1 binds 3 Ca2+ ions (Ubach, Zhang et al.
1998) and the C2B-domain 2 Ca2+ ions (Fernandez, Arac et al. 2001). The intrinsic Ca2+
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affinities of the C2-domains are very low (0.5-5 mM) because the coordination spheres for
the Ca2+ ions are incomplete. The apparent Ca2+ affinity of the C2-domains increases
dramatically (up to 1000-fold) when the C2-domains bind to phospholipid membranes as the
negatively charged headgroups provide additional coordination sites for the bound Ca2+
(Sudhof 2004). In addition to phospholipids, synaptotagmin exhibits Ca2+-dependent
interactions with a variety of other molecules including synaptotagmins, the SNARE
complex (which it also binds in a Ca2+-independent manner), syntaxin la, SNAP-25, Ca2+
channels, calmodulin, RIM and phosphoinositides (Li and Chin 2003).
Even if synaptotagmins are, as appears likely, the Ca2+-sensors of regulated exocytosis, it is
not known how they fulfil this function at a molecular level. An early suggestion was that
synaptotagmin acts as a "fusion clamp", its association with the SNARE complex preventing
exocytosis until released by the binding of Ca2+. Acute photolytic knockout of
synaptotagmin I was accomplished by incorporating a tetracysteine motif that binds to a
fluorescein derivative FLAsH, upon illumination of FIAsH synaptotagmin 1 was inactivated,
blocking Ca2+-induced fusion without increasing the frequency of spontaneous fusion events
(Marek and Davis 2002) which argues for a positive role for synaptotagmin in fusion, such
as a Ca2+-induced conformation change causing insertion of some loops of the C2A domain
into the membrane (Bai, Wang et al. 2002).
Although synaptotagmins 1 and 2 play a key role in fast-triggered exocytosis, other Ca2+
sensors must also be present. The most likely candidates for this are other synaptotagmins,
namely synaptotagmins 3, 6 and 7. The best current model is that the different
synaptotagmins have distinct but complementary roles in exocytosis, with synaptotagmins 1
and 2 specialised for fast synaptic vesicle exocytosis, whereas synaptotagmins 3, 6 and 7
(and possibly others) may be responsible for slower exocytosis, such as in endocrine cells
(Gerber and Sudhof 2002). In mouse neurons, knockout of synaptotagmin I blocks the rapid
phase of exocytosis. This can, however, still be induced by treatment with high
concentrations of sucrose, which induces fusion in a Ca2+-independent manner and therefore
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by-passing the regulated fusion step, indicating that the knockout blocks the fusion reaction
itself and not vesicle docking. Although, in Drosophila and C.elegans, knockout of
synaptotagmin I prevents SNARE complex assembly, which suggests that other
synaptotagmins may control these in mouse.
1.11 Investigating exocytosis
So far, investigations into the formation and dissociation of the syntaxin la - muncl8-l
complex have relied on in vitro biochemical assays of protein-protein interactions, in which
protein fragments and chimeras are used, and on mechanistic interpretations of alterations in
functional responses using genetic approaches in isolated cells or whole animals. Although
such studies have provided valuable information an approach is required that will impart
spatial and temporal information on the state of the bimolecular syntaxin la - muncl8-l
complex in response to secretory pathway activation in intact cells. The development of
high-resolution imaging systems has already enabled various aspects of exocytosis to be
investigated, but with the advent of FRET and FLIM microscopy the interaction between
these two proteins can be studied in greater depth.
1.12 Fluorescent proteins
1.12.1 Green Fluorescent Protein
Green fluorescent protein (GFP) was discovered (Shimomura, Johnson et al. 1962) in the
jellyfish Aequorea victoria as one of two closely associated proteins, aequorin and GFP, that
are responsible for the bluish green light that emits from its umbrella margin. Aequorin
binds Ca2+and emits blue light, which is absorbed through fluorescent energy transfer by
GFP to produce green light (Morise, Shimomura et al. 1974). GFP is a 238 amino acid
protein with an apparent molecular weight of 27-30 kDa on SDS PAGE. It absorbs blue
light maximally at 395 nm, with a smaller absorbance peak at 475 nm and emits green light
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at 508 nm (Cubitt, Heim et al. 1995). Its fluorescence is due to the presence of a p-
hydroxybenzylidene-imidazolidinone chromophore, which is formed by the posttranslational
autocatalytic cyclisation of the polypeptide backbone between residues Ser65 and Gly67 and
the oxidation of the a-(3 bond of Tyr66 in a maturation process that takes 2-4 hours and
requires oxygen (Prasher, Eckenrode et al. 1992; Cody, Prasher et al. 1993). The crystal
structure of GFP (Ormo, Cubitt et al. 1996; Yang, Moss et al. 1996) revealed a tightly
packed cylindrical structure of 11 |3-strands surrounding a helical segment containing the
imidazolidinone chromophore.
Widespread interest in GFP as a biological tool did not develop until 1992 when its cDNA
was cloned and sequenced (Prasher, Eckenrode et al. 1992) followed by its expression in a
wide range of prokaryotic and eukaryotic cells (Chalfie, Tu et al. 1994), in which a diffuse
green fluorescence was detected distributed throughout the cytoplasm. The ability of GFP to
fluoresce in a wide variety of organisms indicated that its fluorescence was not species-
specific and that the assembly of the chromophore did not require additional cofactors
specific to jellyfish. In addition, GFP was found to be a resilient protein, remaining stable
for many hours in the presence of denaturants (1 % SDS or 6 M guanidium chloride), as well
as over a broad range of pH values ( 2 to 11) and high temperatures (up to 65 °C) (Cubitt,
Heim et al. 1995).
For use in biological systems, however, wild-type GFP is not ideal as its signal is relatively
faint, susceptible to photobleaching and subject to photoisomerisation, resulting in instability
in the emission wavelength. Furthermore, misfolding of GFP is not uncommon when it is
expressed in mammalian cells at their optimal culture temperature of 37 °C. Mammalian
cells also autofluoresce (Aubin 1979) due mainly to mitochondrial NAD(P)H (Andersson,
Baechi et al. 1998) and endogenous flavins (Benson, Meyer et al. 1979). This fluorescence
is excited and emitted in the near UV and has a wide emission peak, appearing yellow-green;
it can become problematic when the wtGFP signal is very faint, or when attempting
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quantitative fluorescent microscopy (Niswender, Blackman et al. 1995). The possibility that
these problems associated with wtGFP could be overcome and the desire for additional
fluorescent proteins with different spectral properties prompted investigations into GFP
variants (Bajno and Grinstein 1999).
1.12.1.1 Variants of GFP
Genetic manipulations of wtGFP cDNA were made, leading to the generation of mutants
with altered excitation and emission spectra and enhanced fluorescence. These were created
by mutagenesis of the Ser-Tyr-Gly sequence that make up the chromophore and of the amino
acids that interact with the chromophore. To increase the expression of such favourable GFP
variants the GFP gene sequence was re-engineered so as to incorporate codons that have
preferred usage in humans. Examples of GFP variants used today are: (1) the F64L/S65L
mutant, enhanced GFP (EGFP), which has 6-fold greater brightness, 4-fold faster maturation,
less photoisomerisation, reduced photobleaching and better folding in mammalian cells than
wtGFP (Cubitt et al, 1995); (2) the Y66H mutant, which generated a blue shifted GFP called
(E)nhanced B(lue)FP; (3) the Y66W mutant, (E)nhanced C(yan)FP, which is much brighter
than EBFP; and (4) the (E)nhanced Y(ellow)FP mutant, with an aromatic amino acid at
position 203, which has the most red-shifted emission spectra of all the GFP variants (Pollok
and Heim 1999). The generation of such variants of GFP allow the separate labelling of
different subcellular compartments; expression of differently-labelled protein constructs in
the same cell, enabling colocalisation experiments to be performed; and the study of protein-
protein interactions by fluorescence resonance energy transfer (FRET).
1.12.1.2 Applications of GFP and its variants
Such developments revealed the potential of GFP and its variants as tools for imaging
intracellular structures and protein localisation within living cells and as a transcriptional
reporter for studies of gene expression. The GFP gene can be fused in-frame with the gene
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encoding the protein or targeting domain of interest. The resulting chimera can then be
expressed and visualised in the cell of choice, and ideally without affecting the targeting and
physiological functions of the host protein or domain (Cubitt, Heim et al. 1995; Bajno and
Grinstein 1999). GFP has been successfully fused to both the N- and the C-termini of a wide
range of cytoplasmic, cytoskeletal and membrane proteins and can be used as an in vivo
marker for subcellular structures such as the endoplasmic reticulum and the Golgi, through
its fusion to targeting domains.
1.12.1.3 Advantages of using GFP and its variants
The use of GFP and its variants has several advantages over other reporter genes or for use in
cellular structure and protein labelling. For instance GFP does not require any additional
factors for it to fluoresce. The major advantage of GFP over other reporter genes is its
ability to reveal the presence of the gene product in living cells by its fluorescence. Most
other commonly used reporter genes encode enzymes, for example chloramphenicol acetyl
transferase, luciferase and (3-galactosidase, which can be quantified only in the presence of
the appropriate substrate and cofactors, which requires cellular lysis or fixation for detection
of the desired activity. The detection of these reporters in situ is complicated by variable
penetration of substrates that may lead to detection artefacts (Niswender, Blackman et al.
1995).
The advantage of using GFP chimeras compared to other protein labelling techniques is that
they can be visualised in living, unperturbed cells. Most other available techniques for
visualising proteins in cells require fixation and often permeabilisation. These procedures
preclude continuous visualisation and can potentially damage the protein and/or redistribute
it to an artifactual location, whereas GFP chimeras can be used to visualise trafficking
between membrane-bound organelles, the translocation of proteins involved in signal
transduction, and many other cellular processes (Bajno and Grinstein 1999). In a typical
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example, Persley et al. (1997) were able to monitor endoplasmic reticulum-to-Golgi
transport in live cells by following the distribution of a GFP fused to a temperature sensitive
mutant protein from vesicular stomatis virus (Presley, Cole et al. 1997).
1.13 Other labelling techniques used in cells
1.13.1 Other fluorescent proteins
Yellow and red-orange proteins have also been cloned from fluorescent but
nonbiolouminescent corals from the Indian and Pacific oceans (Matz, Fradkov et al. 1999).
One example, DsRed, from the anemone Discosoma striata, is a red fluorescent protein that
has -25 % sequence identity with Aequorea GFP, with a peak emission around 583 nm.
Unfortunately, several problems associated with DsRed have emerged, including slow
protein maturation and a strong tendency to form tetramers (Baird, Zacharias et al. 2000).
Another red fluorescent protein from the indo-pacific sea anemone Heteractis crispa,
HcRed, is the most red-shifted GFP-like protein identified to date with excitation and
emission maxima of 592 nm and 645 nm respectively (Gurskaya, Fradkov et al. 2001).
1.13.2 Fluorescent stains
Most stains used as tools for imaging in cells are small organic molecules and are generally
acidophilic or lipophilic probes, but they have poor subcellular specificity and resolution.
For example the acidophilic probes LysoTracker Red and Acridine Orange have been used to
visualise chromaffin granules and other types of secretory vesicle, but they also stain other
acidic compartments such as lysosomes, endosomes and the trans Golgi. Lipophilic probes,
including FM dyes such as FM1-43, are often used to study endocytosis and exocytosis as
they fluoresce following insertion into lipid bilayers and therefore report plasma membrane




An alternative approach to visualising proteins within cells is to use indirect
immunofluorescence, in which a polyclonal or monoclonal antibody specifically directed
against the protein of interest is recognised by a secondary antibody conjugated to a
fluorescent dye such as fluorescein or rhodamine. This technique is good for investigating
endogenous proteins, although the cells have to be fixed and permeabilised, therefore protein
dynamics cannot generally be studied. Furthermore it is often difficult to look at direct
protein-protein interactions by use of FRET, as the fluorescent tags on the secondary
antibodies are often too far apart for FRET to occur between the fluorophores.
1.14 Fluorescence microscopy
1.14.1 Confocal microscopy
With the discovery of GFP and the development of its variants as well as other fluorescent
proteins a system was required for the visualisation of these fluorochromes, which led to the
development of confocal laser scanning microscopy (CLSM).
Confocal microscopy was developed and patented by Marvin Minsky in the 1950s, but it was
not until the 1980s that the potential of confocal microscopy was realised, through advances
in computer technology that permitted control of laser operation alongside the microscope's
optical system, resulting in the emergence of a new microscopic concept: digital imaging.
Confocal microscopes can be used for studying complex biological structures in 3D
producing high-resolution images without the out-of-focus blur often associated with
standard fluorescent microscopes. Because of the ease in which it can detect fluorescent
proteins, combined with optical sectioning in live and fixed tissues, 3D rendering and the
high resolution, confocal microscopy is now a successful and widely used tool.
In confocal microscopy a laser beam is expanded to make full use of the optics of the
objective and is turned into a scanning beam by an x-y deflection mechanism while an
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objective lens focuses it to a small spot within the specimen of interest. Emitted fluorescent
light and reflected light are collected by this same objective and converted into a static beam
by the x-y scanner device. The emitted photons are passed through an appropriate filter
(dependent of the emission spectra of the fluorescent specimen) and focussed, via a dichroic
mirror (beam splitter), onto a photodetector (photomultiplier). This dichroic mirror blocks
the reflected light while allowing the emitted fluorescent light to pass through in the
direction of the photomultiplier. The confocal microscope uses a pinhole placed in front of
the photo-detector to exclude the out-of-focus signal. The pinhole prevents fluorescent light
originating from points in the specimen that are not within the focal plane of the focussed
laser beam from passing through reaching the photodetector. Therefore, only the region of
the specimen in focus is detected. Finally, the photomultiplier converts the analogue light
signal into a digital signal that is displayed on a computer monitor attached to the
microscope as a 2D pixel-based image. A computer-controlled motor moves the microscope
stage up and down selecting the plane of focus (the x-y plane). By moving the stage in the z-
axis in a number of measured steps while performing lateral scanning of the specimen, a
series of optical steps through the specimen are generated. These 2D optical sections,
collected in a series, can be reconstructed into a 3D 'stack' by the computer, with every
section in focus. To ensure that the x, y and z-axes of the reconstructed specimen reflect the
biological sample of interest, the sampling in each plane of the specimen should match the
sampling in the other two planes, like Nyquist sampling rate.
When collecting an image stack selective bleaching by the laser can occur in the x-y plane
and non-selective bleaching in the other planes. While such bleaching cannot be avoided, it
can be minimized by using the lowest possible laser power. Coincidentally, software
packages have been developed that can improve image quality and restore lost data. Median
and Gaussian filters can be used to reduce noise and background artefacts, while
deconvolution software uses mathematical algorithms, removing any remaining haze and
increasing the resolution of the acquired image. The ideal result is a 3D image that is a
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faithful representation of the specimen imaged. Finally, colocalisation software can be used
to generate statistics relating to the number of voxels that overlap in 3D, providing a measure
of the amount of fluorescence from different fluorochromes in the same volume. Also 3D
software can be used to rotate and animate the image, volume-render it or make parts of it
transparent, allowing a more detailed analysis of the structure.
1.15 Microscopic techniques used in the study of exocytosis
1.15.1 Confocal microscopy
Standard confocal microscopy as described above has been used to study neuropeptide
release in PC 12 cells (Burke, Han et al. 1997). Neuropeptide release is not associated with
active zones, is relatively slow and usually requires bouts of action potentials. Granule
dynamics in nerve growth factor (NGF)-treated PC 12 cells was studied using an ANF-EGFP
fusion protein revealing that secretion is associated with depletion of granules distributed
throughout the terminal. Furthermore, recovery after photobleaching and time-lapse particle
tracking revealed that only a subpopulation of cytoplasmic secretory granules, similar in size
to the releasable pool, can move quickly enough to support release (Burke, Han et al. 1997).
Confocal microscopy has also been used to study the behaviour of dense-core secretory
granules before exocytosis in insulin-secreting INS-1 P-cells and in PC12 cells using a
phogrin-EGFP chimera (Pouli, Emmanouilidou et al. 1998). The phogrin-EGFP chimera
was targeted to secretory vesicles in both cell types. In unstimulated INS-1 cells the
movement of the granules was restricted to 2-3 granule diameters from the starting location,
whereas when stimulated by Ca2+ the vesicles underwent longer, saltatory excursions. By
contrast, in PC 12 cells, long saltatory granule movements were apparent, even in the absence
of stimulus. These appeared to be directed from the cell interior outwards, i.e. towards the
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plasma membrane. This apparent, predominantly anterograde movement is therefore
compatible with previous observations (Pouli, Emmanouilidou et al. 1998).
Confocal microscopy has also been used to study the localisation of the EYFP-syntaxin la,
ECFP-muncl8-l and EGFP-muncl3-l when expressed singularly or co-expressed in
different combinations in HEK293 cells (Gladycheva, Flo et al. 2004). These studies
revealed that when expressed on their own EYFP-syntaxin la and ECFP-muncl8-l remain
trapped within the cell. EYFP-syntaxin la was found to be associated with membranous
structure whereas ECFP-muncl8-l was cytosolic, but when they were expressed together
they were found to colocalise on the plasma membrane. These results support the view that
muncl8s act as chaperones to syntaxin proteins enabling them to reach their correct cellular
localisation. EGFP-muncl3-l was found in the cytoplasm and no change on its distribution
occurred when it was co-expressed with either EYFP-syntaxin la or ECFP-muncl 8-1.
Gladycheva et al. also reported that EYFP-syntaxin la was able to shift the localisation of a
SNAP-25 mutant lacking its membrane anchor from the cytoplasm to the plasma membrane,
although in the presence of ECFP-muncl 8-1 this effect was reversed and the SNAP-25
mutant remained in the cytoplasm. When EGFP-muncl3-l was also expressed, however, the
plasma membrane localisation of the SNAP-25 mutant was restored. They concluded from
this that muncl3-l disrupts the syntaxin la-muncl8-l complex allowing syntaxinlato
interact with its cognate SNAREs.
Confocal microscopy in conjunction with a "fluorescent timer" probe, (ANF)-timer, which is
targeted to large dense-core vesicles (LDCVs) in bovine chromaffin cells (BCC), revealed
that LDCVs were segregated into different vesicle pools dependent on their age (Duncan,
Greaves et al. 2003; Wiegand, Duncan et al. 2003). Atrial natriuretic factor (ANF), a cargo
protein that is targeted to the vesicle lumen of endocrine cells was fused to the fluorescent
protein DsRed-E5. DsRed-E5 is a mutant of the red fluorescent coral protein DsRed, and is
characterised by unusually slow maturation during which the initial green emission changes
to red over approximately 16 hours. Thus newly assembled LDCVs appear green, those of
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intermediate age are yellow and older vesicles (>16 h) are red. The use of (ANF)-timer
made it possible to investigate the location of differently aged LDCVs in BCCs the LDCVs
depending on their age revealing that newly synthesised LDCVs are located in the peripheral
areas of BCCs suggesting newly synthesised peptides are preferentially secreted. LDCVs
that were not released within 16 hours of assembly retreated from the cell membrane and
entered the reserve vesicle pool (Duncan, Greaves et al. 2003; Wiegand, Duncan et al. 2003).
1.15.2 Total Internal Reflection Fluorescence Microscopy
A less widely used microscopic technique for the study of exocytosis is Total Internal
Reflection Fluorescence Microscopy (TIRFM), which makes it possible to observe
individual dye-loaded dense-core vesicles prior to exocytosis. TIRFM can be used to
selectively excite dye molecules in an aqueous environment directly adjacent to a glass
interface. In TIRFM a light beam striking an interface between two media, 1 (e.g. glass) and
2 (e.g. aqueous solution), with refractive indices it] and n2, respectively, is totally internally
reflected if nl>n2 and if the angle of incidence # exceeds the critical angle 0, . Owing to the
interference of the incident and reflected light beam a standing wave is generated in the
optically rarer medium and is known as the evanescent wave, which is used to excite the
sample. The evanescent wave decays exponentially with distance and penetrates about 70-
300 nm into the specimen depending on media refractive indices, incidence angle and
illumination wavelength (Oheim, Loerke et al. 1998).
As applied to biological cell cultures, TIRF microscopy allows selective visualisation of
cell/substrate contact regions. By restricting fluorescence excitation to a thin optical layer
adjacent to the interface to which cells adhere, TIRF microscopy eliminates out-of-focus
fluorescence present in conventional epifluorescence excitation. Thus TIRFM can be used to
visualise the position, extent and motion of these contact regions or to determine dynamics.
For some applications TIRFM has distinct advantages over confocal microscopy, which
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places a high radiation burden on cells, as the entire cell is illuminated with fluorescence
excitation light and most of the fluorescence emission is rejected by the confocal pinhole. In
contrast TIRFM only illuminates a thin layer of the cell and all the emitted light is collected
by the objective (Steyer and Aimers 1999).
TIRFM has been successfully used to study vesicle dynamics next to the plasma membrane
preceding exocytosis. The trajectories of single-dense-core vesicles were analysed as they
approached the plasma membrane and revealed that as they got closer to the plasma
membrane, a 100-fold decrease in 3D-mobility was observed. This was interpreted as the
vesicle undergoing docking at the plasma membrane (Oheim, Loerke et al. 1999). In the
absence of stimulation, vesicles changed from a less mobile to a more mobile state and vice
versa, while some vesicles disappeared and were replaced by others, suggesting a dynamic
equilibrium between the docked and free vesicle pools. Upon stimulation, readily releasable
vesicles fused with the plasma membrane in a cloud of released dye molecules and despite
the exocytotic fusion of a large number of vesicles during prolonged stimulation the number
of vesicles at the plasma membrane remained constant due to the recruitment of new vesicles
from the invisible reserve pool (Oheim, Loerke et al. 1999).
TIRFM was also used to image single-vesicle exocytosis in a preparation of 'unroofed'
bovine adrenal chromaffin cells, in which part of the plasma membrane had been removed
with a jet of liquid, leaving a patch of membrane, with attached LDCVs, adhering to a glass
coverslip (Wiegand, Don-Wauchope et al. 2002). These vesicles were induced to fuse by an
increase in [Ca +].
More recently TIRFM was used to monitor individual fusion events between
proteoliposomes containing SNAREs and a supported planar bilayer containing cognate
target SNAREs (Fix, Melia et al. 2004). Approach, docking and fusion of individual
vesicles to the target membrane were quantified revealing that fusion was initiated within
<100 ms of the rise in of Ca2+ and membrane mixing was complete within 300 ms. Removal
of the N-terminal domain of syntaxin la increased the fusion probability > 30-fold compared
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to the full-length protein. This suggested that formation of the SNARE core complex is
sufficient to fuse opposing membrane bilayers at a speed commensurate with most fusion
processes in cells (Fix, Melia et al. 2004).
Although the above techniques are very powerful and have imparted valuable information
regarding exocytosis, when used to study the interaction between specific proteins, they can
only report on the location of the proteins of interest. They can show whether two proteins
share the same space within a cell, but they cannot show whether these proteins are
interacting. An advanced technique that can give information about the interactions between
proteins is FRET microscopy.
1.15.3 Fluorescence Resonance Energy Transfer Microscopy and
Fluorescence Lifetime Imaging Microscopy
Fluorescence resonance energy transfer (FRET) is a physical effect that can be measured and
thus used for quantifying the distance between two different fluorophores. FRET describes
the non-radiative energy transfer from a 'donor' fluorophore (e.g. ECFP) to an 'acceptor'
(EYFP), when there is overlap between the emission spectrum of the donor and the
excitation spectrum of the acceptor. When the two excited-state dipoles, in a favourable
mutual orientation, come within a critical distance (usually between 2-8 nm), the fluorescent
lifetime of the donor fluorophore is shortened (Pollok and Heim 1999; Elangovan, Day et al.
2002; Duncan, Bergmann et al. 2004). At the critical distance where 50 % of the donor
energy is transferred to an acceptor - the Forster radius - the donor emission and fluorescent
lifetime are each reduced by 50 %, and sensitised emission (acceptor emission specifically
under donor excitation) is increased. FRET is inversely proportional to the 6th-power of
inter-dipole distance, and can therefore be used as a quantitative spectroscopic measure of
protein-protein proximity. The possibility of FRET measurement and quantification between
spectrally distinct fluorescent proteins means that this approach has become used widely in
cell biology to visualise protein-protein interactions in intact cells. FRET is predictable,
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quantitative and can be imaged in single cells with high temporal and spatial resolution; it is
therefore ideal for monitoring the dynamic association of macromolecular partners. It needs,
however, a general method for labelling one macromolecule participant with a donor
fluorophore and the other with an acceptor fluorophore, such as expressing fusions of the
two prospective partners with differently coloured GFP variants (Cubitt, Heim et al. 1995).
Two GFP pairs have so far been used in FRET-based biological systems; BFP (donor) and
EGFP (acceptor) have been widely used, however BFP is only weakly fluorescent, which
limits its usefulness. An alternative FRET pair is ECFP (donor) and EYFP (acceptor). ECFP
is significantly brighter than BFP, permitting accurate ratiometric measurements of both
donor and acceptor fluorophores by a variety of fluorescent detectors (Pollok and Heim
1999).
To date FRET has been used to study the equilibrium between the open and the closed
conformation of syntaxin la (Margittai, Widengren et al. 2003) and the interaction between
syntaxinla and muncl8-l in HEK293 cells (Liu, Ernst et al. 2004), but in these studies
FRET images were not collected, so there was no spatial information.
Margittai et al (2003) showed that there is a dynamic equilibrium between the open and the
closed conformation of syntaxin la in isolation with a relaxation time of 0.8 ms, suggesting a
rationale for regulatory proteins that stabilise it in one conformation or the other during
exocytosis.
Studies in HEK293 cells revealed that syntaxin la and muncl8-l interacted with each other
in the Golgi complex at early expression time points, with strong plasma membrane
colocalisation apparent at later times. Also the trafficking of syntaxin la was found to be
dependent on the presence ofmuncl8-l. Furthermore the use of phosphomimetic mutants of
muncl8-l suggested that Ser313, a protein kinase C phosphorylation site, and Thr574, a
Cdk5 phosphorylation site, regulate the syntaxin la - muncl8-l interaction (Liu, Ernst et al.
2004).
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Although FRET is a powerful tool for investigating the interaction between proteins, it
requires complicated arithmetical manipulations of the donor, acceptor and sensitised
emission data to correct for spectral bleed-through and cross-talk. In addition FRET
measurements using steady-state fluorescence emission intensity data are affected by
photobleaching and uncorrected data can be influenced by relative donor/acceptor
concentration changes. An alternative to this approach is fluorescence lifetime imaging
microscopy (FLIM). The fluorescence lifetime of a fluorophore is the mean time that it
spends in the excited state. This is usually a few nanoseconds, but is strongly dependent on
microenvironmental factors; any energy transfer between an excited molecule and
environment changes the fluorescence lifetime in a predictable way, independent of
chromophore concentration. Importantly FRET shortens the fluorescence lifetime of a donor
fluorophore, therefore FLIM is a direct approach quantifying effects that involve energy
transfer. FLIM is not affected by photo-bleaching, relative donor/acceptor concentration
changes or excitation intensity and since only the donor lifetime is measured, spectral bleed-
through is not an issue. The combination of FRET and FLIM provides high spatial
(micrometer) and temporal (nanosecond) resolution for studying the association of
macromolecules in single cells (Elangovan, Day et al. 2002; Duncan, Bergmann et al. 2004).
Duncan et al used time-correlated single photon counting (TCSPC)-FLIM to measure ECFP
fluorescent lifetime and energy transfer. (TCSPC)-FLIM requires two-photon excitation
(TPE) microscopy, which uses near-infra-red excitation energy, exciting the fluorophore
when two photons, each contributing half the energy required to excite fluorescence, are
absorbed by the molecule in quick succession (10 18 seconds), and can be less phototoxic to
cells than conventional laser energy (Cahalan, Parker et al. 2002; Duncan, Greaves et al.
2003). PC 12 or HEK293 cells, transfected with ECFP or CY24, were imaged as described
using 800 nm TPE, enabling efficient excitation of ECFP and no detectable excitation or
emission from EYFP in the absence of FRET. This revealed that ECFP or the CY24 fusion
was distributed throughout the cell cytoplasm. Duncan et al quantified donor fluorescence
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lifetime and energy transfer in the fixed-distance construct, by applying TCSPC FLIM to
cells expressing the ECFP alone or CY24 constructs, acquiring data from a 512 x 512 pixel
image (146 nm x 146 nm pixel dimensions) using 128 x 128 binned TCSPC pixels (i.e. 4 x
TCSPC binning) and 256 time bin per pixel. TCSPC data acquisition using different BP or
LP filters to separate spectral components of the ECFP emission revealed that of ECFP
(alone) fluorescent decay data were best fit using the Levenberg - Marquardt algorithm to a
bi-exponential decay (average reduced weighted chi-squared residual (%2) value <1.1), as
previously described (Pepperkok, Squire et al. 1999; Tramier, Gautier et al. 2002); Figure
1.9). These data yielded a long lifetime component of 2.19 ± 0.24 ns (x2). A short lifetime
component (xD was also present, with lifetime of 0.42 ±0.12 ns. These combined data
yielded a mean time constant value, X, of 1.57 ± 0.06 ns (mean ± SD, n = 12). TCSPC
analysis of intramolecular FRET between tandem ECFP and EYFP moieties revealed a
specific, significant decrease in the donor lifetime participating in FRET. Duncan et al
provided further evidence that the donor-specific decreases in the mean fluorescent lifetime
was due to energy transfer, they specifically photo-bleached the acceptor, EYFP fluorophore
(Figure 1.10). Photo-bleaching required 500 iterations from a 514 nm laser line, at 100%
laser power, in a defined intracellular region of interest. FLIM imaging after acceptor photo-
bleaching revealed that the mean fluorescence lifetime of the donor, ECFP, fluorophore had
increased within the photo-bleached region. These data were plotted as lifetime vs. pixel
frequency distributions, emphasising the appearance of a longer mean donor lifetime (-1500
ps, comparable with that measured for ECFP alone in a non-FRET system) in the image after
photobleaching (Duncan 2003).
Since TCSPC-FLIM has been used extensively in the present work, its theory and practice
are described in more detail in the next Chapter.
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1.16 Project Aims
When starting the project years of biochemical studies had shown that syntaxin 1 a and
muncl8-l interacted with each other with nanomolar affinity. However most of these
studies were done using a fragment of syntaxin la and their interaction had not been
investigated in cells, which led to several questions: Do syntaxin la and muncl8-l interact in
cells? Where in cells does this interaction occur? What regulates this interaction in cells?
To address some of these questions, the interaction between endogenous and fluorescently
labelled proteins was investigated using confocal microscopy in conjuction with
colocalisation analysis and Fluorescence Lifetime Imaging Microscopy in absence and





2.1 Chemicals and Biochemicals
Amersham Biosciences Ltd. Bucks. U.K
[35S]-methionine, (cat. no. AG1094) GSH- Sepharose. HiTrap affinity columns
BP Biosciences. CA. U.S.A
BD TALON Metal Affinity Resin, CHROMA SPIN-30 DEPC H20 columns
OIAGEN Ltd. Dorking, Surrey. U.K
Ni-superflow columns
Roche Diagnostics Ltd. East Sussex. U.K
Complete protease inhibitor tablets and Complete protease inhibitor tablets EDTA-free
Sigma-Aldrich Chemical Company, Dorset. U.K
All general chemicals used. Kodak Biomax film for autoradiography, leupeptin and
pepstatin protease inhibitors, Protease inhibitor cocktail (purification of poly(histidine)-
tagged proteins, cat. no. P-8849), Protease inhibitor cocktail (cat. no. P-8340),
Phosphoramidon.
2.1.1 Molecular Biology Reagents
Eppendorf, Cambridge. U.K
The Perfectprep® Gel Cleanup Kit
Gibco BRL, Paisley, U.K
All reagents and media for mammalian cell culture
Invitrogen, Paisley, U.K
All vectors used. Top 10 competent cells
New England Biolabs, Herts, U.K
All restriction endonucleases used: Age I, BamHI, BsrGI, EcoRI, Hind III, Nhel, Ndel,
Xbal, Xhol
Novagen, Nottingham, U.K
Bugbuster® Protein Extraction Reagent
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Pharmacia Biotech. Cambridge. UK.
Deoxyribonucleotide triphosphates
Promega Corporation UK. Southhampton, U.K
Pfu polymerase. Taq polymerase. T4 DNA Ligase. RNasin. In vitro Coupled Transcription
Translation Kit
QIAGEN Ltd. Dorking. Surrey, U.K
QIAfilter™ Plasmid Maxi Kit, Ni-NTA Superflow column
Roche, Lewes. East Sussex. U.K
Expand High fidelity PCR System
Strategene Europe. Amersterdam, The Netherlands
Quickchange® II XL Site-directed Mutagenisis Kit
2.1.2 Escherichia coli Strains Used
ToplO, BL21 REL, BL21 DE3, M15[pREP4]
2.1.3 Culture Media
Media were prepared according to standard recipes (Sambrook, Fritsch et al. 1989). The
media used in this study were Luria-Bertani (LB) (10 g NaCl, 10 g Tryptone, 5 g Yeast
extract, pH7.0 made up to 1 litre with dH20), Terrific Broth (TB) (12 g Tryptone, 24 g Yeast
extract, 4 ml Glycerol made up to 900 ml with dH20). Following autoclaving the media was
left to cool to 60 °C then 100 ml of a sterile solution of 0.17 M KH2P04, 0.72 M K2HP04
(2.31 g KH2P04, 12.54 g K2HP04 in 90 ml of dH20) was added) and Supermedia (5 g NaCl,
15 g Tryptone, 25 g Yeast extract, pH7.0 made up to 1 litre with dH20)
2.1.4 Antibodies
Mouse monoclonal antibodies were directed against V5 epitope (Invitrogen, cat no: R960-
25, 1 in 1000 dilution), muncl8 (BD Biosciences, cat no: 610336, 1 in 500 dilution) and
49
syntaxin la (HPC-1, cat no: S0664, 1 in 500 dilution). Rabbit anti-mouse IgGs were
horseradish peroxidase-coupled (SAPU, product no: S081-201, 1 in 4000 dilution) and
alexa546-coupled (Molecular Probes, Invitrogen, cat no: A-21123, 1 in 1000 dilution).
2.2 Standard DNA manipulations
Several of the protocols used were as described (Sambrook, Fritsch et al. 1989). These
included phenol extraction of nucleic acids, (ppE3-E4), nucleic acid precipitation, (ppElO-
E15), agarose gel electrophoresis, (pp6.9-6.12) and restriction endonuclease digestion
(pp5.28-5.32). DNA was extracted from agarose gels using a commercial kit (Eppendorf)
according to the manufacturer's protocol.
2.3 Polymerase chain reaction (PCR)
PCR was performed on an Applied Biosystems GeneAmp PCR system 9700 PCR machine
and for all the work reported in this thesis the PCR reaction mixes, dependent on the DNA
polymerase used, were as follows:
2.3.1 Expand High Fidelity PCR System™ reaction mix
component pi
10 X PCR Buffer 5
dNTP mixture (10 mM each) 1
forward primer (10 pM) 1
reverse primer (10 pM) 1
template DNA (10 ng/p 1) 1
DEPC treated H20 40.25
The reaction mix was placed in the PCR machine and incubated at 95 °C for 1 min to
separate the two strands of the DNA double helix, 0.75 pi Taq/Rho polymerase (Roche) was
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then added, followed by a suitable PCR cycle dependent on the size of the PCR template,
which is described in the relevant chapters.
2.3.2 Pfu polymerase reaction mix
Component pi
10 X PCR Buffer 5
dNTP mixture (10 mM) 1
EGFP/muncl8-l forward primer (10 pM) 1
Muncl8-1 reverse primer (10 pM) 1
Munc 18 - 1-EGFP-C2/Muncl8-1r39C-EGFP-C2 (10 ng/pl) 1
DEPC treated H2Q 40
The reaction mix was incubated at 95 °C for 1 minute to separate the DNA template strands
then 1 pi Pfu was added followed by a suitable PCR cycle dependent on the DNA template
used described in the relevant chapter.
2.3.3 Taq polymerase reaction mix
component pI master mix (xl3) pi
10 x Buffer 5 65
MgCl2 3 39
dNTP mixture (10 mM each) 1 13
ECFP Forward Primer (10 pM) 2.5 32.5
Syn la-(cyt) Reverse Primer (10 pM) 2.5 32.5
DEPC-treated H20 35.5 461
Taq polymerase 0.5 6.5
The master mix was assembled on ice, mixed thoroughly before being aliquoted into PCR
tubes. 10 colonies were picked and each one was dipped into a different PCR tube before
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being spotted onto a LB-agar plate containing ampicillin (100 pg/ml) and a suitable PCR
cycle was used, described in the relevant chapter.
2.3.4 Deoxynucleotide primers
Oligodeoxynucleotide primers used for sequencing were generally 16-24 nucleotides long.
The forward primer was a direct copy of the DNA sequence at the overlapping the start
codon of the DNA template, sometimes containing a restriction endonuclease site 5' to the
start codon. The reverse primer was a direct copy of the DNA template complementary
strand written 5'-3'. All PCR primers were ordered from MWG Biotech (0.05 pmol,
MALDI purification). Oligodeoxynucleotide primers used for sequencing reactions were
approximately 20 nucleotides long, preferentially containing a GC and AT content that gave
a melting temperature of less than 60 °C, as recommended by MWG Biotech. Sequencing
primers were designed so that they overlapped the vectoninsert junction, with subsequent
primers overlapping the end of the previous sequencing round by -200 bp and were ordered
from MWG Biotech.
2.3.5 Site directed mutagenesis PCR
For this the oligonucleotide primers were complementary to each other, containing the
desired mutation with 15 bp on either side and were ordered from MWG Biotech. PCR was
performed using the Quickchange II XL Site-Directed Mutagenesis kit (Strategene)
following the manufacturer's instructions with the reaction mix components as follows:
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Component pi







The reaction mix was incubated at 95 °C for 1 min, followed by the addition of 1 pi Turbo
Pfu (Stratagene) followed by the appropriate PCR cycle dependent on the DNA template
used and is described in the relevant chapter.
2.4 Cloning in TOPO plasmid vectors
Two types of TOPO vectors were used during this study. The pCR T7/CT TOPO vector was
used for non-directional cloning in which the vector has T-overhangs and the insert has A-
overhangs, added during the PCR reaction by Expand™ polymerase (Roche). The other
vector used was pET directional TOPO, which allows directional cloning by having one
overhanging end and one blunt end. The vectors were linearised and have Topoisomerase I
from Vaccinia virus attached to the 3' ends (Shuman 1991). The bond between the enzyme
and the DNA can be broken by the 5' hydroxyl of the original cleaved strand reversing the
reaction and releasing the enzyme (Shuman 1994). TOPO cloning exploits this process to
allow the insertion of DNA fragments into vectors.
2.5 Cloning in plasmid vectors
Both non-directional and directional cloning were used, depending on the vector. In non-
directional cloning the inserts generated by PCR contain A-overhangs and the vectors are
linearised therefore no preparation for both the vector and the insert DNA was required.
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With directional cloning both the vector and the insert were digested by two different
restriction endonucleases, usually resulting in the insert annealing into the vector in the
correct orientation in a T4 Ligase-dependent reaction. In both cases the resulting
recombinant plasmids were then used to transform bacteria. Plasmids containing the insert
in the correct orientation were distinguished from those where the insert has inserted in the
wrong orientation or from recircularised vector with no insert by restriction endonuclease
analysis of small scale plasmid preparations (see below)
2.5.1 Preparation of vector DNA for cloning
With non-directional cloning the PCR product was ligated directly into the vector without
any preparation since the vectors are supplied linearised.
In directional cloning, the vector was first cleaved by appropriate restriction endonucleases,
usually two. Normally 1-5 pg of the vector and 10 units of each restriction enzyme was used
in a 20 pi reaction mix for two hours at 37 °C. Depending on the restriction endonucleases
used, both enzymes could be added to the same mix if they worked well in a common buffer.
If not the enzymes were used sequentially, starting with the enzyme that required the buffer
of lower ionic strength. The reaction products were analysed and then purified from an
agarose gel using the Eppendorf kit.
2.5.2 Preparation of the DNA fragments for ligation
No preparation of the DNA fragments was required for non-directional cloning since A-
overhangs are added during the PCR reaction therefore the insert can be ligated directly into
a linearised vector. For directional cloning the DNA fragment was prepared in the same way
as the vector.
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2.6 Ligation of insert DNA and plasmid vector
The ligation reaction was optimised using various ratios for each individual ligation and was
based on the following equation:
ng vectorxinsertsizeikb) , . insert
ng insert- —r Xmolar ratio
vector sizeykb) vector
Usually a molar mass ratio of 1:1 or 1:3 of vector:insert works best. For this the DNA
concentration of the linearised vector and the insert were estimated by agarose gel
electrophoresis and comparison with DNA weight markers of known concentration. The
ligation reaction was then set up in a 10 pi reaction mix using the appropriate vectoninsert
ratios and was performed according to the T4 DNA Ligase manufacturers protocol
(Promega) The mix was incubated overnight at 16 °C and terminated by incubation for 10
min at 70 °C.
2.7 Production of competent Escherichia coli
E.coli cells were made competent for transformation using rubidium chloride following the
protocol in the Promega Protocols and Applications Guide (p.45).
2.8 Transformation of Escherichia coli
The TOPO vectors came with competent E.coli TOPIO cells (Invitrogen) and were
transformed following the manufacturer's protocol.
Competent cells produced in-house were used with the other vectors used. The 10 pi
ligation reaction mix was added to a 100 pi aliquot of the cells. This was then incubated on
ice for 20 min, followed by a heat shock at 42 °C for 30 seconds. The cells were allowed to
recover on ice for 2 min before 500 pi of Luria-Bertani (LB) medium (Sambrook, Fritsch et
al. 1989) was added followed by incubation at 37 °C for 30-60 min, depending on the
antibiotic selection. 200 pi of the transformed cells were plated on a pre-warmed LB/agar
plate containing the appropriate antibiotic.
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2.9 Analysis of transformants
2.9.1 Small-scale plasmid preparation: 'miniprep'
The routinely used method for identifying the insert in recombinant vectors was to purify the
plasmid DNA from individual clones and check for its presence using restriction digestion
and agarose gel electrophoresis. The miniprep protocol used in this study, which is
described elsewhere, was the Alkaline Lysis method (Sambrook, Fritsch et al. 1989)
(pp 1.25-1.28).
2.9.2 Analysis of transformants by restriction digests
Restriction digests were performed to check that recombinant vectors had been made and to
ensure that the DNA fragment had inserted in the correct orientation. This was especially
important when non-directional cloning was used. In most cases two enzymes, one known
to cut the vector and the other known to cut the insert at a unique site, were used. The
enzymes were also chosen so that they would produce fragments of appropriate size that
would indicate whether or not the DNA fragment had inserted into the vector in the correct
orientation. In each reaction 10 pi of the 'miniprep' DNA was used. The results were
analysed by running 10 % (v/v) of the digested plasmid on an agarose gel.
2.9.3 Large scale plasmid preparations
The large-scale plasmid preparations followed the Alkaline Lysis protocol (Sambrook,
Fritsch et al. 1989) using the QIAGEN QIAfilter™ Plasmid Maxi Kit according to the
manufacturer's instructions (Qiagen).
2.10 Quantification of plasmid DNA
Plasmid DNA concentration was measured by spectrophotometry, at 260 nm and 280 nm.
Absorbance at 260 nm allowed the calculation of the concentration of nucleic acid in the
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sample, an absorbance of 1 corresponding to approximately 50 pg/ml for double stranded
DNA. The ratio between absorbances at 260 nm and 280 nm (A26o/A28o) provides an
estimate of the purity of the nucleic acid, the value for pure DNA being 1.8. Contamination
with protein results in a smaller value of A260/A280 (Sambrook, Fritsch et al. 1989).
2.11 DNA sequencing
When PCR is used to amplify a fragment of DNA for cloning the polymerase can make
errors, introducing mutations in the sequence. The error frequency depends on the
polymerase used: the error frequency for Pfu, for example, is 1 x 10"6 /bp/duplication (Cline,
Braman et al. 1996). In this study all PCR products were sequenced by MWG Biotech and
the DNA was prepared following their instructions. 1 pg of DNA was precipitated using 0.5
vol of 7.5 M ammonium acetate and 2 x vol of 100 % ethanol in the freezer for 20 min. The
DNA was pelleted by centrifugation at 13000 rpm for 15 min, followed by washing with 70
% (v/v) ethanol and centrifugation. The pellet was then left to dry in air before being sent
off.
2.12 Electrophoretic separation and detection of proteins
SDS polyacrylamide gels (SDS-PAGE) were used for the separation of proteins, using the
protocol of Laemmli, (1970). The Hoeffer Tall Mighty Small apparatus was used with the
following solutions for a 10 % acrylamide gel. The separating gel (appendix 1.1.1) was
poured between glass plates to the appropriate level and then was overlaid with water-
saturated butan-2-ol and left to polymerise. Once polymerised the butan-2-ol was removed
and the gel was rinsed with water before the stacking gel (appendix 1.1.2) was poured,
followed by insertion of a comb allowing wells to form before the gel polymerised. The
samples were denatured by heating to 100 °C for 5 min in 1 x SDS sample buffer (appendix
1.1.3).
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Once the stacking gel had polymerised the tank was filled with electrophoresis buffer
(appendix 1.1.4). The comb was then carefully removed and the samples loaded. A
potential of 50 mV was then applied until the dye front entered the separating gel, and then
increased to 200 mV until the dye front reached the bottom of the gel.
2.12.1 Coomassie blue R staining
Following electrophoretic separation the protein bands were visualised by Coomassie blue
staining. First the gels were fixed by immersing them in fixing solution (appendix 1.2.1) for
15 min. Next the gels were covered in Coomassie blue R250 stain (appendix 1.2.2) for 20
min. Following this the gel was destained (appendix 1.2.3), and the destaining solution
changed every 15 min until the protein bands were clear. The gel was then dried onto filter
paper using a heated bed vacuum gel drier at 65 °C for 1 hour (Biorad)
2.12.2 Silver staining
When there was not enough protein on a polyacrylamide gel to be visualised by Coomassie
staining, silver staining was used as it is more sensitive (Wray, Boulikas et al. 1981). The
polyacrylamide gel was run and fixed as before. The gel was then immersed in 50 % (v/v)
methanol for 30 min followed by rinsing in water for 5 min. This procedure was repeated
three times. The staining solution C was then prepared by adding solution A (appendix
1.3.1) drop wise, with vigorous stirring, to solution B (appendix 1.3.2). The gel was stained
in solution C for 15 min followed by washing in H20 for 5 min. The stained gel is then
developed using solution D (appendix 1.3.4) until the protein bands have appeared.
Development was stopped by rinsing the gel in 50 % (v/v) methanol, 10 % (v/v) acetic acid
followed by rinsing in H20. The gel was then dried as before.
58
2.13 Transfer of proteins from gels to solid supports: immunological
detection of immobilised proteins (Western blotting)
The transfer of proteins from a polyacrylamide gel to a membrane was achieved by
electrophoretic elution (Towbin, Staehelin et al. 1979). The method used in this study was
wet transfer, in which the gel sandwich (2 pieces of blotting paper, gel, membrane, 2 pieces
of blotting paper) is fully immersed in transfer buffer (appendix 1.4.1) in a tank between
platinum electrodes with the membrane closest to the anode. This was done using a LKB
Transfer apparatus and a current of 0.8 mA for 2 hours. The membrane used was Hybond-P
(Amersham), which had been pre-soaked in methanol.
2.13.1 Blocking
Following transfer of the proteins, the membrane was blocked to prevent any non-specific
binding of the antibody. The membrane was fully immersed in 5 % (w/v) Marvel in TBS
containing 0.5 % Tween-20 (v/v) (appendix 1.4.3) for 1 hour at room temperature.
2.13.2 Antibody Incubations
After the blocking solution was removed the membrane was washed 3 x in TBST (appendix
1.4.3) followed by incubation in the primary antibody, diluted appropriately depending on
the antibody (appendix 1.4.4), for at least 3 hours at room temperature or usually overnight
at 4 °C. The primary antibody was then removed and the membrane was washed three times
over 5 min in TBST (appendix 1.4.3) as before, followed by further washing for 1 hour
changing the wash every 10 min. After washing the membrane was then incubated with the
secondary antibody, horseradish peroxidase conjugated anti-mouse IgG (SEPA), diluted
1:4000 in blocking buffer, for 1 hour. The membrane was then washed as with the primary
antibody.
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2.13.3 Detection of immune complexes on immunoblots
The detection of the horseradish conjugate used enhanced chemiluminescent reagent (ECL),
which involved incubating the membrane for 1 min using 2 solutions in a 1:1 ratio, ECL
solution 1 (appendix 1.4.5) and ECL solution 2 (appendix 1.4.6). Following this the protein
bands were visualised by exposing the membrane to Konica x-ray film for an appropriate
length of time, depending on how much protein is on the membrane, typically 1-5 min. The
film was then developed (Konica SRX-101A developer).
2.14 Production of fusion proteins in Escherichia coli
2.14.1 Induction of expression from a lac promoter
The expression plasmid, containing a gene under the control of the lac promoter, was first
transformed into E.coli strain BL21 RIL (see 2.8). A bacterial culture, harbouring the
expression plasmid, was grown in selective medium at 37 °C to an optical density 0.6-0.8
(measurement at 600 nm). Expression was then induced using 0.5-1 mM IPTG. Cells were
grown at an appropriate temperature and time dependent on the protein being expressed, as
discussed in subsequent chapters.
2.14.2 Lysis and fractionation of a bacterial culture
Following induction the bacteria were harvested by centrifugation at 5000 x g for 10 min.
The bacteria were then resuspended in 1/20 of the original culture volume in Bugbuster®
containing 1 pi Benzonase® Nuclease per 1 ml Bugbuster reagent, complete protease
inhibitor tablets (from lOx stock), 1 mM PMSF, 10 pg/ml pepstatin and 10 pg/ml leupeptin,
following the manufacturer's instructions. Bugbuster Protein Extraction Reagent is
formulated for the gentle disruption of the cell wall of E.coli, resulting in the liberation of
soluble proteins.
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The lysate was centrifuged at 50000 rpm for 15 min to separate the soluble and insoluble
fractions.
2.14.3 The purification of oligohistidine-tagged proteins
During this study three methods were used for purifying oligohistidine-tagged proteins, the
HiTrap affinity column (Amersham) and BD TALON™ Metal Affinity Resin (BD
Biosciences) and the Ni-NTA Superflow columns (Qiagen). With both the HiTrap columns
and the BD Talon the soluble fraction from bacterial lysis using Bugbuster was used without
further treatment and was fractionated according to the manufacturer's instructions, but with
the Ni-NTA Superflow columns the bacteria were lysed and the soluble fraction was treated
following the manufacturer's instructions.
2.14.3.1 Purification of oligohistidine-tagged proteins using HiTrap columns
With the HiTrap (Amersham) columns the soluble protein sample, obtained by
ultracentrifugation, was passed through a 0.2 micron syringe filter, loaded and recirculated
through the column using a peristaltic pump. The column was then washed with 5 column
volumes of wash buffer (appendix 1.5.1.1). The oligohistidine-tagged protein was eluted
using a step gradient of imidazole in elution buffer (appendix 1.5.1.2). The individual steps
used were 2 mis of each of the following, 50 mM, 100 mM, 350 mM and 500 mM
imidazole, collected as 1 ml fractions. The purification was analysed by SDS PAGE
followed by Coomassie staining.
2.14.3.2 Purification of oligohistidine-tagged proteins using BD Talon
With the BD TALON™ (BD Biosciences) resin a batch elution method was used. The
soluble protein fraction (10 ml) obtained by ultracentrifugation was passed through a 0.2
micron syringe filter then incubated with 500 |ll slurry of resin in a 50 ml Falcon tube with
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rolling at 4 °C for 2 hours. Following incubation the resin was harvested by centrifugation at
700 x g and then washed twice with 10 x bed volumes in wash buffer (appendix 1.5.2.1).
The resin was then resuspended as 1:1 slurry with wash buffer and transferred to a 1 ml
gravity-flow column. The resin was washed with a further 5 bed volumes of wash buffer.
The oligohistidine-tagged protein was then eluted using a step imidazole gradient of 50 mM,
150 mM and 500 mM in elution buffer (appendix 1.5.2.2), collected as 500 pi fractions. The
results of the purification were assessed using SDS-PAGE and Coomassie blue staining.
2.14.3.3 Purification of oligohistidine-tagged proteins using Ni-NTA Superflow
columns
When using the Ni-NTA Superflow columns (Qiagen) the bacterial pellet was resuspended
in 1/50 of the original culture volume in lysis buffer (Appendix 1.5.3.1) containing protease
inhibitors (Sigma), 200 pi for 500 ml starting culture and Benzonase (1/100 dilution).
Lysozyme was then added to a final concentration of 1 mg/ml and the slurry kept on ice for
30 mins. The bacterial lysate was then sonicated, 8x10 sees at 6 microns, with cooling at 0
°C for 10 sees between each burst. The lysate was then separated into soluble and insoluble
fractions with centrifugation at 10000 x g for 30 mins. During this time the NI-NTA matrix
was removed from the column and washed 3 x with 10 mis of lysis buffer in a 15ml falcon
tube. The bacterial supernatant was then incubated with the washed beads for 2 h at 4 °C
with rolling. Following incubation, the beads were packed into the supplied column and the
supernatant was left to flow by gravity through the column. The beads were washed with 20
mis of wash buffer (Appendix 1.5.3.2) before being eluted with 3 mis of elution buffer
(Appendix 1.5.3.3), which was collected as 500 pi fractions. Samples were then prepared
for SDS PAGE analysis followed by Coomassie staining.
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2.14.4 Purification of GST-tagged proteins
For the purification of GST fusion proteins, Glutathione Sepharose 4B (GSH) (Amersham)
was used. The GST fusion proteins used in this study were used in pull-down experiments
so were not removed from the Glutathione Sepharose 4B. The soluble protein fraction
(10ml) was incubated with 500 pi of the resin in a 50 ml Falcon tube with rolling at 4 °C for
2 hrs. The resin was then harvested by centrifugation at 500 x g for 5 min, washed five times
with 10 x bed volumes. The first wash was with PBS pH7.5, followed by three washes with
wash buffer (appendix 1.6.1) and a final wash with PBS, these washes were performed to
remove non-specific binding. The resin was resuspended in 1:1 slurry with PBS. The results
of the purification was analysed using SDS-PAGE and Coomassie blue staining.
2.15 Estimation of protein concentration
For several applications it was important to measure the concentration of purified protein.
During this study two methods were used.
2.15.1 Bradford method
The Bradford method is a fast and fairly sensitive way to measure protein concentration.
The method used here was adapted from Methods in Molecular Biology, Vol.32, Basic
Protein and Peptide Protocols. First a standard curve was generated using known
concentrations of a BSA standard (120 mg/ml), the concentration of which was calculated
from its absorbance at 280 nm (A2so1% = 6.60). Samples were made using BSA
concentrations ranging from 0 - 80 pg per sample made up to a final volume of 100 pi. To
this 1 ml of Bradford's Reagent (appendix 1.7.1) was added and vortexed. The absorbance
at 595 nm of the samples relative to a blank was measured up to 60 min after the reagent was
added. These measurements were used to plot a standard curve of protein concentration vs
absorbance at 595 nm. The unknown protein sample concentration was measured in the
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same way using different volumes of the sample, each in triplicate. This method proved
unsuitable for determining the concentrations of protein coupled to Sepharose.
2.15.2 Lowry method
The Lowry method was used to measure the protein concentration of a GST fusion proteins
still attached to Glutathione Sepharose as it elutes the fusion protein from the beads, which
are then removed. The method used was adapted from Lowry et al, (Peterson 1977). BSA
standards were made ranging in concentration from 0 - 100 pg per sample. To each of these
50 pi of 10 % (w/v) sodium deoxycholate was added followed by vortexing. 1 ml of TCA
was added, to precipitate the protein, followed by vortexing. The samples were centrifuged
at maximum speed for 2 min in a microfuge and the supernatant removed. 1 ml of solution C
(appendix 1.8.3) was added, followed by vortexing. 100 pi of solution D (appendix 1.8.4)
was added and each sample must be vortexed immediately. The samples were then
incubated at room temperature for 1 hour before the absorbance at 750 nm was measured.
The BSA standards were used to plot a standard curve, which was used to determine the
protein concentration of the fusion protein samples, also assayed in triplicate.
2.16 Solubilisation and refolding of insoluble fusion proteins
2.16.1 Solubilising and refolding of insoluble fusion proteins using non
detergent sulfobutane
It is often difficult to obtain soluble and active proteins from expression in prokaryotes, as
they often misfold and form aggregates, known as inclusion bodies. These can easily be
purified because of known size and density, however solubilisation of the expressed protein
can usually only be obtained using strongly denaturing conditions and it is difficult to
achieve efficient folding in vitro. In most cases the denaturant is removed by dialysis but
this exposes the protein to a decreasing denaturant concentration over a few hours leading to
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the protein being exposed to an intermediate denaturant concentration where they are not yet
folded and are prone to aggregate. In an attempt to avoid this, the solubilised protein in
denaturant was diluted 10-fold in a mild solubilising agent, non detergent sulfobutane
(NDSB), which aids refolding.
First the inclusion bodies were washed twice with 2 ml PBS / 0.1% Triton X-100 followed
by centrifugation at 30000 rpm for 30 min. The pellet was then solubilised by incubating for
1 hour at 4 °C in 2 ml solubilising solution (appendix 1.9.1). Insoluble material was then
removed by centrifugation at 100000 x g for 10 min. The protein concentration was
determined using Bradford's method and adjusted to 1 mg/ml with solubilising solution.
The solubilised protein was then diluted as quickly as possible 1 in 10 into cold folding
buffer (appendix 1.9.2) with vigorous stirring during and for 2 min after addition. This was
then left at 4 °C for 1 hour. The remaining guanidine and NDSB were the removed through
dialysis into a phosphate buffer (appendix 1.9.3). The solubilised protein was then purified
using the BD TALON resin. The solubilisation and purification was analysed with SDS-
PAGE and Coomassie blue staining and circular dichroism spectroscopy was used to
determine whether the protein had refolded properly.
2.16.2 Solubilising and refolding of insoluble GST-fusion proteins using Q-
Sepharose
It has been documented, (Hoess, Arthur et al. 1988), that GST-fusion proteins can be
recovered from inclusion bodies in a soluble and biologically active by using ion exchange
resins such as Q-Sepharose. The inclusion bodies were harvested and the insoluble protein
was resuspended in 3 ml of Buffer A (appendix 1.10.1). 1.5 ml of the resuspended pellet was
incubated in 1.5 ml of Q-Sepharose (pre-washed in Buffer A) at 4 °C with rolling for 2
hours. The beads were then harvested by centrifugation at 2000 x g for 5 minutes and the
supernatant removed and kept for analysis. The beads were then washed with 3 ml of Buffer
A and harvested as before. The wash was removed and added to the first supernatant. The
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beads were then incubated for a further 30 minutes at 4 °C rolling in 3 ml of high salt buffer
A (appendix 1.10.2), then harvested as before. The supernatant, which should contain the
GST-Fusion protein, was kept. The solubilisation and purification was analysed with SDS-
PAGE and Coomassie blue staining.
2.17 Circular Dichroism
Purified protein samples were dialysed into 50 mM sodium phosphate pH8.0 and Circular
Dichroism spectra were obtained in a Jasco J-810 spectropolarimeter using 0.05 cm cells,
scanning between 260 and 190 nm at 10 nm/min and a data pitch of 0.2 nm. For each
sample, 5 spectra were accumulated, the buffer-only baseline spectrum was subtracted and
the data were analysed using CDSSTR (Compton and Johnson 1986; Manavalan and
Johnson 1987), CONTINLL (Provencher and Glockner 1981) and SELCON3 (Sreerama and
Woody 2000) and reference set 7 (Sreerama and Woody 2000) from the Dichroweb website
(Lobley, Whitmore et al. 2002).
2.18 Coupled in vitro transcription and translation
This process expresses [,5S]-methionine labelled proteins from a desired gene under the
control of the bateriophage Lambda T7 promoter. The reaction was carried out according to
the manufacturer's instructions (Promega). The following components were assembled into
a 1.5 ml tube:
66
TnT Rabbit Reticulocyte Lysate 25 |il
TnT reaction buffer 2 |il
TnT RNA T7 polymerase 1 |tl
Amino acid mixture minus methionine 1 |ll
RNasin 1 |tl
DNA template (0.5 |tg/|tl) 2 |tl
[35S]-methionine (370 MBq/ml, >37 TBq/mmol) 2 |tl
Nuclease-free deionised water was added to a final volume of 50 |il. The reaction mix was
then incubated at 30 °C for 1 hour. Following this the reaction mix was passed through a
size exclusion column (CHROMA SPIN-30 DEPC H20 columns, BD Biosciences) to
remove the unincorporated [35S]-methionine. 5 ql aliquots of the eluate were then taken to
either be analysed by SDS-PAGE and autoradiography or used in binding experiments
described below.
2.18.1 Binding of [35S]-methionine labelled munc18-1, EGFP-munc18-1,
munc18-1R39c and EGFP-munc18-1R39c to GST-syntaxin 1a-(cyt)
In this study a comparison between the binding to GST-syntaxin la-(cyt), which is 1-799 bp
of syntaxin la, and of either wild-type muncl8-l, EGFP-muncl8-l, muncl8-lR39c and
EGFP-muncl8-lR39c was made, in order to determine whether the addition of the green
fluorescent protein had any effect on the interaction of these two proteins and also to
investigate the effect of a point mutation on this interaction. Full length syntaxin la was not
used in this study because when expressed in bacteria it was insoluble, but the removal of the
transmembrane domain overcomes this problem, and therefore the cytoplasmic domain of
syntaxin 1 a was fused to the C-terminus of GST. First the interaction between the proteins
was looked at and the following reaction was set up:
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GST-syntaxin la-(cyt)-GSH Sepharose (0.5 mg/ml) 5 pi
Muncl8-1 variant in vitro transcription translation reaction 5 |il
B inding Buffer (Appendix 1.11.1) 40 pi
This mixture was incubated at 4 °C for 2 hours with rolling. The beads were harvested by
centrifugation 6000 rpm for 2 min. The beads were then washed with 5 x 500 pi binding
buffer with incubation at 4 °C, rolling for 15 min for each wash. The final wash was
removed leaving approximately 40 pi of liquid in the tube, which was then totally removed
from the Sepharose Beads using a piece of tissue paper. The beads were resuspended in 15
pi of 1 x SDS PAGE loading buffer and boiled for 5 min. The bound proteins were analysed
by SDS-PAGE followed by drying the gel and autoradiography. To quantify the bands a
phosphorimager was used.
2.18.2 Competition Binding Between [35S]-methionine labelled munc18-1,
EGFP-munc18-1 and munc18-1 peptides for binding to GST-syntaxin1a-
(cyt)
To further investigate differences between the wild-type muncl8-l and EGFP-muncl8-l
binding to GST-syntaxin la-(cyt), their relative binding affinity was assessed. This was
done using a munc 18-1 -derived peptide that was reported to compete for binding to syntaxin
la (Dresbach, Burns et al. 1998). The in vitro transcription and translation were performed
and the binding experiment was set up as before but with the addition of increasing
concentration of the competitive peptide similar to the concentrations described previously,
with a scrambled peptide as a control. The results were analysed in the same way as before,
except that before drying the gels they were Coomassie Blue stained so that each binding
reaction could be normalised with respect to the amount of GST-syntaxin la-(cyt) present.
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2.18.3 Competitive Binding Between [35S]-methionine labelled munc18-1,
EGFP-munc18-1 and munc18-1-His6 for GST-syntaxin 1a-(cyt)
This experiment was done in the same way as before, but instead of using a peptide as
competitor purified muncl8-l-His6(muncl8-l fused to a hexahistidine tag), at suitable
concentrations to compete off the radiolabeled muncl8-l and EGFP-muncl8-l, was used.
The results were analysed in the same way as before.
2.19 Autoradiography
Autoradiography was performed using Kodak biomax film, which was exposed to the
radioactive gels for a suitable time depending on how hot the gel, which was determined
using a Geiger counter (Morgan series 900 mini monitor) in a Kodak x-ray cassette. The
film was then developed using a Konica SRX-101A developer.
2.20 Phosphorimager
The radioactive gels were exposed to the filter for an appropriate length of time, depending
on how hot the gels were as with autoradiography; typically they were exposed for
approximately 24 hours. Following exposure the filter was scanned using the
phosphorimager (Fujifilm FFA2000) and the densities of the protein bands were analysed
using the Aida programme by drawing a rectangle around the band of interest and also
another rectangle of the same size above the band to acquire a background value. For each
experiment the exact same size of rectangle was used to select each band.
2.21 Mammalian cell culture
2.21.1 HEK293 cells
HEK293 (transformed human embryonic kidney cell-line) were cultured in DMEM (Gibco
BRL) supplemented with 10 % (v/v) foetal calf serum (Invitrogen) and 2 mM L-glutamine
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(Gibco BRL). Cells were cultured and passaged according to standard procedures (Doyle,
Griffiths et al. 1994)
2.21.2 AtT20 cells
AtT20 cells (anterior pituitary corticotroph tumour cell-line) were cultured in DMEM with
L-glutamine, Na pyruvate (Gibco BRL) supplemented with 5 % (v/v) foetal calf serum
(Harlen Serolabs). Cells were cultured and passaged according to standard procedures
(Booth, Tian et al. 1998).
2.22 Transfection of mammalian cells
During this study cells were transfected using Lipofectamine 2000 (Invitrogen) and the
manufacturer's protocol was followed. Cells to be transfected were cultured in a 6 or 12
well tissue culture dish on 12 or 16 mm glass coverslips, which allows the cells to adhere to
the coverslip so they can be visualised easily using an upright confocal microscope.
2.22.1 Fixation of transfected cells using 4 % paraformaldehyde
Following transfection the cells were incubated for 48 h before being fixed in 4 %
paraformaldehyde. The culture medium was removed and the cells were washed three times
with PBS, 50 mM CaCL (PBS tablets, Sigma), followed by fixing (4 % (w/v)
paraformaldehyde in PBS). The fixative was removed by aspiration and the cells were
washed three times in PBS. Following washing the cells were immersed in 50 mM NH4Cl in
PBS for 10 min, to quench autofluorescence. The cells were then washed three times with
PBS before being mounted in Mowiol and stored in the fridge until imaged using CLSM.
2.23 Indirect immunofluorescence
Transfection was carried out 48 hours before immunofluorescence. The cells were fixed as
above and then incubated for 4 min with PBS containing 0.1 % Triton X-100 to permeabilise
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the cell membranes. The cells were washed another three times with PBS followed by
washing the cells three times over 5 min with 0.2 % (v/v) fish skin gelatin / PBS. The cells
were then incubated with a monoclonal antibody against syntaxin la, diluted 500 fold in 0.2
% (v/v) fish skin gelatin / PBS, for 3 hours. After the incubation the cells were washed three
times in 0.2 % (v/v) fish skin gelatin / PBS over 5 min followed by three times with PBS
over 5 min. The cells were then incubated with rabbit anti-mouse IgG rhodamine-
conjugated secondary (Molecular Probes) diluted 1:1000 in PBS/0.2 % (v/v) fish skin gelatin
and washed as before with the primary antibody. The cells were then mounted in Mowiol
and kept at 4 °C until imaged.
2.24 Imaging fixed cells by confocal laser scanning microscopy
Paraformaldehyde-fixed cells on glass coverslips, mounted in Mowiol, were imaged with a
Zeiss LSM Axioscope 510 confocal laser scanning microscope. In AtT20 cells FITC
(EGFP) emission was collected through a reflection short pass (RSP) filter 580 nm then
through a Band Pass (BP) filter 500-550 and Alexa 546 excitation was with the 546 nm line
of a Kr-ion laser, with emission collected through a Long Pass 560 nm filter. In HEK293
cells, ECFP image data were acquired using the 458nm excitation line of an Argon ion laser
with filtering through BP 480-520 and EYFP image data were acquired using the 514 nm
excitation line of an Argon laser and emission collected through a BP 535-590 filter. Co-
localisation image data were sampled at Nyquist rates and deconvoluted using the Huygens
II package (Scientific Volume Imaging, The Netherlands) to remove the out-of-focus haze,
which is characterised by the microscope's point spread function (PSF). The deconvoluted
images were analysed using the Bitplane suite of image analysis software (Bitplane AG,
Zurich, Switzerland) on Silicon Graphics Octane 2 workstations. The PSF, optical
aberration and thresholding levels were determined in advance using 200 nm diameter
fluorescent latex beads (490 nm excitation/517 nm emission; Molecular Probes).
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2.25 Fluorescence lifetime imaging
2.25.1 Fluorescence imaging
All fluorescence lifetime imaging experiments were performed and analysed by Dr Rory
Duncan using a Zeiss LSM 510 Axiovert confocal laser scanning microscope, equipped with
a pulsed excitation source (MIRA 900 Ti:Sapphire femtosecond pulsed laser, with a coupled
VERDI 10 W pump laser (Coherent, Ely, UK) (Figure 2.1). The laser was tuned to provide a
TPE wavelength of 800 nm, which efficiently excited ECFP, without any detectable
excitation/emission from EYFP in the absence of FRET from a donor. Live cells on
coverslips (37 mm) were imaged in an incubation chamber (H. Saur, Reutlingen, Germany);
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fixed cells were mounted using FLUORSAVE (Calbiochem, San Diego, CA). TPE data
acquisition was performed using 512 x 512 or 1024 x 1024 pixel image sizes, with 4 x frame
averaging, using a Zeiss Plan NeoFLUAR 1.3 NA 40 x oil immersion, or a Zeiss C-
Apochromat 1.2 NA 63 x water corrected immersion objective lens. Band pass and long
pass (480 - 520 nm for cyan) emission filters were used in conjunction with a Schott (New
York, NY) BG39 IR filter to attenuate the TPE light.
2.25.2 TCSPC-FLIM
TCSPC imaging requires that the scan control pulses of the microscope, i.e. the frame clock,
line clock, and, if possible the pixel clocks be available. TCSPC measurements were made
under 800 nm TPE, using a non-descanned detector (Hamamatsu R3809U-50; Hamamatsu
Photonics UK Ltd, Herts, UK) multichannel plate-photomuliplier tube (MCP-PMT), coupled
directly to the rear port of the Axiovert microscope and protected from room light and other
sources of overload with a Uniblitz shutter (Rochester, NY) (Figure 2.1). This MCP-PMT is
a key to measuring very fast fluorescent lifetimes as it achieves a transit time spread (TTS;
the limiting factor for TCSPC measurements) of 30 ps, and is free of after-pulses. Dark
count rates were 102 - 103 photons per second. The MCP-PMT was operated at 3 kV, and
signal pulses were pre-amplified using a Becker & Hickl HFAC-26 26 dB, 1.6 GHz
preamplifier. TCSPC recording used the "reversed start stop" approach, with accurate laser
synchronisation using a Becker & Hickl SPC-730 card together with a PHD-400 reference
photodiode, routinely at 79.4 MHz. In contrast to conventional TCSPC devices, the SPC
boards use a novel analogue-to-digital (AD) conversion (ADC) technique that cancels the
unavoidable errors of an ultra-fast ADC chip. Together with a speed-optimised time-
amplitude-converter (TAC), this achieves an overall dead time of only 25 ns per photon. BP
and LP filters were used to dissect the components of ECFP emission and also to enable
spectral separation of donor and acceptor FRET- and sensitised-emissions. 3-6 mm Schott
BG39 filters were positioned directly in front of the MCP-PMT. TCSPC recordings were
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acquired routinely for between 5 s and 25 s, mean photon counts were between 105 - 106
counts per second. Images were recorded routinely with 128 x 128 pixels from a 512 x 512
scan, with 256 time bins per pixel, or 256 x 256 pixels from a 1024 x 1024 image scan with
64 time bins.
2.25.3 FLIM data analysis and FRET calculations
Off-line FLIM data analysis used pixel-based fitting software (SPCImage, Becker & Hickl),
able to import the binary data generated by the FLIM module.
The fluorescence was assumed to follow a multi-exponential decay. In addition an adaptive
offset-correction was performed. A constant offset takes into consideration the time-
independent baseline due to dark noise of the detector and the background caused by room
light, calculated from the average number of photons per channel in front of the rising part of
the fluorescence trace. To fit the parameters of the multi-exponential decay to the
fluorescence decay trace measured by the system, a convolution with the instrumental
response function was carried out. The optimisation of the fit parameters was performed by
using the Levenberg-Marquardt algorithm, minimising the weighted chi-squared (%2)
quantity.
2.25.4 Features of TCSPC imaging technique
2.25.4.1 Time resolution
The time resolution of TCSPC technique is given by the transit time spread in the detector.
A system response shorter than 30 ps full width half maximal (fwhm) is achieved with MCP
PMTs, which in conjunction with the minimum time channel width in TCSPC modules of
813 fs, allowed lifetimes down to a few picoseconds to be determined (see below).
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2.25.4.2 Acquisition time
TCSPC data were acquired at the full scanning rate of the microscope, with scan times of
approximately 900 ms at 512 x 512 frame size. The FLIM image was recorded by
accumulating over several frames with a lower pixel resolution of 128 x 128 pixels using a
non-descanned detector couple to the rear port of the microscope. Non-descanned detection
resulted in mean photon counts of -104 - 106 per second (Elangovan, Day et al. 2002; van
Kuppeveld, Melchers et al. 2002).
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Chapter 3




Exocytosis is a multistep process that requires a large number of proteins interacting with
each other, presumably in a complex series of steps, the details of which are still unclear.
One protein that is believed to have a pivotal role in exocytosis is syntaxin. Syntaxin la is
integral to the plasma membrane of mammalian neuronal and neuroendocrine cells and is
known to interact with many proteins that are involved in exocytosis. Although there is still
debate about the molecular mechanism of membrane fusion, it is well established that
SNARE complex formation is essential in the exocytotic fusion process, and syntaxin la has
even been proposed to be a component of the fusion pore itself (Han, Wang et al. 2004). The
function of syntaxin 1 a appears to be regulated by its interaction with various regulatory
proteins, including muncl8-l (Jahn 2000). A major aim of the work reported in this thesis
was to further understand the role of syntaxin la in exocytosis, by investigating its
interactions with other exocytotic proteins, such as muncl8-l, both in vitro and in vivo.
Recent developments in molecular biological and biochemical techniques have facilitated the
investigation of such protein interactions; in particular the addition of protein 'tags', such as
oligohistidine, GST and the V5 epitope, allows the identification, purification and
experimental manipulation of proteins of interest. Furthermore, the arrival of high resolution
imaging systems makes it possible to visualise and investigate the behaviour of proteins,
particularly those bearing fluorescent tags, in vivo. This technique requires the use of
fluorescently coupled antibodies and/or the fusion of fluorescent proteins, for example
EGFP, ECFP or EYFP to the C- or the N -terminus of the proteins of interest.
In this chapter I describe the attempted cloning and expression of full-length syntaxin fused
to EGFP and carrying a hexahistidine tag, for use in binding experiments with munc-18 in
vitro; the expression of GST-syntaxin la (cytoplasmic domain), the fusion protein that was
eventually chosen for the in vitro work; and the expression and purification of GST-ECFP-
syntaxin la (cytoplasmic domain), which was also required for in vitro binding studies to
complement work with intact cells. EGFP-syntaxinla and ECFP-syntaxin la fusion protein
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clones were available, by courtesy of Dr Rory Duncan, but before they could be used in in
vivo experiments the effect of the addition of such a large protein on syntaxin la's behaviour
and on its interactions with other exocytotic proteins had to be investigated. This involved
the cloning and expression in bacteria of oligohistidine- and GST- fusions syntaxin la and
EGFP/ECFP-syntaxin la followed by their purification for use in binding experiments.
3.2 GST-syntaxin 1a-cytoplasmic domain (cyt) fusion protein expression and
purification
A plasmid encoding the cytoplasmic domain of syntaxin la fused to GST in a pGEX-KG
vector was obtained from Dr R D Burgoyne, University of Liverpool, which was used for in
vitro binding experiments, for two reasons: first, syntaxin la without its transmembrane
domain is known to be more soluble, and therefore easier to express and purify, than full-
length syntaxin la; and second, it was reported (R D Burgoyne, personal communication)
that when hexahistine-tagged constructs are used in pull-down experiments, there are often
high background levels of non-specifically-bound proteins, giving false positives. GST-
syntaxin la-(cyt) was transformed into E.coli BL21 RIL cells, chosen because they carry
extra copies of the genes encoding tRNAs for arginine, isoleucine and leucine. This aids in
the production of recombinant proteins, which can be inefficient when the codon use in the
recombinant gene differs from the codon use in the host cell. High-level expression of a
gene containing codons that are rarely used in E.coli ('codon bias') results in depletion of the
internal tRNA pools with consequent delay in the translation of the recombinant protein and
its eventual degradation. A colony was picked for an overnight 5 ml LB culture with
ampicillin (100 pg/ml), 1 ml of which was used to seed 100 ml Supermedia culture,
containing ampicillin. This was grown at 37 °C until A^o was 0.6-0.8. Protein expression
was then induced, using 1 mM IPTG, at 37 °C for 3 hours followed by cell harvesting by
centrifugation at 5000 x g for 10 minutes. The bacteria were lysed using Bugbuster followed
by centrifugation at 50000 rpm for 15 minutes to separate the soluble and insoluble fractions.
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Samples were then prepared for analysis by SDS PAGE and Coomassie staining (Figure
3.1). The gel revealed that the GST-syntaxin la-(cyt) was expressed at a high level, but that
it was insoluble, probably in inclusion bodies. It has been documented, (Hoess, Arthur et al.
1988), that GST-fusion proteins can be recovered from inclusion bodies in a soluble and
biologically active form using ion exchange resins such as Q-Sepharose. GST-syntaxin la-
(cyt) was induced and the bacteria were processed as before, however the insoluble fraction
was kept for attempted solubilisation of the GST-syntaxin la-(cyt) using Q-Sepharose
(Chapter 2.16.2). Samples were made and analysed by 10 % SDS PAGE and Coomassie
staining, (Figure 3.2A). The gel showed that most of the GST-syntaxin la-(cyt) was in the
insoluble fraction following induction and after incubation with Q-Sepharose the protein was
not eluted by any of the washing steps, suggesting it was either still bound to the Q-
Sepharose or in inclusion bodies. To determine whether the GST-syntaxin la-(cyt) was
bound to the Q-Sepharose or in inclusion bodies 200 pi samples of the Q-Sepharose were
taken and treated either with SDS, 2 M NaCl, 4 M Urea or 2 M Guanidine thiocyanate for 30
minutes at 4 °C with rolling. The beads were then harvested as before and the supernatants
removed and analysed by SDS PAGE and Coomassie staining (Figure 3.2B) The gel
revealed that GST-syntaxin la-(cyt) remained bound to the Q-Sepharose and that even
treatment with high concentrations of salt, urea or guanidine thiocyanate failed to elute it.
Since the recovery of the GST-syntaxin la-(cyt) from inclusion bodies was unsuccessful
different induction conditions were investigated to reduce the amount of GST-syntaxin la-
(cyt) produced to prevent the formation of inclusion bodies. The induction was repeated at
37 °C as before but only for 1 hour to determine whether the product was more soluble than
after a 4 hour induction. It was also repeated at 16 °C overnight, which slows the rate of
bacterial growth and hence protein synthesis, inhibiting reformation of inclusion bodies.
Both inductions were done using Supermedia and the bacteria were harvested, lysed and








2: No induction: soluble fraction
3: No induction: pellet fraction
4: Induction: soluble fraction
5: Induction: insoluble fraction
Figure 3.1: GST-syntaxin 1a-(cyt) induction
Coomassie blue-stained gel. GST-syntaxin la-(cyt) was induced using 1 mM IPTG in BL21 RIL






4: Supernatant after Q-Sepharose treatment of pellet
5: Supernatant after high salt wash of Q-Sepharose
Figure 3.2A: Attempted solubilisation of GST-syntaxin 1a-(cyt) using Q-Sepharose
Coomassie stained gel of the attempted solubilisation of GST-syntaxin la-(cyt) revealing that the




2: Q-sepharose + SDS
3: Q-sepharose + 2M NaCI
4: Q-sepharose + 4M Urea
5: Q-sepharose + 2M Guanidine thiocyanate
Figure 3.2B: Attempted solubilisation of GST-syntaxin 1a-(cyt) using Q-Sepharose
Coomassie blue-stained gel analysing the various washes used to try and remove the GST-syntaxin
la-(cyt) from the Q-Sepharose.
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(Figure 3.3). The gel revealed that GST-syntaxin la-(cyt) was still mainly insoluble under
these different induction conditions.
Another method for reducing protein production rates is to reduce the IPTG concentration
used for the induction, so the different IPTG concentrations investigated were: 0.1, 0.2, 0.5
mM in inductions at 37 °C for 1, 2, 3 and 4 hours or 16 °C overnight. Following these
inductions samples were analysed as before (Figure 3.4 A-D). The gels revealed that the
GST-syntaxin la-(cyt) was still mainly insoluble when the IPTG concentration and the
length of the induction were varied at 37 °C. When these conditions were varied during a 16
°C overnight induction, there was more soluble protein produced with the highest yield at 0.5
mM IPTG, although most of the protein was still insoluble. To slow down the protein
production further the induction was repeated using LB instead of Supermedia. An 8 hour
time course was carried out at 16 °C to investigate the optimum length of expression
required. After induction samples were taken every 2 hours and the bacteria were harvested
and samples prepared for SDS PAGE analysis (Figure 3.5 A-B). The gels revealed that
using LB media instead of Supermedia did produce more soluble protein and after an
overnight expression there were similar amounts of protein in the soluble and insoluble
fractions, which was the most soluble protein that had so far been generated. This protocol ,
using LB and induction with 0.5 mM IPTG at 16 °C overnight, was used continuously
throughout the remainder of the study to produce soluble GST-syntaxin la-(cyt) for use in
binding studies in vitro.
Before the GST-syntaxin la-(cyt) could be used in future experiments it had to be purified.
This was done using Glutathione Sepharose 4B (GSH) (Amersham). A 250 ml LB culture of
BL21 (RIL), transformed with GST-syntaxin la-(cyt), was induced at 16 °C overnight with
0.5 mM IPTG. The bacteria were harvested and lysed using Bugbuster (Chapter 2.13.2)
followed by centrifugation as before. The soluble fraction was then incubated with 500 pi of
a 50 % (v/v) suspension of Glutathione Sepharose 4B as previously described (Chapter
2.13.4), and the beads washed: 3 x with PBS, 0.1 % Triton X-100 (15 ml), 5 mM DTT
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2: No induction, 16 °C, o/n supernatant
3: No induction, 16 °C, o/n pellet
4: Induction, 16 °C, o/n supernatant
5: Induction, 16 °C, o/n pellet
6: No induction, 37 °C, 1 hr, supernatant
7: No induction, 37 °C, 1 hr pellet
8: Induction, 37 °C, 1 hr, supernatant
9: Induction, 37 °C, 1 hr pellet
10: Induction, 37 °C, 4 hrs pellet
Figure 3.3: Induction of GST-syntaxin 1a-(cyt) expression at 37 °C for 1 hour and 16
°C overnight
Coomassie stained gel analysing the induction of GST-syntaxin la-(cyt) at 37 °C for 1 h and 16 °C
overnight.
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2: 1 h induction, 0.1 mM IPTG, 37 °C' S
3: 1 h induction, 0.1 mM IPTG, 37 °C' P
4: 1 h induction, 0.2 mM IPTG, 37 °C, S
5: 1 h induction, 0.2 mM IPTG, 37°C, P
6: 1 h induction, 0.5 mM IPTG, 37 °C, S
7: 1 h induction, 0.5 mM IPTG, 37 °C, P
8: 2 h induction, 0.1 mM IPTG, 37 °C, S
9: 2 h induction, 0.1 mM IPTG, 37 °C, P
10: 2 h induction, 0.2 mM IPTG, 37 °C, S
Figure 3.4 A: Induction of GST-syntaxin 1a-(cyt) expression with varying time, IPTG
concentration at 37 °C.
A Coomassie stained gel for GST-syntaxin la-(cyt) induction using different IPTG concentrations;
0.1, 0.2 or 0.5 mM, for different time periods, 1 or 2 hours at 37 °C.








2: 2 h induction, 0.2 mM IPTG, 37 °C, P
3: 2 h induction, 0.5 mM IPTG, 37°C, S
4: 2 h induction, 0.5 mM IPTG, 37 °C, P
5: 3 h induction, 0.1 mM IPTG, 37 °C, S
6: 3 h induction, 0.1 mM IPTG, 37 °C, P
7: 3 h induction, 0.2 mM IPTG, 37 °C, S
8: 3 h induction, 0.2 mM IPTG, 37 °C, P
9: 3 h induction, 0.5 mM IPTG, 37 °C, S
10: 3 h induction, 0.5 mM IPTG, 37 °C, P
Figure 3.4 B: Induction of GST-syntaxin 1a-(cyt) expression with varying time, IPTG
concentration at 37 °C.
A Coomassie stained gel for GST-syntaxin la-(cyt) induction using different IPTG concentrations; 0.1,
0.2 or 0.5 mM, for different time periods, 2 or 3 hours at 37 °C.











2: 4 h induction, 0.1 mM IPTG, 37°C, S
3: 4 h induction,0.1 mM IPTG, 37 °C, P
4: 4 h induction, 0.2 mM IPTG, 37 °C, S
5: 4 h induction, 0.2 mM IPTG, 37 °C, P
6: 4 h induction, 0.5 mM IPTG, 37 °C,S
7: 4 h induction, 0.5 mM IPTG, 37 °C, P
8: 4 h no induction, 37 °C, S
9: 4 h no induction, 37°C, P
Figure 3.4C: Induction of GST-syntaxin 1a-(cyt) expression with varying IPTG
concentration for 4 hours at 37 °C.
Coomassie stained gel of GST-syntaxin la-(cyt) inductions at 37 °C for 4 h with different IPTG
concentrations: 0.1, 0.2 or 0.5 mM.





2: Overnight induction, 0.1 mM IPTG, 16 °C, S
3: Overnight induction, 0.1 mM IPTG, 16 °C, P
4: Overnight induction, 0.2 mM IPTG, 16 °C, S
5: Overnight induction, 0.2 mM IPTG, 16 °C, P
6: Overnight induction, 0.5 mM IPTG, 16 °C, S
7: Overnight induction, 0.5 mM IPTG, 16°C, P
8: Overnight no induction, 16 °C, S
9: Overnight no induction, 16°C,P
Figure 3.4D: Induction of GST-syntaxin 1a-(cyt) expression with varying IPTG
concentration overnight at 16 °C.
Coomassie stained gel analysing the results of GST-syntaxin la-(cyt) inductions performed at 16°
overnight.
S = Supernatant fraction, P = Pellet fraction
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2: No induction, 16 °C S
3: No induction, 16 °C P
4: 2hr induction, 16 °C S
5: 2hr induction, 16 °C P
6: 4hr induction, 16 °C S
7: 4hr induction, 16 °C P
Figure 3.5A: Induction of GST-syntaxin 1a-(cyt) expression using LB medium at 16°
time course.
Coomassie stained gel analysing GST-syntaxin la-(cyt) time course induction using 0.5 mM IPTG at
16 °C.










2: 6 hr induction, 16 °C, S
3: 6 hr induction, 16 °C, P
4: 8 hr induction, 16 °C, S
5: 8 hr induction, 16 °C, P
6: Overnight induction, 16 °C, S
7: Overnight induction, 16 °C, P
Figure 3.5B: Time course of induction of GST-syntaxinla-(cyt) expression using LB
medium at 16 °C.
Coomassie blue-stained gel of an induction time course of GST-syntaxin la-(cyt) analysing the
results from the time points 6 and 8 hours and overnight.
S = Supernatant fraction, P = Pellet fraction
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followed by 2 washes in PBS (15 ml). The products were analysed by SDS PAGE and
Coomassie staining (Figure 3.6). The results showed that the purification worked well and
that GST-syntaxin la-(cyt) accounted for about 95 % of the gel-bound protein. Accordingly,
GST-syntaxin la-(cyt) was not eluted from the Glutathione Sepharose 4B, but stored as
protein-loaded beads in PBS with 0.1 % azide at 4 °C, ready for use in future binding
experiments, although it was possible to elute the GST-syntaxin la-(cyt) using glutathione.
Following purification of GST-syntaxin la-(cyt), the protein concentration was determined
using a modification of the Folin-Lowry method, (Chapter 2.15.2). First a standard curve
was obtained using BSA standards. 3 different volumes of the protein loaded GSH beads
were used; 10, 15 and 20 pi, all done in triplicate and A750 was measured. The standard
curve was used to calculate the concentration of GST-syntaxin la-(cyt), which was typically
about 0.5 mg/ml suspension.
3.3 Production of GST-ECFP-syntaxinla-(cyt)
To compare the munc 18-1-binding affinity of ECFP-syntaxin la, used in the cell imaging
experiments, with that of native syntaxin la, the production of a GST ECFP-syntaxin la
cytoplasmic domain fusion protein was required. The cytoplasmic domain only of syntaxin
la was used because, as described above, it had already been decided to use GST-syntaxin
la-(cyt) in binding experiments in vitro. To produce the fusion protein ECFP-syntaxin la-
(cyt) had to be cloned in to a vector allowing the addition of GST so pGEX-5X-l was
chosen, which would attach GST to the N-terminus of the protein, the same arrangement as
in GST-syntaxin la-(cyt). First ECFP-syntaxin la-(cyt) had to be generated with suitable
restriction enzyme sites added to the 5' and 3'of the coding sequence. These had to be sites
that occurred in the multiple cloning site of the pGEX-5X-l, allowing the insertion of ECFP-
syntaxin la-(cyt) into the pGEX-5X-l vector in frame using directional cloning. This was
done using PCR with suitable primers.
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Figure 3.6 GST-syntaxin 1a-(cyt) expression and purification
Coomassie blue-stained gel analysing the purification of GST-syntaxin la-(cyt) using Glutathione
Sepharose 4B.
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3.3.1 PCR for production of ECFP-syntaxin 1a-(cyt) flanked by the restriction
sites for Sail and Not1
To generate ECFP-syntaxin la-(cyt) PCR was performed using full length ECFP-syntaxin
la, (supplied by Dr Rory Duncan) as the template, using a forward ECFP primer with a Sail
site and a reverse syntaxin la primer which annealed to syntaxin 1 a at the end of its
cytoplasmic domain, at 71 bp from the C-terminus and just ahead of the transmembrane
domain. This contained a Not 1 site. Initially the ECFP-syntaxin la was cloned into pCR2.1
(Invitrogen), so it would be easy to determine whether digestion by Sail and Notl was
complete. This required the addition of 3' A-overhangs so the Expand High Fidelity PCR
System™ (Roche) was used and the PCR reaction mix was assembled (Chapter 2.3.1).
The reaction mixes were then heated to 95 °C for 1 min to separate the DNA double helix
before 0.75 pi of Taq/Rho was added followed by 25 cycles of 95 °C, 30 sees, 60 °C, 30
sees, 72 °C, 70 sees. The PCR was completed by incubation at 72 °C for 7 mins and the
products were then left at 4 °C until needed. A parallel negative control was also done in the
same way omitting the template DNA. 5 pi of each PCR reaction was analysed by a 1 %
(w/v) agarose gel alongside a 1 kb DNA ladder, which was also used to estimate the
concentration of the amplified product. The gel revealed a product of -1500 bp as expected
and there was no product in the negative control lane. The PCR products were then cloned
into pCR2.1 (Invitrogen).
3.3.2 Cloning of ECFP-syntaxin 1a-(cyt) PCR product into pCR2.1
The amplified product of the PCR reaction was ligated into the pCR2.1 vector (Invitrogen)
using the estimated concentration and the equation below to calculate the required volume as
stated in the Manufacture's instruction,where a 50 times molar ratio of PCR product to
vector was used.
The ligation reaction mix was set up containing the appropriate volume of amplified PCR
product, 1 pi 10 X ligation buffer, 1 pi T4 DNA ligase (Invitrogen) and 2 pi pCR2.1 then
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made up to a final volume of 10 pi with dHzO before being incubated overnight at 16 °C. 5
pi of each ligation reaction mix was used to transform TOP10 E.coli cells (Chapter 2.8) and
200 pi was spread on to an LB-agar plate containing ampicillin then incubated overnight at
37 °C. Positive clones were detected using PCR to screen colonies (Chapter 2.3.3). The
master mix was mixed thoroughly and 49 pi aliquots were then pipetted into 12 PCR tubes
on ice. 10 colonies were picked and each one was dipped into a different PCR tube before
being spotted onto a LB-agar plate containing ampicillin (100 pg/ml). A positive control
containing 1 pi ECFP-syntaxin la (10 ng/pl) and a negative control with no DNA were set
up in the remaining two tubes. The heating block of the PCR machine was brought to 95 °C
before the tubes were place inside and incubated for 1 min to lyse the bacteria and separate
the DNA strands followed by 25 cycles of 95 °C, 30 sees, 60 °C, 30 sees, 72 °C, 70csecs.
The reaction was completed with incubation at 72 °C for 7 mins then the products were
stored at 4 °C until analysed. The LB-agar plate with the spotted on bacteria was incubated
at 37 °C. 5 pi of each of the PCR products was analysed by 1 % (w/v) agarose gel
electrophoresis alongside a 1 kb DNA ladder revealing that several of the lanes were from
positive clones, having a PCR product of -1500 bp as expected for ECFP-syntaxin la-(cyt).
A positive colony was chosen and used to seed a 100 ml LB-ampicillin culture, which was
incubated overnight at 37 °C for "maxiprep". The "maxiprep" (Qiagen) was done according
to the manufacturer's instructions. The ECFP-syntaxin la-(cyt) was then restriction digested
from the pCR2.1 vector using the restriction endonucleases Sail and Notl, so that it could be
sub-cloned into the pGEX-5X-l vector, which was also cut with the same enzymes. 3 pg
each of pCR2.1 -ECFP-syntaxin la-(cyt) and pGEX-5X-l were incubated with 10 units Sail
and 10 units Notl at 37 °C for 2 h before being analysed by 1 % (w/v) agarose gel
electrophoresis, which revealed that the restriction digestions had been successful. The
bands corresponding to ECFP-syntaxin la-(cyt) and pGEX-5X-l were excised and the DNA
was purified using a gel extraction kit (Eppendorf) and its concentration was estimated
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(Chapter 2.6). Following purification the ECFP-syntaxin la-(cyt) was the cloned into the
pGEX-5X-l vector.
3.3.3 Cloning of ECFP-syntaxin 1a-(cyt) into pGEX-5X-1
Once the concentration of the restriction digested ECFP-syntaxin la-(cyt) and pGEX-5X-l
DNA had been estimated, ligation reactions were set up with vectoninsert ratios of 1:1, 3:1
and 1:3, produced by adding the appropriate volume of both insert and vector DNA (Chapter
2.6). The ligation reaction mixes were incubated overnight at 4 °C. 5 pi of each ligation
reaction mix was used to transform competent E.coli TOPIO cells (Chapter 2.8) and then 200
pi of each transformation was plated on a LB-agar plate containing ampicillin followed by
incubation at 37 °C overnight. Colonies were then picked and used to seed 5 ml LB-
ampicillin (100 pg/ml) cultures for "minipreps" (Chapter 2.9.1), which were incubated
overnight at 37 °C. The purified plasmid DNA from the "minipreps" was then restriction
digested to check for positive clones, with the ECFP-syntaxin la-(cyt) inserted into the
pGEX-5X-l vector in the correct orientation. lOpl of each "miniprep" was digested with 10
units of BamHl for 2 h at 37 °C before being analysed by 1 % (w/v) agarose gel
electrophoresis alongside a 1 kb DNA ladder. The gel revealed several positive clones
where a DNA fragment ~1100 bp in size had been excised, as expected. One of the positive
clones was chosen and the remainder of the "miniprep" culture was used to seed a 100 ml
LB-ampicillin culture (1:100 dilution), which was grown overnight at 37 °C for "maxiprep"
(Qiagen), done according to the manufacturer's instructions.
3.3.4 Sequencing of ECFP-syntaxin 1a-(cyt) in pGEX-5X-1
The production of this construct involved the use of PCR so it was important to sequence the
insert to confirm that no mutations had been introduced during that process, and that the
insert was correctly oriented in the vector. Primers were designed that would cover the
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GST:ECFP, ECFP:syntaxin la-(cyt) and syntaxin la:Vector junctions. Samples of DNA
were prepared (Chapter 2.11) and sequenced by MWG Biotech revealing that ECFP-
syntaxin la had been accurately amplified and correctly inserted into the pGEX-5X-l vector,
in frame with GST. The protein could then be expressed in bacteria.
3.3.5 Expression of GST-ECFP-syntaxin 1a-(cyt) in E.coli BL21 RIL and
purification using Glutathione Sepharose 4B
Since the conditions for expressing GST-syntaxin la-(cyt) had already been optimised
(Chapter 3.3) these conditions were used for the expression and purification of GST-ECFP-
syntaxin la-(cyt). It was transformed into E.coli BL21 RIL cells grown in LB-ampicillin
(100 pg/ml) and induced at 16 °C overnight using 0.5 mM IPTG. The cells were harvested
and lysed using Bugbuster (Amersham) before being separated into soluble and insoluble
fractions using ultracentrifugation. The soluble fraction was incubated with 300 pi slurry of
Glutathione Sepharose 4B for 2 h before being washed five times (Chapter 2.14.4). Finally
0.1 % NaN3 was added and the Glutathione Sepharose 4B coupled with GST-ECFP-syntaxin
la-(cyt) was stored at 4 °C. SDS PAGE followed by Coomassie staining (Figure 3.7)
revealed that the expression and purification protocol developed for GST-syntaxin la-(cyt)
also worked well for GST-ECFP-syntaxin la-(cyt). The GST-ECFP-syntaxin la-(cyt) was
not eluted from the Glutathione Sepharose 4B but was used directly in binding experiments
(Chapter 5).
Following purification, the concentration of the GST-ECFP-syntaxin la-(cyt) coupled
Glutathione Sepharose 4B was determined using the modified Folin-Lowry method (Chapter
2.15.2). A standard curve was plotted using BSA standards first, which was then used to
determine the concentration of GST-ECFP-syntaxin la-(cyt). 3 different volumes; 10, 15
and 20 pi, of the protein-coupled Sepharose, each in triplicate, were used. The concentration








5: GSH-GST-ECFP-syntaxin 1a- (cyt)
Figure 3.7: GST-ECFP-syntaxin 1a-(cyt) expression and purification




A protocol is described for the production and expression of constructs encoding GST-
syntaxin la-(cyt) and GST-ECFP-syntaxin la-(cyt), for use in pull-down experiments to
measure the binding of muncl8-l. These in vitro binding controls are an essential
complement to the use of ECFP-syntaxin la in cellular imaging.
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Chapter 4




Regulated exocytosis requires the interaction of a large number of proteins, some of which
are directly responsible for membrane fusion while others have regulatory roles. One protein
known to have a key role in exocytosis is syntaxin la (Chapter 3). A major aim of this thesis
was to investigate more fully the way in which syntaxin 1 a participates in exocytosis, and in
particular how it is regulated by its interaction with other proteins, such as muncl8-l.
Muncl8-1 is essential for exocytosis in yeast, C.elegans, Drosophila and mouse. Muncl8-1
has a very high affinity for syntaxin 1 a and has been reported to have both positive and
negative effects on exocytosis (Brenner 1974; Novick and Schekman 1979; Hata, Slaughter
et al. 1993; Schulze, Littleton et al. 1994; Halachmi and Lev 1996; Jahn 2000; Verhage,
Maia et al. 2000; Rowe, Calegari et al. 2001) presumably through its interaction with
syntaxin la, although interactions with other proteins cannot be excluded. Muncl8-1
binding maintains syntaxin la in its 'closed' conformation, preventing it from interacting
with the other SNARE proteins and hence blocking membrane fusion (Margittai, Fasshauer
et al. 2003). In order for exocytosis to occur the interaction between muncl8-l and syntaxin
la must change, so that syntaxin la can adopt its open conformation and bind the other
SNARE proteins, but the process by which this occurs remains unclear. The work reported
in this thesis made use of confocal microscopic imaging techniques to study the interaction
between muncl8-l and syntaxin la in secretory cells in the presence and absence of various
stimuli, using fluorescent fusion proteins, (i.e. EGFP, EYFP and ECFP) based on muncl8-l
itself and a muncl8-l mutant form, muncl8-lR39C, which has a lower affinity for syntaxin la
(Fisher, Pevsner et al. 2001).
In vitro studies of protein interactions have been facilitated by recent advances in
biochemical and molecular biological techniques, which enable the bacterial production and
affinity purification of proteins with ohgohistidine tags and the cell free production of
radiolabelled proteins.
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This chapter describes the attempted production and purification of a hexahistidine tagged
muncl8-l for bacterial expression for use in in vitro competitive binding experiments.
EGFP-muncl8-l and EGFP-muncl8-lR39C fusion protein clones were made available by Dr
Rory Duncan. These were cloned into a vector suitable for the expression of the proteins in
vitro and then modified so as to produce EYFP-muncl8-l and EYFP-muncl8-lR39C. Before
the interactions between these fusion proteins and ECFP-syntaxin la could be studied in
vivo, binding studies had to first be carried out in vitro to determine whether the addition of
the fluorescent tags had any significant effect on their interaction. This required the cloning
and bacterial expression ofmuncl8-l-V5-His6, which was used as a competitor in the
binding of [35S]-labelled muncl8-l, muncl8-lR39C, EGFP-muncl8-l and EGFP-muncl8-
1r39c to GST-syntaxin la constructs.
4.2 PCR amplification of munc18-1, EGFP-munc18-1, munc18-1R39c and
EGFP-munc18-1R39c for cloning into pET101/D-TOPO
Genes for EGFP-muncl 8-1 and EGFP-muncl8-lR39c were cloned into a vector that was
suitable for bacterial and in vitro expression. The pETlOl/D-TOPO vector was chosen
because it contained a T7 promoter and could be used to add on the V5 and His6 tags.
Forward and reverse primers were designed (Figure 4.1), and since 3' A-overhangs were not
needed Pfu polymerase (Promega) was used instead. The PCR reaction mix components
were assembled (Chapter 2.3.2), then incubated at 95 °C for 1 minute to separate the DNA
template strands, then 1 pi Pfu was added followed by two cycles of 95 °C, 30 seconds; 55
°C, 30 seconds; 72 °C, 2 minutes (muncl8-l and muncl8-lR39c) or 72 °C, 5 minutes (EGFP-
muncl8-l and muncl8-lR39c). 25 cycles of 95 °C, 30 seconds; 60 °C, 30 seconds; 72 °C 2
minutes or 5 minutes were then used as above. The PCR reactions were then finished by
incubation at 72 °C for 7 minutes then stored at 4 °C until analysed. A parallel negative
control reaction was also set up in which only the DNA template was omitted. 5 pi of each
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Directional EGFP forward Primer Nhe1
5'- CACCGT CAG ATC CGC TAG CGC TAC CGG TCG CCA
CCA TGG T-3'
Directional munc18-1 Forward Primer Xba1
5'-CAC CTC TAG AAT GGC CCC CAT TGG CCT CAA GGC
GGC GGT GGT
EGFP-munc18-1 Reverse Stop Xba1
5 -TCT AGA TTA ACT GCT TAT TTC TTC GTC TGT TTT ATT-3'
EGFP-munc18-1 Reverse No Stop
5'-ACT GCT TAT TTC ATC TGT TTT ATT CAG-3'
Figure 4.1: Sequences of forward and reverse primers for EGFP-munc18-1, EGFP-
munc18-1R39C, munc18-1 and munc18-1R39C
Forward primers that incorporated a 4 bp overhang (shown in red) were required for cloning into
the pETlOl/D-TOPO vector. Reverse primers were designed with and without a stop codon .
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PCR product was electrophoresed on a 1 % (w/v) agarose gel along side a lkb DNA ladder
(Figure 4.2). There were no bands present in the negative control lane, but in the muncl8-l
and muncl8-lR39c lanes there was a band of approximately 2 kb, close to the expected size of
1.8 kb) and a band of approximately 2.5 kb in the EGFP-muncl8-l and EGFP-muncl8-lR39C
lanes. 2 pi of each PCR mix was used for cloning into pETlOl/D-TOPO (Invitrogen)
according to the manufacturer's instructions. These reaction mixes were then used to
transform E.coli TOPIO competent cells (Invitrogen) following the manufacturer's manual.
150 pi of each transformation reaction was plated out on an ampicillin (100 pg/ml)-agar
plate before being incubated overnight at 37 °C. Colonies were picked and grown at 37 °C
overnight in 5 ml LB-ampicillin media. "Minipreps" (Chapter 2.9.1) were then performed to
purify the plasmid DNA. Restriction digestion analysis was used to identify positive clones
where 10 pi of each "miniprep was incubated with 10 units Age I for 2 hours at 37 °C for
EGFP-muncl8-l and EGFP-muncl8-lR39c and 10 units EcoRl andlO units BamHl for
muncl8-l and muncl8-lR39C constructs. 10 % of each digestion product was analysed using
a 1 % (w/v) agarose gel (Figure 4.3). The gel illustrates an example of positive clones for
EGFP-muncl8-l and EGFP-muncl8-l-V5-His6, with digests giving an insert band of
approximately 2.5 kb. The remainder of the 5 ml cultures of positive clones were used
(1:100 dilution) to seed a 100 ml LB-ampicillin (100 pg/ml) overnight culture for
"maxiprep" (Qiagen) performed according to the manufacturer's instructions.
4.2.1 Sequencing of constructs encoding munc18-1, munc18-1-V5-His6,
munc18-1R39c, munc18-lR39c-V5-His6, EGFP-munc18-1, EGFP-munc18-1-
V5-His6, EGFP-munc18-1R39c and EGFP-munc18-1R39C-V5-His6
Since PCR was used during the cloning of these constructs their sequences had to be checked
to ensure that no mutations that would alter the amino acid sequence of the proteins had been
introduced. These proteins are rather large so it took several sequencing reactions to
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Figure 4.2: PCR of EGFP-munc18-1, EGFP-munc18-1R39C, munc18-1 and munc18-
R39C
5 pi of each PCR reaction mix was analysed by 1 % agarose gel electrophoresis. The stop











Figure 4.3: Restriction digestion of EGFP-munc18-1-V5-His and EGFP-munc18-
1R3gc-V5-His with Agel
10 pi of each restriction digest was analysed by electrophoresis on a 1 % agarose gel. Positive
clones gave inserts of approximately 2.5 kb. Arrows show approximate sizes in kb.
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sequence the proteins fully on both strands as each sequencing reaction generates a run of
approximately 700 bp, therefore the sequencing was done in stages. First primers were
designed to cover the vector/insert junctions and the EGFP/ muncl8-l or muncl8-lR39c
junction (Appendix 2). The sequencing results were then aligned against the coding
sequences of Rat muncl8-l and EGFP. The sequencing of all of the constructs revealed that
the junctions in muncl8-l-V5-His6, EGFP-muncl8-l-V5-His6, muncl8-lR39C-V5-His6 and
EGFP-muncl8-lR39C-V5-His6 were correct, but that in all the stop variants (i.e. those in
which there was no C-terminal tag) the junction between muncl8-l and the vector was
altered. In these clones the stop codon had been mutated and there was an insertion of 13
base pairs. The first explanation for this was there may have been a mistake in the reverse
primer containing the stop codon so a new primer was ordered and the cloning repeated. On
completion the sequencing over the junctions was repeated as before, but the same alteration
had occurred. The cloning and the sequencing were then repeated, but again the stop codon
was mutated and several base pairs inserted between the muncl8-l and vector junction. The
reason for the mutations and the insertion of random base pairs could have been due to the
way that the TOPO cloning worked (Chapter 2.4)
During this period the tagged clones were further sequenced by designing primers to overlap
the sequence already obtained (Appendix 2.1), until the full sequence of each clone was
generated. This revealed that the muncl8-lR39c-V5-His6 and the EGFP-muncl8-lR39c-V5-
His6 clones were of the correct sequence, whereas the muncl 8-l-V5-His6 and the EGFP-
muncl8-l-V5-His6 clones had several point mutations throughout their sequences,
presumably introduced during the PCR reaction.
Because of the problems encountered during the initial cloning it was decided to generate the
wild-type sequences by back-mutation of the muncl8-lR39c constructs, using site-directed
mutagenesis.
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4.2.2 Site-directed mutagenesis of munc18-1R39c-V5-His6 and EGFP-munc18-
1R39c-V5-His6.
Site-directed mutagenesis was performed using the Stratagene Quick Change kit (Chapter
2.3.2). Primers were designed (Figure 4.4), complementary to each other and with 15 base
pairs on either side of the point mutation. The PCR reaction mixture was assembled
(Chapter 2.3.5) then incubated at 95 °C for 1 min, followed by the addition of 1 pi Turbo Pfu
(Stratagene), then 18 cycles of 95 °C, 50 seconds; 60 °C, 50 seconds; 68 °C, 8 minutes and
15 seconds. The PCR reaction was completed by 68 °C, 7 minutes then stored at 4 °C until
the reaction was analysed by electrophoresis of 5 pi in a 1 % (w/v) agarose gel along side a 1
kb DNA ladder (Figure 4.5), which revealed multiple bands in each lane that could be
attributed to the the template DNA or varying amounts of supercoiling of the PCR products.
Although multiple bands were seen it was decided to carry on with the protocol. 10 units of
the methyl-specific restriction enzyme, Dpnl, was added to each PCR mix to digest the
template DNA for 1 h at 37 °C. 2 pi of each digested PCR mix was used to transform E.coli
XL-10 Gold competent cells according to the manufacturer's instructions (Stratagene),
which were then plated on to LB-agar plates containing ampicillin (100 pg/ml) and
incubated at 37 °C overnight. Colonies were picked for "minipreps" (Chapter 2.9.1), which
were analysed by digestion (total vol of 20 pi) with 10 units Agel, 2 h at 37 °C for EGFP-
muncl8-l-V5-His6 "minipreps" or 10 units of both EcoRI and BamHI for 2 h at 37 °C for
muncl8-l-V5-His6 'minipreps'. Positive clones were chosen and the remainder of the 5 ml
cultures were used to seed 100 ml LB-ampicillin (100 pg/ml) cultures (1:100 dilution) for
"maxiprep" (Qiagen) following the manufacturer's instructions. The positive clones of
muncl8-l-V5-His6 and EGFP-muncl8-l-V5-His6 were then sent off for sequencing.
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Munci 8-1R39C —> wildtype forward mutagenic primer
5'- GAC CAG TTA AGC ATG AGG ATG CTG TCT
TCC TGC -3'
Munc18-1R39C —► wildtype reverse mutagenic primer
5'- GCA GGA AGA CAG CAT CCT CAT GCT TAA
CTG GTC -3'
Figure 4.4: Sequences of the mutagenic primers used in the production of wildtype
munc18-1 constructs from muncl8-1R39C constructs
The mutagenic primers were complementary to each other, with 15 bp on either side of the point







Figure 4.5: Site-directed mutagenesis of munc18-1R39C-V5-His6 and EGFP-munc18-1-
V5-His6
Site-directed mutagenic PCR was used to revert the muncl8-lR39C-V5-His6 and EGFP-muncl8-l-V5-
His6 back to wild-type. 5 pi of each PCR reaction mix was electrophoresed alongside a 1 kb DNA
ladder in a 1 % agarose gel. Arrows show approximate sizes in kb
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4.2.3 Sequencing of munc18-1-V5-His6 and EGFP-munc18-1-V5-His6
constructs
The muncl8-l-V5-His6 and EGFP-muncl8-l-V5-His6 constructs were sent off for
sequencing using the same primers that were used before (Chapter 4.2.1, Appendix 2). The
sequencing confirmed that the site-directed mutagenesis had been successful and that no
other mutations had been introduced by the PCR. These constructs, munc 18-1 -V5-His6,
EGFP-muncl8-l-V5-His6, muncl8-lR39C-V5-E[is6 and EGFP-muncl8-lR39C-V5-His6 could
then be used for in vitro transcription/translation (Chapter 5) and bacterial expression.
4.3 Bacterial Expression of munc18-V5-His6 in E.coli BL21 DE3
To investigate the relative binding affinities between [35S]-muncl8-l-V5-His6 and EGFP-
muncl8-l-V5-His6, unlabelled muncl8-l was needed to compete with the radiolabelled
protein in binding to GST-syntaxin la-(cyt) (Chapter 5). E.coli BL21s (DE3) was used to
generate soluble muncl8-l-V5-His6, which could then be purified using its oligohistidine
tag.
Muncl8-1-V5-His6 was transformed into BL21 DE3 (Chapter 2.8). A colony was picked
and grown in a 5 ml LB-ampicillin (100 pg/ml) overnight culture at 37 °C. This was then
used to seed two 100 ml cultures (1 in 100 dilution) containing 100 pg/ml ampicillin, for
induction (Chapter 2.13.1). One culture was induced at 37 °C for 4 h and the other culture
was induced overnight at 16 °C using 1 mM IPTG, but before induction a 1 ml non-induced
sample was collected. Following induction 1 ml samples of the cultures were taken and the
bacteria harvested by centrifugation and lysed with Bugbuster (Chapter 2.13.2). The lysates
were separated into soluble and insoluble fractions by centrifugation at 14000 rpm for 20
minutes. Samples were then made for SDS PAGE analysis with Coomassie staining. The
Coomassie stained gel contained no obvious band corresponding to muncl8-V5-His6, so
western blotting was carried out, (Chapter 2.13) using anti-muncl8-l to detect the product.
The western blot revealed that there was some protein expression, but that the product was
111
mostly insoluble (Figure 4.6). Because of the poor expression of muncl8-l-V5-His6 and the
gift of a muncl8-l-His6 construct from Prof Alan Morgan that was known to be well
expressed it was decided to make use of this construct for bacterial expression of muncl8-
His6.
4.4 Expression and purification of Munc18-1-His6 in E.coli M15[pREP4]
Muncl8-His6 cloned into pQE plasmid (Qiagen) was obtained already transformed into
E.coli M15[pREP4] cells. These cells contain a pREP4 plasmid encoding the lacl repressor,
which allows tight control of recombinant protein expression from a lac promoter. Protein
expression was carried out following the instructions that came with the plasmid. An
overnight 5 ml culture containing ampicillin (100 pg/ml) and kanamycin (30 pg/ml) was set
up and used to seed a 100 ml Supermedia-antibiotic culture (100 fold dilution). The bacteria
were grown at 37 °C to Am)= 0.6-0.8 before being induced with 1 mM IPTG and incubated
at 37 °C for 4 h. Following the 4 h induction the bacteria were lysed using Bugbuster
(Chapter 2.14.2) and separated into soluble and insoluble fractions by centrifugation at
14000 rpm for 20 min. Samples were made for SDS PAGE followed by Coomassie staining
(Figure 4.7). The gel revealed that muncl8-His6 was highly expressed, but that most of it
was insoluble. In an attempt to produce soluble protein the grow-up was repeated using LB-
media, which has less nutrients, and therefore should result in a reduced growth rate and
hence slower protein production. This induction was performed, as before, at 37 °C for 4 h
and also at 16 °C overnight. Samples were lysed, separated into soluble and insoluble
fractions then analysed by SDS PAGE and Coomassie staining. Growth under these
conditions resulted in less recombinant protein production, and it was still insoluble. Lower
IPTG concentrations and expression at 16 °C were also investigated, but the muncl8-His6
was still insoluble. It was reasoned that since growth on Supermedia at 37 °C and induction







2: Uninduced, 37 °C, pellet fraction
3: Uninduced, 37 °C, soluble fraction
4: Induced, 37 °C, pellet fraction
5: Induced, 37 °C, soluble fraction
6: Induced, 16 °C, O/N, pellet fraction
7: Induced, 16 °C, O/N, soluble fraction
8: Positive control, purified munc18-1-His6
Figure 4.6: Expression of munc18-1-V5-His6
Western blot analysis ofmuncl8-l-V5-His6 expression in BL21 DE3 at 37 °C for 4 h and 16 °C







5: Positive control, purified munc18-1-His6
Figure 4.7: Expression of munc18-1-His6
Coomassie blue stained gel ofmuncl8-l-His6 expression in M15[pREP4] in Supermedia at 37 °C
for 4 h
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have produced a useful level of soluble protein, even though the bulk of the product was
insoluble. An attempt was made to purify soluble muncl8-l-His6 after induction under these
conditions, using a HiTrap affinity column (Amersham) (Chapter 2.14.3.1). Samples from
each of the fractions were taken for SDS PAGE analysis followed by Coomassie staining
(Figure 4.8 A-B). The gel revealed that some muncl8-l-His6 had been purified, but it was
eluted over a wide range of imidazole concentrations (50 - 500 mM). There was also a
contaminant protein band at -40 kDa present in larger quantities than munc 18-1 -His6 itself,
which was not recognised by the munc 18-1 antibody. To try and improve the purification
process various different washing strategies were investigated, for example washing with a
large volume of 25 mM imidazole followed by elution with 500 mM imidazole or washing
with 70 mM imidazole and eluting with 500 mM imidazole. None of these processes
improved the purification or removed the -40 kDa contaminant so a different affinity matrix
for purifying His6-tagged proteins, BD Talon (BD Biosciences), was tried (Chapter 2.14.3.2).
Munc 18-1- His6 expression was carried out as before, using Supermedia and inducing at 37
°C for 4 h with 1 mM IPTG. Analysis of the eluates by SDS PAGE and Coomassie staining
revealed that the -40 kDa contaminant protein was still present.
Since the greatest problem in producing muncl8-l-His6 was that insufficient soluble protein
was produced, we attempted to resolubilise muncl8-l-His6 from E.coli lysates. The method
used was treatment with a non-detergent sulphobutane (NDSB) 3-(l-pyridinio)-l-
propanesulphonate, which has been shown to aid in the solubilisation of proteins in a
biologically active form (Vuillard, Braun-Breton et al. 1995) (Chapter 2.16.1). Solubilised
protein was purified using the BD TALON resin in the same way as with the soluble
muncl8-l-His6 and fractions analysed by SDS PAGE and Coomassie staining (Figure 4.9 A-
B). The gels revealed that muncl 8-l-His6 had been solubilised, but to determine whether the
protein was in a biologically active torm, the folded state of the protein was investigated
using Circular Dichroism spectroscopy (CD) (Chapter 2.17). The CD spectrum (Figure
4.10) revealed that the solubilised muncl8-l-His6 had some secondary structure, but
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6: Fraction 1, 25 mM Imidazole
7: Fraction 2, 25 mM Imidazole
8: Fraction 3, 25 mM Imidazole
9: Fraction4, 25 mM Imidazole
10: positive control, purified munc18-1-His6
Figure 4.8A: Purification of munc18-1-His6
Coomassie blue-stained gel of fractions in the purification ofmuncl8-l-His6. The arrow indicates
the band corresponding to muncl8-l-His6 A stepwise imidazole gradient (25, 50, 50, 100 mM)











2: Fraction 5, 25 mM Imidazole
3: Fraction 6, 50 mM Imidazole
4: Fraction 7, 50 mM Imidazole
5: Fraction 8, 50 mM Imidazole
6: Fraction 9, 100 mM Imidazole
7: Fraction 10, 100 mM Imidazole
8: Fraction 11, 100 mM Imidazole
9: Fraction 12, 100 mM Imidazole
10: Positive control, purified munc18-1-His6
Figure 4.8B: Purification of munc18-1-His6







3: Soluble protein after guanidine treatment
4:lnsoluble pellet after guanidine treatment
5: Soluble protein after NDSB
6: Soluble protein after dialysis
7: Flow through
8: Fraction 1, 500 mM Imidazole
9: Fraction 2, 500 mM Imidazole







Figure 4.9A: Attempted solubilisation of munc18-1-His6
Coomassie blue- stained gel showing the attempted solubilisation ofmuncl8-l-His6 from inclusion
bodies with a non-detergent sulphobetaine and purification using a BD Talon column.
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2: Fraction 3, 500 mM Imidazole
3: Fraction 4, 500 mM Imidazole
4: Fraction 5, 500 mM Imidazole
5: Fraction 6, 500 mM Imidazole
6: Fraction 7, 500 mM Imidazole
7: Fraction 8, 500 mM Imidazole
8: Fraction 9, 500 mM Imidazole
9: Fraction 10, 500 mM Imidazole
munc-18-1-Hisc
10: Positive control, purified munc18-1-His6
Figure 4.9B: Attempted solubilisation and Purification of munc18-1-His6
Coomassie stained gel analysing the attempted solubilisation of muncl8-l-His6 with a non-detergent
sulphobetaine and purification on a BD Talon column. The arrow shows the muncl8-l-His6 band.
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Muncl 8-1 CD
Figure 4.10: CD Spectra of the solubilised munc18-1-His6
Following solubilisation and refolding, the folded state ofmuncl 8-1 was investigated using
circular dichroism, revealing that the second solubilisation protocol used, where the inclusion
bodies were washed more stringently using an inclusion body wash buffer (Appendix 1.9.2)
resulted in the muncl8-l-His6 containing more secondary structures
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included a high proportion of unordered structure (with 18 % a-helical, 17 % (3-strands, 18 %
turns and 47 % unordered). In attempt to improve the folded state of the muncl81-His6 the
isolated inclusion bodies were washed three times with inclusion body wash buffer
(Appendix 1.9.2) followed by centrifugation at 30000 x g for 30 mins before being
solubilised, refolded and purified as before. CD spectroscopy was used to analyse the folded
state of the muncl8-l-His6 revealing that there was more secondary structure present (Figure
4.10; 61 % a-helical, 10 % (3-strand, 11 % turns and 18 % unordered). To determine whether
it was in a biologically active form a binding experiment was set up using solubilised
muncl8-l-His6 and immobilised GST-syntaxin la-(cyt) as follows:
100 pi of GST-syntaxin la-(cyt)-coupled Glutathione Sepharose 4B was incubated with 25,
50, 75 and 100 pg of solubilised muncl8-l-His6 in 200 pi binding buffer (Appendix 1.9.2)
for 2 h at 4 °C with rolling. The beads were harvested by centrifugation at 1000 x g for 2
minutes followed by washing five times with binding buffer with rolling at 4 °C for 15
minutes. Following the final wash the residual binding buffer was removed with tissue
paper, and the beads resuspended in 15 pi SDS loading buffer. The gel revealed that the
muncl8-l-His6 had not bound significantly to GST-syntaxin la-(cyt), suggesting that the
solubilised muncl8-l-His6 was biologically inactive.
4.5 Expression of munc18-1-V5-His6 and purification using Qiagen Ni-NTA
superflow column
The problems encountered when expressing muncl8-l-His6 in M15[pREP4] E.coli cells,
and particularly the presence of the -40 kDa contaminant protein, led to work on expressing
muncl8-l-V5-His6 in pETlOl/D-TOPO and the use of Ni-NTA Superflow columns
(Qiagen) for protein purification. Expression was initially carried out in LB medium
(Chapter 4.2) and a relatively small amount of soluble muncl8-l-V5-His6 was produced.
Expression was repeated using Supermedia to increase the yield of soluble protein, induction
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being with 1 mM IPTG, either at 37 °C for 4 h or 16 °C overnight. After induction samples
of the cultures were taken, lysed with Bugbuster (Chapter 2.14.2) and separated into soluble
and insoluble fractions by centrifugation at 13000 rpm for 20 minutes. SDS loading buffer
was added to the soluble and insoluble fractions and the protein expression was analysed by
SDS PAGE followed by Western blotting (Chapter 2.13) using anti-muncl8-l. The western
blot revealed that the best condition for inducing expression of soluble muncl8-l-V5-His6
was 37 °C for 4 h with 1 mM IPTG in Supermedia.
Following the determination of the optimum expression conditions, a 1 litre induction was
set up in Supermedia containing ampicillin (100 pg/ml) and muncl8-l-V5-His6 was induced
using 1 mM IPTG for 4 h at 37 °C. Purification of muncl8-l-V5-His6 was carried out
according to the manufacturer's instructions (Qiagen) (Chapter 2.14.3.3). The bacteria were
harvested by centrifugation, 10 min at 5000 x g and resuspended in lysis buffer (Appendix
1.5.3.1) then incubated on ice for 1 h. The bacterial lysate was then sonicated (Soniprep
150), 8x10 sees at amplitude == 6 microns then separated into soluble and insoluble fractions
by centrifugation at 12000 x g for 30 min. The soluble fraction was then incubated with 1 ml
of the NTA Ni resin for 2 h at 4 °C with rolling before being packed into a gravity flow
Supercolumn. The resin was washed with 10 ml of binding buffer (10 mM imidazole,
Appendix 1.5.3.2), then 50 ml of wash buffer 1 (20 mM imidazole, Appendix 1.5.3.3),
followed by 6 ml of wash buffer 2 (50 mM imidazole, Appendix 1.5.3.4), collected as 1 ml
fractions. The protein was eluted in 3 ml of elution buffer (250 mM imidazole, Appendix
1.5.3.5), collected as 0.5 ml fractions. Samples were prepared for SDS PAGE followed by
Coomassie staining. The gel revealed (Figure 4.11 A-B) that soluble muncl 8-l-V5-His6 had
been purified; however there was a contaminant band of approximately 70 kDa that could
not be separated from the muncl8-l-V5-His6. To determine whether the muncl8-l-V5-His6
could he used in future binding experiments binding to GST-syntaxin la-(cyt) was tested in
the same way as described in Chapter 4.3. It was again found that the muncl8-l-V5-His6
did not interact with GST-syntaxin la-(cyt). The reason for this could that the 70 kDa
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3: Wash 1, 20 mM imidazole
4: Wash 2, 20 mM imidazole
5: Wash 3, 20 mM imidazole
6: Wash 4, 20 mM imidazole
7: Wash 5, 20 mM imidazole
8: Fraction 1, 50 mM imidazole
9: Fraction 2, 50 mM imidazole
10: Fraction 3, 50 mM imidazole
Figure 4.11 A: Purification of munc18-1-V5-His6
Coomassie blue stained gel of the purification ofmuncl8-l-V5-His6 using a Quiagen Ni-NTA
superflow column.
123
















2: Fraction 4, 50 mM imidazole
3: Fraction 5, 50 mM imidazole
4: Fraction 6, 50 mM imidazole
5: Fraction 7, 250 mM imidazole
6: Fraction 8, 250 mM imidazole
7: Fraction 9, 250 mM imidazole
8: Fraction 10, 250 mM imidazole
9: Fraction 11, 250 mM imidazole
10: Fraction 12, 250 mM imidazole
Figure 4.11B: Purification of munc18-1-V5-His6
Coomassie blue stained gel of the purification of muncl8-l-V5-His6 using a Quiagen Ni-
NTA Superflow column. The gel shows the presence of the 70 kDa contaminant band that
could not be separated from the muncl8-l-V5-His6.
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contaminant was binding tightly to muncl8-l-V5-His6 and thus preventing its interaction
with GST-syntaxin la-(cyt). If this was the case the 70 kDa contaminant protein could be
Hsc70, which is a bacterial chaperone protein that may interact with the muncl8-l-V5-His6
and aid in its folding. To test this hypothesis the binding experiment between GST-syntaxin
la-(cyt) and muncl8-l-V5-His6 was repeated in the presence of 2 mM ATP and 5 mM
MgS04, since MgATP is required by chaperone proteins to release proteins. Under these
conditions muncl8-l-His6 still did not
interact with GST-syntaxin la-(cyt), suggesting that the 70 kDa contaminant protein was not
Hsc70.
4.6 Purification of munc18-1-His6 on Qiagen Ni-NTA Superflow
Since the purification of muncl8-l-V5-His6 on the Qiagen Ni-NTA superflow column was
unsuccessful it was decided to try to purify muncl8-l-His6 using the Quiagen Ni-NTA
superflow column. The protein was expressed in E.coli Ml5(pREP4) (Chapter 4.3) in 1 litre
of Supermedia containing ampicillin (100 pg/ml) induced at 37 °C for 4 h with 1 mM IPTG.
Following expression the protein was purified in the same way as detailed in Chapter 4.4 and
analysed by SDS PAGE and Coomassie staining (Figure 4.12 A-B). The gel revealed that
muncl8-I-His6 had been successfully purified, eluting from the column in fractions 8-10.
Approximately 95 % of the protein eluted from the column was muncl8-l-His6 and the 70
kDa contaminant protein was not present in this protein preparation. To check that the
muncl8-l-His6 was folded correctly its interaction with GST-syntaxin la-(cyt) was
investigated as before (Chapter 4.3) revealing that the muncl8-l-His6 was bound to the GST-
syntaxin la-(cyt) (Figure 4. 13). The purified muncl8-l-His6 could now be used as a












5: Wash 1, 20 mM imidazole
6: Fraction 1, 50 mM imidazole
7: Fraction 2, 50 mM imidazole
8: Fraction 3, 50 mM imidazole
9: Fraction 4, 50 mM imidazole
10: Positive control, purified munc18-1-V5-His6
Figure 4.12A: Purification of munc18-1-His6
Coomassie blue stained gel of purification ofmuncl8-l-His6 purification using a Qiagen
Ni-NTA Superflow column
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5, 50 mM imidazole
6, 250 mM imidazole
7, 250 mM imidazole
8, 250 mM imidazole
9, 250 mM imidazole
10, 250 mM imidazole
11, 250 mM imidazole
Figure 4.12B : Purification of munci 8-1-His6
Coomassie blue stained gel ofmuncl8-l-His6 purification using the Quiagen Ni-NTA superflow
columns. Eluted muncl8-l-His6 was mainly in fractions 5-8.
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Figure 4.13: Binding experiment between purified munc18-1-His6 and GST-syntaxin
1a-(cyt) or GST-ECFP-syntaxin 1a-(cyt)
Coomassie blue stained gel of binding experiments set up between muncl8-l-His6 and either GST-
syntaxin la-(cyt) or GST-ECFP-syntaxin la-(cyt), where soluble muncl8-l-His6 was incubated
with Glutathione Sepharose 4B coupled with either GST-syntaxin la-(cyt) or GST-ECFP-syntaxin
la-(cyt). The beads were harvested and the supernatants removed. Both the pellet and supernatant
fractions were analysed by SDS PAGE revealing that the purified proteins do interact with each
other
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4.7 Cloning of EGFP-munc18-1 and EGFP-munc18-1R39c into a Mammalian
expression vector.
To investigate the interaction between muncl8-l and syntaxin lam vivo by expression in
cultured mammalian cells, the EGFP-muncl8-l sequence had to be moved into a
mammalian expression vector. The expression vector chosen was pcDNA3 (Invitrogen). In
order to accomplish this subcloning, restriction sites had to be added on either side of the
gene sequence by PCR, present in pcDNA3. Initially EGFP-muncl8-l and EGFP-muncl 8-
lR39c were cloned into the vector pCR2.1 (Invitrogen) using blunt cloning, then sub-cloned
into pcDNA3 using the restriction enzymes. This approach was used because excision of the
insert from a vector ensured that it been cut by the restriction enzymes, whereas this cannot
be guaranteed if a PCR product is digested.
4.7.1 PCR of EGFP-munc18-1 and EGFP-munc18-1R39c to add restriction sites
for Xba1
EGFP-muncl8-l and EGFP-muncl8-lR39c were first cloned into pCR2.1. This required the
addition of 3' A-overhangs, so the Expand High Fidelity PCR System (Roche) was used. An
EGFP forward primer, containing and Xbal site and a reverse primer, also incorporating an
Xbal site, were used (Figure 4.14). The components of the PCR reaction mix were
assembled as before and the same PCR conditions used (Chapter 4.2.1). PCR products were
analysed by electrophoresis on a 1 % (w/v) agarose gel alongside a 1 kb DNA ladder. The
gel contained a band of approximately 2.5 kb for both EGFP-muncl 8-1 and EGFP-muncl 8-
1 R39c as expected and the negative control lane was empty. The DNA concentration of the
PCR products was also estimated from this gel, and used to calculate the amount of the PCR
products required for the ligation.
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EGFP Forward Primer Xba1
5'-GTC AGA TCC TCT AGA GCT ACC GGT CGC CAC CAT
GGT GAG CAA GG-3'
EGFP-munc18-1 Reverse Stop Xba1
5-TCT AGA TTA ACT GCT TAT TTC TTC GTC TGT TTT ATT-3'
Figure 4.14: Sequences of forward and reverse munc18-1 PCR primers
Primers used for muncl8-l PCR so that it could be cloned into the mammalian expression vestor
pcDNA3
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4.7.2 Cloning of EGFP-munc18-1 and munc18-1R39c into pCR2.1
Once the DNA concentration on the PCR products of EGFP-muncl8-l and EGFP-muncl8-
1r39c was estimated the following equation was used to calculate the volume of each of the
PCR products required for the ligation, following the manufacturer's instructions
X = 50N/V
where X = amount of PCR product (ng), N = size of PCR product (bp) and V = size of
pCR2.1 vector (~3900bp)
The ligation reaction mix was set up containing the correct volume of PCR product, 1 pi of
ligation buffer, 2 pi pCR2.1 vector, 1 pi T4 DNA Ligase and made up to 10 pi with dH20.
The reaction was then incubated overnight at 16 °C before being transformed into competent
E.coli TOPIO cells (Chapter 2.8). The transformed bacteria were spread on an LB-Agar
plate containing ampicillin and incubated at 37 °C overnight. Colonies were analysed using
PCR to screen for positive clones, where the components were assembled into a master mix
on ice (Chapter 2.3.3) and thoroughly mixed, then 49 pi was aliquoted into PCR tubes. 10
colonies were picked and each one was dipped into a different PCR tube several times before
being spotted on to an LB-Agar plate containing ampicillin (100 pg/ml). 1 pi of template
DNA was added to one of the remaining PCR tubes for a positive control and the other was
used as a negative control containing no DNA. The heating block of the PCR machine was
brought to 95 °C before the samples were placed inside and incubated for 1 min to lyse the
bacteria and separate the DNA strands. The same PCR conditions were used as before
(Chapter 4.2.2). The LB-agar plate with spotted colonies was incubated at 37 °C. The PCR
reaction products were analysed by electrophoresis on a 1 % (w/v) agarose gel alongside a 1
kb DNA ladder and lanes containing a band of -2500 bp indicated the colonies that were
positive clones. One of the positive clones was chosen and the corresponding colony that
had grown on the LB-Agar plate was used to seed an overnight 100 ml LB-ampicillin (100
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pg/ml) culture for a "Maxiprep". The "Maxiprep" (Qiagen) was done following the
manufacturer's instructions.
4.7.3 Sequencing of EGFP-munc18-1 and EGFP-munc18-1R39c in pCR2.1
Since PCR had been used during cloning of EGFP-munc 18-1 and EGFP-muncl8-lR39C into
pCR2.1 the sequence had to be checked for mutations. Samples were prepared (Chapter
2.11) and the same primers used as before (Appendix 2) to fully sequence the clones. DNA
sequencing revealed that no mutations had been introduced into the sequences of EGFP-
muncl8-l and EGFP-munc 18-1R39C during the PCR reaction. These could now be excised
from pCR2.1 by restriction digestion and sub-cloned in pcDNA3.
4.7.4 Cloning of EGFP-munc18-1 and EGFP-munc18-1R39c into pcDNA3
The restriction enzyme used to clone EGFP-munc 18-1 and EGFP-munc 18-1R39C into pcDNA
was Xba1. 3 p g of EGFP-munc 18-1, EGFP-munc 18-1 R39c and pcDNA3 vector were
digested by 10 units of Xbal for 2 h at 37 °. The restriction digests were analysed by
electrophoresis of the entire restriction digest reaction mix in a 1 % (w/v) agarose gel. The
bands corresponding to EGFP-munc 18-1, EGFP-munc 18-lR39c and pcDNA were excised
from the gel and the DNA purified using a gel extraction kit (Eppendorf) following the
manufacturer's instructions. 10 % (v/v) of each of the purified DNA samples was analysed
by 1 % (w/v) agarose gel to estimate their concentration. The DNA concentrations were
then used to calculate the amount of the vector and each of the insert required for the ligation
reactions (Chapter 2.6)
Three ligation reaction mixes for EGFP-munc 18-1 and EGFP-munc 18-lR39Cwere set up with
vectoninsert ratios of 1:1, 3:1 and 1:3 containing 1 pi Ligase buffer, 1 pi T4 DNA Ligase
(Promega) and made up to 10 pi with dH20. One control was also set up containing no T4
DNA ligase to show whether any of the pcDNA3 vector was undigested. These reaction
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mixes were incubated overnight at 4 °C then transformed into competent E.coli TOP 10 cells
(Chapter 2.8). Colonies were picked and grown overnight at 37 °C in 5 ml LB-ampicillin
(100 pg/ml) cultures for "minipreps" to purify the plasmid DNA. The "minipreps" were
done (Chapter 2.9.1) and positive clones containing EGFP-muncl8-l and EGFP-muncl8-
1 R39c inserted in the correct orientation were determined by restriction digestion. 10 pi of
each "miniprep" was digested with 10 units ofNotl for 2 h at 37 °C followed by digestion
with 10 units of BamHl for 2 h at 37 °C and the results were analysed by 1 % (w/v) agarose
gel alongside a 1 kb DNA ladder. Lanes containing a band ~ 2500 bp represented positive
clones, one of which was chosen for each EGFP-muncl8-l and EGFP-muncl8-lR39C and
using the remainder of their 5 ml "miniprep" culture to seed a 100 ml (1:100 dilution) LB-
ampicillin (100 pg/ml) culture grown overnight at 37 °C for "maxiprep". The "maxiprep"
(Qiagen) was made according to the manufacturer's instructions. Samples were then
prepared for sequencing over the vector/insert junctions, to check that the EGFP-muncl8-l
and EGFP-muncl8-lR39c had been ligated properly into pcDNA3, using the sequencing
primers T7 forward and EGFP Reverse (Appendix 2) for the N-terminal junction and
muncl8-l Forward 3 and BGH reverse for the C-terminal junction. The sequencing revealed
that the ligations had been successful and the constructs could then be used to transfect
mammalian cells.
4.8 Transfection of mammalian cells with EGFP-munc18-1 and EGFP-
munc18-1R39c
HEK293 cells and AtT20 cells were transfected with both EGFP-muncl8-l and EGFP-
muncl8-lR39c to investigate the expression of these proteins and the interaction between
EGFP- muncl8-l and EGFP-muncl8-lR39c with native syntaxin la. This work is discussed
more fully in Chapter 6. In AtT20 cells endogenous syntaxin la was immuno-stained using
a commercial monoclonal antibody and second antibody conjugated with Alexa Fluor 546.
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Although there was colocalisation ofmuncl8-l and syntaxin la no FRET was detected.
Two possible reasons for the lack of FRET were that the Alexa 546 fluorophor was highly
quenched during excitation, or the distance between EGFP and the antibody conjugated
flurophor was too large for FRET to occur. To overcome this problem exogenous ECFP-
syntaxin la was used instead, but this required EGFP on muncl8-l to be replaced by EYFP,
which is a better FRET acceptor for ECFP than is EGFP.
4.9 Exchange of EGFP for EYFP to produce EYFP-munc18-1 and EYFP-
munc18-1R39c in pcDNA3
The easiest way to exchange EGFP for EYFP was to remove EGFP by restriction digestion
and replace it with EYFP from pEYFP-Nl (Clontech) and since EGFP and EYFP sequences
only differ from each other by several base pairs an appropriate internal restriction site was
used. The restriction enzymes chosen were Kpnl, which was found in both pcDNA3 and
pEYFP-Nl upstream of EGFP and EYFP, and BsrGl for which there was one site in both
the EGFP and the EYFP genes, located 46 bp from the C-terminus. Accordingly, 3 pg each
of EGFP-muncl8-l, EGFP-muncl8-lR39c in pcDNA3 and pEYFP-Nl was digested with 10
units of Kpnl for 2 h at 37 °C (total volume = 20 pi) followed by incubation for a further 2 h
at 37 °C with 10 units of BsrGl (total volume = 50 pi). The whole volume of each
restriction digest was loaded for electrophoresis on a 1 % (w/v) agarose gel, alongside a 1 kb
DNA ladder. The DNA bands corresponding to muncl8-l-pcDNA3, muncl8-lR39C-
pcDNA3 and EYFP were excised and the DNA purified using a gel extraction kit
(Eppendorf) following the manufacturer's instructions. The concentration of the extracted
DNA was estimated by comparison with the ladder on 1 % (w/v) agarose gel electrophoresis
so that the ligations of EYFP into muncl8-l-pcDNA and muncl8-lR39c-pcDNA could be set
up as before (Chapter 4.4.4). The reaction mixes were incubated at 4 °C overnight preceded
by transformation in competent E.coli TOPIO cells (Chapter 2.8). Colonies were then
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screened for positive clones using PCR (Chapter 4.4.2) which would gave a product of
-2500 bp if the cloning had been successful. Positive clones of EYFP-muncl8-l and EYFP-
muncl8-lR39c were chosen and used to seed overnight 100 ml LB-ampicillin (100 pg/ml)
cultures for "maxipreps" (Qiagen), which were made according to the manufacturer's
instructions. Samples were sent for sequencing (Chapter 2.11) to ensure that EGFP had been
replaced by EYFP.
4.9.1 Sequencing of EYFP-munc18-1 and EYFP-munc18-1R39c in pcDNA3
The clones were sequenced to ensure that EGFP had been replaced by EYFP in frame. The
sequencing primers used were; T7 Forward, EGFP Forward, and munc 18-1 /EGFP junction
Reverse and EGFP Reverse (Appendix 2). Sequencing results revealed that the cloning had
been successful, producing EYFP-muncl8-l and EYFP-muncl8-lR39C in pcDNA3 that could
now be used to transfect mammalian cells.
4.9.2 Transfection of mammalian cells with EYFP-munc18-1 and EYFP-
munc18-1R39c in pcDNA3
Transfections were done in HEK293 cells to investigate the interactions between EYFP-
muncl8-l and EYFP-muncl8-lR39C with ECFP-syntaxin la and are discussed in Chapter 6.
4.10 Summary
This chapter outlines the production of various muncl8-l constructs for bacterial expression,
in vitro transcription/translation and transfection of mammalian cells.
During the building of these constructs several time-consuming problems were encountered,
such as the mutations introduced during PCR amplification and the unexpected deletion of
the muncl8-l sequence during the TOPO cloning. These problems were eventually
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overcome, allowing the production of muncl8-l constructs that could be used both for
bacterial expression and in vitro transcription/translation. These constructs produced usable
radiolabelled products on in vitro transcription/translation, however bacterial expression of
muncl8-l-V5-His6 was problematic. Even when a successful expression protocol was
devised, purification of the His-tagged protein by three different purification protocols was
unsuccessful. However, a muncl8-l-His6 construct, a gift from Prof Alan Morgan, was
successfully expressed and the protein purified, although only one of the purification
methods was successful in generating native protein that could then be used in future
experiments. In addition to the muncl8-l constructs produced for the in vitro expression of
muncl8-l, muncl8-l fused to variant GFP fusion proteins were successfully produced, and
expressed in mammalian cells. The use of these is described in the next chapters.
136
Chapter 5
In vitro Binding of munc18-1
constructs to syntaxin 1 a constructs
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5.1 Introduction
The principal aim of this thesis was to investigate the interaction in cells between the
SNARE protein syntaxin la and the SNARE regulator muncl8-l, and to study their
respective roles in exocytosis using both in vitro and in vivo approaches.
With the production of fluorescent (ECFP, EGFP, EYFP) fusion proteins and the use of
high-resolution imaging systems involving FRET and FLIM, the interaction between
syntaxin la and muncl8-l can be investigated within secretory cells in response to various
stimuli, in order to further elucidate their role in exocytosis. However this approach had to
be validated by carrying out in vitro binding experiments, to check that fusion of the
fluorescent proteins to muncl8-l and syntaxin la did not significantly affect their
interaction. This chapter describes the in vitro binding studies that were performed, using
radiolabeled muncl8-l constructs and immobilised syntaxin la.
First the effect, if any, of the addition of fluorescent GFP variants to syntaxin la and
muncl8-l on their interaction had to be determined. This involved comparing the relative
binding affinities of the wild-type and the fluorescently labelled proteins. The approach
taken in this thesis was to quantify the binding of [35S]-muncl8-l and [35S]-EGFP-muncl8-l
to GST-syntaxin la-(cyt) and GST-ECFP-syntaxin la-(cyt), using competition by
unlabelled, bacterially expressed muncl8-l-His6 to determine the relative binding affinities.
The syntaxin la constructs were derived from the cytoplasmic domain of syntaxin la, N-
terminally fused to glutathione S-transferase (Figure 5.1): These were bound to GST-
Sepharose, and used in 'pull-down' assays. [35S]-muncl8-l and [35S]-EGFP-muncl8-l were
produced using a cell-free protein translation system. This enables a specific protein of
interest to be transcribed from its cDNA under the control of a T7 promoter, and then
translated with the incorporation of a radiolabeled amino acid ([35S]-methionine) allowing
quantification of the bound protein after separation by SDS-PAGE.
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Habc domain linker H3 domain TMDooq,,
C-terminal
Figure 5.1: Diagram of the GST-syntaxin 1a fusion proteins
A: Full length syntaxin la
B: GST-syntaxin la (cyt)
C: GST-ECFP-syntaxin la-(cyt)
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5.2 In vitro transcription/translation of munc18-1-V5-His6, EGFP-munc18-1-
V5-His6, munc18-1R39c-V5-His6 and EGFP-munc18-1R39c-V5-His6
For production of [35S]-labelled muncl8-l through transcription and translation of its cDNA
by the TnT Coupled Reticulocyte Lysate system (Promega), the reaction was carried out as
described in Chapter 2.18 and 5 pi of each reaction product was analysed by SDS PAGE
followed by autoradiography (Figure 5.2). The autoradiogram revealed that muncl8-l,
EGFP-muncl8-l, muncl8-lR39C and EGFP-muncl8-lR3c>c were in vitro transcribed/translated
well, appearing as a doublet (not well resolved in Figure 5.2 - see Figure 5.6A), which could
then be used in binding experiments. Recombinant muncl8-l has been shown to run as a
doublet during electrophoretic separation (Barclay, Craig et al. 2003), thought to be due to
some limited proteolysis, and the two forms were found to behave identically in their binding
assays (but see section 5.4).
5.3 [35S]-labelled munc18-1, EGFP-munc18-1, munc18-1R39c and EGFP-
munc18-1R39C binding to GST-syntaxin 1a-(cyt)
Initially it was decided to investigate whether each of the muncl8-l constructs associated
with the syntaxin la-(cyt) before measuring their relative binding affinities. [35S]-muncl8-l,
[35S]-EGFP-munc 18-1, [35S]-muncl8-lR39Cand [35S]-EGFP-muncl8-l R39C were produced by
in vitro transcription/translation reactions (Chapter 2.18) and binding reaction mixes were set
up in triplicate for each one, using either GST-syntaxin la-(cyt) or GST (used as a control)
coupled to Glutathione Sepharose 4B. 5 pi of protein coupled beads was incubated with 5 pi
of the in vitro transcription/translation reaction in binding buffer (Appendix 1.11.1, total
volume of 50 pi) for 2h at 4 °C with rolling. The beads were then washed 5 times with 500
pi of binding buffer (Chapter 2.18.1). The samples were then analysed by SDS PAGE, but
before being dried the gels were stained with Coomassie Blue R (Figure 5.3) so that the













Figure 5.2: In vitro transcription/translation
Autoradiograph of a 10 % Polyacrylamide-SDSgel showing the production of [35S] muncl8-l, [35S]














Figure 5.3: Assessment of amount of GST-syntaxin 1a-(cyt) in binding mixes
Coomassie blue stained gel of components of an experiment to study the binding of
[35S] muncl8-ls to either GST or GST-syntaxin la-(cyt). Each lane contained the translation mix
shown and either GST or GST-syntaxin la (cytoplasmic domain) An autoradiograph of this gel is
shown in Fig. 5.3
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The gels were dried and analysed by autoradiography (Figure 5.4) and a phosphor imager
(Chapter 2.20) to quantify the amount of [35S]-labelled protein bound to the protein-coupled
glutathione. Once the amount of 13^S]-labelled protein had been determined there were
several corrections that had to be done before the quantification was complete. These were:
1. A correction for transcription/translation efficiency - these differed between the
different muncl8-l constructs used and between the same constructs produced
on different days.
2. The number of methionine residues in each protein had to be taken into account
since the EGFP variants contain 12 methionines whereas the untagged muncl8-l
variants contain 8. Consequently the EGFP variants incorporated more [35S]-
methionine and a correction was made for this.
3. The amount of protein-coupled Glutathione Sepharose 4B present in each
binding reaction had to be normalised because this would affect how much [35S]-
labelled protein had bound. Although this was meant to be identical in each
binding reaction, in practice accurate pipetting of suspensions of Sepharose is
difficult, so a correction was made for variations between samples.
The results (Figure 5.4) revealed that both [35S]-muncl8-l and [35Sl-EGFP-muncl8-l bound
to the GST-syntaxin la-(cyt) whereas binding of [35S]-muncl8-lR39c and [35S]-EGFP-
muncl8-lR39c was not significantly above background levels. To get a more accurate
comparison of the binding affinities competition experiments were done to investigate the
relative binding affinities of [35S]-muncl8-l and [35S]-EGFP-muncl 8-1 with GST-syntaxin
la-(cyt), since these were the variants that bound significantly above background levels.
Initially this was attempted using a munc 18-1-derived peptide as a competitor with [35S]-
muncl8-l variants. Relatively short munc 18-1-derived peptides have been reported to block
the muncl8-l - syntaxin la interaction (Dresbach, Burns et al, 1998), and since, at this time
problems were being encountered in expressing and purifying muncl8-l-V5-His6from



















Figure 5.4: [35S] Munc18-1 constructs binding to GST-syntaxin 1a-(cyt)
An autoradiogram of and SDS-polyacrylamide gel showing binding of [35S]-muncl8-l, [35S]-
EGFP-muncl8-l, [35S]-muncl8-lR39C and [35S]-EGFP-muncl8-lR39Cto either GST or GST-
syntaxin la-(cyt)
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problems of muncl8-l expression had been overcome, subsequent experiments involved
competition of purified muncl8-l with the [35S]-labelled constructs.
5.4 Competition between [35S]-munc18-1 or [35S]-EGFP-munc18-1 and a
munc18-1 peptide for binding to GST-syntaxin 1a-(cyt)
Studies in squid axon have shown that short muncl8-derived peptides inhibit the interaction
between the squid syntaxin (s-syntaxin) and muncl8 (s-Secl) homologues. s-Secl has 66 %
sequence identity with muncl8-l, throughout the entire sequence. A dose response curve of
one such peptide (secpep3) revealed a half-maximal inhibition of binding to s-syntaxin at
75pM (Dresbach, Burns et al. 1998). Based on the secpep3 peptide sequence a 24-
aminoacid peptide (Figure 5.5) was designed that covered the same region in the mammalian
muncl8-l sequence (amino acids 463 - 487) to be used in competitive binding-experiments.
The binding experiment outlined in Chapter 5.3 was repeated with the inclusion of
increasing concentrations (0 - 260 pM) of this muncl8-l peptide or a scrambled peptide, as
a control, made up in binding buffer (Appendix 1.11.1), total volume of 50 pi (Figure 5.6 A-
B). The results were analysed by SDS PAGE followed by Coomassie Staining,
autoradiography and using the phosphorimager, and showed that the muncl8-l peptide did
not fully displace the [35S]-muncl8-l, removing only the lower band in the doublet. This
appears to be the only reported incidence of a difference in behaviour between the two forms
of recombinant muncl8-l that are resolved by SDS-PAGE, in that the two bands are not
equally displaced from syntaxin la by the competing peptide. The experiment was repeated
with the concentration of competitive peptide doubled, the highest concentration used being
520 pM, but this also failed fully to compete off the [35S]-muncl8-l. A 'scrambled' version
of this peptide had no significant effect on the binding of [35S]-muncl8-l to GST-syntaxin
la-(cyt) (Figure 5.6B). Since the muncl8-l peptide failed to act as a satisfactory competitor
for [35S]-muncl8-l this experiment was not extended to [35S]-EGFP-muncl8-l. The

















4: GST-syn 1a-(cyt), 0 peptide 1
5: GST-syn 1a-(cyt), 26 pM peptide 1
6: GST-syn 1a-(cyt), 65 pM peptide 1
7: GST-syn 1a-(cyt), 130 pM peptide 1
8: GST-syn 1a-(cyt), 260 pM peptide 1
9: GST-syn 1a-(cyt), 520 pM peptide 1
Figure 5.6A: Displacement of [35S]-munc18-1 from its complex with GST-syntaxin 1a-
(cyt) by a munc18-1 derived peptide








2: GST-syn 1a-(cyt), 0 peptide-2
3: GST-synla-(cyt), 26 pM peptide-2
3: GST-syn 1a-(cyt), 65 pM peptide-2
4: GST-syn 1a-(cyt), 130 pM peptide-2
5: GST-syn 1a-(cyt), 260 pM peptide-2
6: GST-synla-(cyt), 520 pM peptide-2
Figure 5.6B: Effect of the 'scrambled' munc18-1 derived peptide-2 on binding of
[35S]-munc18-1 to GST-syntaxin 1a-(cyt)
Autoradiogram showing binding of [35S]-Muncl8-1 in the presence of increasing
concentrations of the 'scrambled' peptide -2
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expressed unlabelled muncl8-l protein, in order to determine the relative binding affinities
of [35S]-muncl8-l for GST-syntaxin la-(cyt) and [35S]-EGFP-muncl8-l for GST-ECFP-
syntaxin la-(cyt).
5.5 Competition between [35S]-munc18-1 or [35S]-EGFP-munc18-1 and
bacterially expressed munc18-1-His6 for binding to GST-syntaxin 1a-(cyt)
or GST-ECFP-syntaxin 1a-(cyt) respectively
Experiments in AtT20 cells led to the conclusion that FLIM could not be used to study the
interaction between immuno-labelled endogenous syntaxin la and EGFP-muncl 8-1, so the
interaction between ECFP-syntaxin la and EYFP-muncl8-l was investigated in HEK293
cells (Chapter 6), which lack endogenous syntaxin la. To validate these experiments it had
to be determined whether the addition of GFP variants to both syntaxin la and muncl8-l
interfered with their interaction, so a comparison was made between the binding affinity of
GST-syntaxin la-(cyt) for [35S]-muncl8-l with that of GST-ECFP-syntaxin la-(cyt) for
[35S]-EGFP-muncl8-l. Binding experiments (Chapter 5.4) were set up with GST-syntaxin
la-(cyt) and [35S]-muncl8-l alongside binding experiments with GST-ECFP-syntaxin la-
(cyt) and [35S]-EGFP-muncl8-l in the presence of increasing concentrations [0-3 pM] of
bacterially expressed, purified muncl8-l-His6, which was diluted in binding buffer
(Appendix 1.11.1) to the appropriate concentration (stock muncl8-l-His6 = 22 pM, total
binding reaction volume = 50 pi, Chapter 2.18.3)
Analysis of bound protein, by Coomassie staining, autoradiography and the phosphorimager
as before (Figure 5.7), revealed that the bacterially expressed purified muncl8-l-His6
successfully competed with [35S]-muncl8-l for binding to GST-syntaxin la-(cyt) and with
[35S]-EGFP-muncl8-1 for binding to GST-ECFP-syntaxin la. This data is shown in a graph
(Figure 5.8) of radioactive counts vs. [muncl8-l-His6], revealing that as the concentration of
unlabelled muncl8-l-His6 increased, the amount of bound [35S]-muncl8-l and [35S]-EGFP-
muncl8-l decreased. However when these competitive binding experiments were repeated
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2: 0 |JM munc18-1-His6
3: 0.06 |JM munc18-1-His6
4: 0.16 pM munc18-1-His6
5: 0.32 |JM munc18-1-HiSg
6: 0.48 [jM munc18-1-HiSg
7: 0.64 pM munc18-1-HiSg
8: 0.96 pM munc18-1-HiSg




2: 0 pM munc18-1-HiSg
3: 0.15 (jM munc18-1-HiSg
4: 0.37 [JM munc18-1-His6
5: 0.75 |JM munc18-1-HiSg
6: 1.12 [JM munc18-1-HiSg
7: 1.50 |JM munc18-1-His6
8: 2.24 |JM munc18-1-His6
9: 2.98 |JM munc18-1-His6
Figure 5.7: Competitive binding experiments
A: Autoradiograph of SDS-polyacrylamide gel showing [35S]-muncl8-l bound to GST-syntaxin
la(cyt) in the presence of increasing concentrations of bacterially expressed muncl8-l-His6
B: Autoradiograph of SDS-polyacrylamide gel showing [35S]-EGFP-muncl8-l bound to GST-
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Figure 5.8: Displacement of rnunc18-1 variants from complex with syntaxin
Triangle trace: Displacement of [35S]muncl8-l from GST-syntaxin la-(cyt) by bacterially
expressed muncl8-l-His6
Circle trace: Displacement of [35S]-EGFP-muncl8-l from GST-ECFP-syntaxin la-(cyt) by
bacterially expressed muncl8-l-His6
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on different occasions, there was a variation in the concentration of the cold muncl8-l-His6
required to successfully compete off the radiolabelled protein, which can be seen in Figure
5.7, which shows the results of competition experiments carried out on different days. One
possible explanation for these differences could be that when the cold muncl8-l-His6 was
thawed, after storage in aliquots at -80 °C, some of the protein came out of solution.
Accordingly, the concentration of the protein remaining in solution was determined before
each binding experiment, but measuring the protein concentration does not indicate the
stability of the soluble protein, some of which might not have been folded properly, and
might therefore not bind to syntaxin. This could result in a higher concentration of the cold
muncl8-l being required for successful competition. The muncl8-l-His6 could have been
unstable because it was frozen as it came off the column in a buffer containing 250 mM
imidazole, thus in future purifications the imidazole should be removed before freezing the
muncl8-l-His6. Furthermore, as the concentration of muncl8-l-His6 was increased from
zero, there was an initial enhancement of radiolabelled protein binding before it was
competed off. This effect is thought to be an artefact; it could be due to the presence in the
in vitro transcription/translation reaction mix of some component with a high affinity and
low binding capacity for the radiolabelled muncl8s, which sequesters some of the protein
making it unavailable for binding to syntaxin la. When a small amount of cold muncl8-l-
His6 was added to the reaction it would displace the radiolabelled muncl8-l from this factor,
making it available to syntaxin and resulting in the initial enhancement of binding.
Curiously, this effect appeared to increase with successive binding experiments performed,
where higher concentrations of cold muncl8-l-His6 were required to overcome this
enhancement, which could be a result of an increase in age of the in vitro
transcription/translation mixes used. Even with such variations seen between experiments
done on different days, comparisons could be made between the tagged and untagged
proteins' binding affinities done on the same day.
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A convenient way of treating binding data, when the concentration of a competitive inhibitor
can be varied but the concentration of the binding component cannot, is to use the Dixon plot
(Dixon 1953). This was originally devised for displaying enzyme inhibition data, but is
equally applicable to simple ligand binding. The theory is given in Appendix 3. In enzyme
assays the total enzyme concentration is usually much less than the concentration of
substrate. The situation in the experiments described here is different in that the amount of
ligand used is much less than the amount of protein binding it - it is calculated that each
binding mix contains approximately 1 pmol of GST-syntaxin la-(cyt) and 0.06 pmol of
[35S]-muncl8-l; however the equation is still valid (see Appendix 3). A plot of the
reciprocal of the amount of bound ligand ([35S]-muncl8-l, in this case) against the
competitor (unlabelled muncl8-l) should be a straight line, where:
1 LT + B + K m KT max D_ _|_ r J1 D
B B ,Lt K,.B ,Ltmax T I max T
This predicts that a plot of 1/B against [I] will be a straight line of slope KD/^.Bmax.Lx.
In this expression Bmax is the concentration of GST-syntaxin la-(cyt), which is the same in
each experiment; and LT is the amount of [35S]-muncl8-l, which is the same in each titration
but may vary between titrations, depending on the efficiency of the transcription/translation
system. Assuming that LT is approximately constant, the relative slopes of the plots will
depend on Kd/Ki, the ratio of dissociation constants of [35S]-muncl8 (or [35S]-EGFP-
muncl8-l) and muncl8-His6 from GST-syntaxin la-(cyt) (or GST-ECFP-syntaxin la-(cyt)).
For binding of munc 18-1 the value of ICd/K^ should be 1; the ratio of the slopes of the plots
gives the value of Kd/Kj for binding of EGFP-muncl8 to ECFP-syntaxin la, which is also
close to 1.
Two Dixon plots were drawn for competitive binding experiments done on two separate
occasions (Figures 5.9 and 5.10), one of which contained all the binding data obtained in




















Figure 5.9: Dixon plots of competitive binding experiments
A: Dixon plot of all the data showing competition
1. between [35S]-muncl8-l and muncl8-l-His6 for binding to GST-syntaxin la-(cyt), and
2. between [35S]-EGFP-muncl8-l and muncl8-l-His6 for binding to GST-ECFP-
syntaxinla -(cyt)
B: Dixon plot of the dame data, but normalised to the maximal value for radiolabelled
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Figure 5.10: Dixon plots of competitive binding experiments
A: Dixon plot of all the data showing competition
1. between [35S]-muncl8-l and muncl8-l-His6 for binding to GST-syntaxin la-(cyt), and
2. between [35S]-EGFP-muncl8-l and muncl8-l-His6 for binding to GST-ECFP-
syntaxin 1 a -(cyt)
B: Dixon plot of the dame data, but normalised to the maximal value for radiolabelled
muncl8-l binding to their respective syntaxin la-coupled beads
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was expressed as a percentage of the point where the highest binding of radiolabeled protein
was detected. Figure 5.9A shows all the binding data obtained in the two competition
experiments: the slopes of the plots for [35S]-muncl8-l binding to GST-syntaxin la-(cyt)
and [35S]-EGFP-muncl8-l binding to GST-ECFP-syntaxin la-(cyt) were similar (gradient =
0.002 and 0.0026 respectively). When the binding data were normalised (Figure 5.9B) both
slopes are again very similar (gradient = 0.0077 and 0.011 respectively) suggesting that the
relative binding affinities between the tagged and the untagged proteins are not significantly
different. Dixon plots were drawn for competitive binding experiments done at later date
(Figure 5.10) and although the enhancement of radiolabelled protein binding was found to be
much greater, when the data were normalised as before (Figure 5.9B) the gradients of these
lines were similar. To compare the competition experiments done on different days the
gradients from the normalised Dixon plots were averaged (Figure 5.11) revealing that the
gradient of the GST-syntaxin la-(cyt)/muncl8-l competition was 0.010±0.0012 and the
gradient of the GST-ECFP-syntaxin la-(cyt)/EGFP-muncl8-l was 0.0045±0.006, which
were found to be not significantly different (P = 0.1918, t-test). From these experiments it
was concluded that the addition of fluorescent fusions to both syntaxin la-(cyt) and muncl8-
1 had no significant effect on their interaction.
5.6 Comparison between the binding of [35S]-EGFP-munc18 and its mutants;
[35S]-EGFP-R39c, EYFP-munc18-1S306H:S3i3Eand EYFP-munc18-
1R39C:S306E:S313E to GST-ECFP-syntaxin 1a-(cyt)
As in vitro controls for experiments in FIEK293 cells (Chapter 6), the binding of several
other EGFP/EYFP-muncl8-l mutants to GST-ECFP-syntaxin la-(cyt) was studied. These
experiments were carried out by Dr Rory Duncan and Dr David Apps, using constructs and
proteins described here. A plate based assay (Chapter 2, (Craig, Evans et al. 2003) was used
in which GST-ECFP-syntaxin la-(cyt) was immobilised on glutathione-coated plates and
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Figure: 5.11: Dixon plot gradients from the competitive binding experiments
Dixon plots were drawn for each of the GST-syntaxin la-(cyt)/muncl8-l and GST-ECFP-syntaxin
la-(cyt)/EGFP-muncl8-l competition experiments and the gradients from the plots averaged to
compare their relative binding experiments ( n = 3 for each experiment)
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muncl8-lR39c> the phosphomimetic double mutant EYFP-muncl8-lS306E:S3i3Eand the triple
mutant EYFP-munc 18-1 R39C:S306E:S313e-
These binding experiments revealed (Figure 5.12) that the presence of the R39C mutation in
muncl8-l resulted in an approximately 8-fold reduction in binding to GST-ECFP-syntaxin
la-(cyt). Binding of the phosphomimetic S306E:S313E muncl8-l mutant to GST-ECFP-
syntaxin la-(cyt) was stronger than that of the R39C mutant, but when both the R39C and
phosphomimetic mutations are present in muncl8-l, their effects are additive, resulting in
the EYFP-muncl 8-1r39c:s306E:S313emutant having negligible binding to GST-ECFP-syntaxin
la-(cyt).
5.7 Summary
This chapter reports the use of in vitro GST-pull-down assays to investigate the syntaxin la-
muncl8-l bimolecular complex and to determine whether the fusion of GFP variants to the
N-terminus of these proteins has any effect on their interaction. In initial experiments the
binding of various muncl8-l constructs to either GST-syntaxin la-(cyt) or GST-ECFP-
syntaxin la-(cyt) was investigated. As discussed earlier, several corrections had to be
applied to the data before direct comparisons of the muncl8-l variants could be made. After
these corrections had been applied, the binding data revealed that there were differences in
the affinity of the different muncl8-l constructs for syntaxin la: the binding of the EGFP-
muncl8-lR39C mutant was barely detectable above background, and the phosphomimetic
mutants also showed reduced binding to syntaxin la. However when comparisons were
made between experiments done with different preparations of [35S]-muncl8, variations
were seen in the absolute amount ofmuncl8 bound. To try and overcome this variability it
was decided to carry out competition assays to determine the relative binding affinities of the
untagged syntaxin la and muncl8-l in comparison with the GFP-tagged fusion proteins.
Because of problems in the production of bacterially expressed muncl8-l, muncl8-l-
















Figure 5.12: Comparison between the various [35S]-EGFP/EYFP-munc18-1 constructs
binding to GST-ECFP-syntaxin 1a-(cyt)
A plate based assay (Craig et al, 2004) was used to investigate the binding of a range of different
[35S]-EGFP/EYFP-muncl8-1 mutants to GST-ECFP-syntaxin la-(cyt), where the percentage of bound
radiolabelled protein with respect to total radiolabelled protein was calculated (n = 8 for each
experiment).
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syntaxin la. The corresponding peptide had been previously shown to inhibit the binding of
the squid homologue of muncl8 to squid syntaxin with a Ki of about 100 pM, but in our
assay the muncl8-l competitive peptide was unsuccessful in competing off the [35S]-
muncl8-l from GST-syntaxin la-(cyt), even at concentrations above 500 pM. Only one of
the forms of muncl8-l was successfully competed off, which is unusual since both forms of
muncl8-l have been found to behave identically in previous studies. A possible explanation
that different muncl8s have been shown to bind to their respective syntaxins in different
ways, therefore s-Secl may interact with s-syntaxin differently from muncl8-l and syntaxin
la. It is assumed that the two bands within the doublet arise through proteolysis, and
therefore that the two sub-forms differ by a short stretch of the aminoacids at the N- or C-
terminal. The syntaxin-competitive peptide lies within the muncl8-l sequence (aminoacids
463 - 487)
With the availability of bacterially expressed muncl8-l-His6 from the laboratory of Prof
Alan Morgan and the development of a protocol for the expression and purification of
muncl8-l-His6, experiments could be done using cold muncl8-l-His6 as the competitor.
These revealed that the addition of the GFP tags to both syntaxin la and muncl8-l had no
significant effect on their interaction. However this assay was very time-consuming so for a
comparison between the binding, to syntaxin la, of a range different muncl8-l mutants a
plate based assay (Craig, Evans et al. 2003) was used. This assay was chosen since it is
much quicker, potentially more reproducible and a large number of samples can be
processed at the same time. It was not used to compare the binding of muncl8-l to syntaxin
la and EGFP-syntaxin la because it is not possible to quantitate the amount of native GST-
syntaxin immobilized in each well, making the comparison between two different syntaxin
variants difficult. These plate based experiments revealed that introduction of either the
R39C or the phosphomimetic mutation resulted in similar reduction in the binding affinity of
muncl8-l for syntaxin la and that these mutations are additive resulting in an even lower
affinity for syntaxin la (Figure 5.12). These results however, do not indicate the relative Kd
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of the various mutants because in such experiments the major contributing factor the Kd of
an interaction is the off rates of the protein. Therefore in the case of these mutants, if the
binding affinity is reduced by a factor of 100, then the koff time is greatly reduced so that the
proteins would dissociate during the washing, resulting in an underestimation of weak
binding in the plate based assay.
Although the plate-based assay has the advantages over the more traditional GST-pull-down
assay of high speed, reproducibility and the large number of data points that can be
generated it does have some disadvantages. In this assay only total radioactive counts
(bound and unbound) are measured and in vitro transcription/translation produces not only
full length protein, but also some truncated forms. These may bind differently to the
immobilised protein and in this method, which measures only free and bound counts, it is
impossible to distinguish between truncations and full-length proteins. In contrast the full-
length protein is quantified in the GST-pull-downs, by measuring a specific band on a gel.
Such in vitro binding experiments provide valuable information, but the relevance of such
data to cellular conditions can be disputed. In the case of syntaxin la and muncl 8-1 in vitro
binding experiments, only the cytoplasmic domain of syntaxin la is used because it is
difficult to express full length syntaxin la in bacteria. The transmembrane domain of
syntaxin la is important for some of its protein interactions (Lewis, Dong et al. 2001), so the
removal of this domain may alter syntaxin la's binding properties. Furthermore, in cells
syntaxin la is associated with membranes, however, in these in vitro binding experiments
syntaxin 1 a has no transmembrane domain and no membranes are present, which may also
have implications in syntaxin la's binding properties. Finally, the ionic conditions may be
rather different, in the in vitro experiments, from those within cells. Although the in vitro
approach can be justified as a basis for comparing the affinities of different fusion proteins
under the same conditions, and indeed is an essential control for the in vivo studies, it must
be borne in mind that the findings may not be quantitatively applicable to intracellular
interactions between muncl8 and syntaxin la.
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Chapter 6
Localisation of the syntaxin 1a -
munc18-1 complex in cells
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6.1 Introduction
Syntaxin la can exist in at least two conformational states: the 'open' conformation, in
which it can interact with other SNAREs to form the ternary complex that leads to
membrane fusion, and the 'closed' conformation in which it forms a bimolecular complex
with muncl8-l and is thus sequestered from binding to the other SNARE proteins (Misura,
Scheller et al. 2000; Margittai, Fasshauer et al. 2003). For exocytosis to occur the syntaxin
la - muncl8-l complex must be dissociated; however the molecular mechanism by which
this occurs remains unclear.
Exocytosis in bovine adrenal chromaffin cells has been shown to be directly regulated by
phorbol ester (PE)/diacylglycerol-mediated protein kinase C (PKC) phosphorylation of
muncl8-l (Barclay, Craig et al. 2003). Muncl8-1 phosphorylation on serines 306 and 313
results in a reduced affinity for syntaxin la and alters the kinetics of catecholamine release.
Another residue, arginine 39 (R39), has been shown to make an electrostatic interaction with
syntaxin la and with other amino acids within each of the domains of muncl8-l, thereby
stabilising the syntaxin la - muncl8-l bimolecular complex (Misura, Scheller et al. 2000).
If R39 is mutated to cysteine (R39C) it can no longer participate in these important
interactions and this mutant also has a reduced affinity for syntaxin la, resulting in altered
release kinetics, such as an increase in the rate of opening and closing of the fusion pore,
which could lead to an increase in the rate of neurotransmitter release. This idea was further
supported in Drosophila, in which the Rop F3 mutant (R50, equivalent to R39 in muncl8-l)
produced an increase in postsynaptic current. Furthermore, the effect of expression of
muncl8-lR39c in cells is identical to the effect of activation of protein kinase C (Wu,
Littleton et al. 1998; Fisher, Pevsner et al. 2001).
Immunocytochemical investigation of the localisation of endogenous syntaxin la in rat
phaeochromocytoma (PC 12) cells, using monoclonal anti-syntaxin la and confocal laser
scanning microscopy, revealed intense staining at the cell periphery, with significant staining
of intracellular structures (Jennifer Greaves, personal communication). In cells treated with
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lOOnM phorbol myristoyl acetate (PMA) for 15 minutes there was significant redistribution
of syntaxin la from intracellular structures to the plasma membrane. However, whether the
phorbol ester modulation of exocytosis is mediated through PKC or muncl3s remains
controversial (Rhee, Betz et al. 2002; Barclay, Craig et al. 2003). Therefore to further
elucidate the molecular mechanisms responsible for the PMA-mediated translocation of
syntaxin la, confocal laser scanning microscopy (CLSM), in conjunction with time-
correlated single photon counting (TCSPC)-based fluorescence lifetime imaging microscopy,
was used to quantify localisation and fluorescence resonance energy transfer (FRET)
between fluorescent protein constructs. Most of these experiments were performed in
HEK293 cells, chosen because they do not express synaptic exocytotic proteins, such as the
SNAREs, muncl8, and muncl3s and therefore the interpretation of the images was not
complicated by possible interaction of the transfected fluorescent proteins with such
endogenous proteins (Groffen, Brian et al. 2004). Some experiments were also carried out
on AtT-20 (mouse anterior pituitary corticotroph) cells, in which endogenous syntaxin la
could be detected immunologically.
6.2 AtT20 cells transfected with EGFP-munc18-1 and immuno-stained for
native syntaxin 1a
AtT20 cells were plated out on glass coverslips in 12-well dishes (Chapter 2.22) and
incubated overnight before transfection with 1 pg of EGFP-muncl8-l or plasmid DNA using
Lipofectamine 2000 (Chapter 2.22). The cells were incubated for 48 h before being fixed
with 4 % (w/v) paraformaldehyde then either mounted on microscope slides in Mowiol
immediately, or immunostained using commercial monoclonal anti-syntaxin la (anti-HPC-1)
(Chapter 2.23) before CLSM.
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6.2.1 Co-localisation analysis between EGFP-munc18-1 or and native
syntaxin 1a
Images were acquired of AtT-20 cells transfected with EGFP-muncl8-l, and immuno-
stained for endogenous syntaxin la. In cells transfected with EGFP-muncl8-l alone the
heterologous EGFP-munc 18-1 was distributed throughout the cytoplasm of the cell (Figure
6.1).
To investigate whether the EGFP-muncl8-l co-localised with native syntaxin la an image
stack was acquired of AtT20 cells transfected with EGFP-munc 18-1 and immuno-stained
with monoclonal anti-syntaxin la and Alexa-546-conjugated second antibody, using multi-
tracking (Chapter 2.24). The image data were deconvoluted using Huygens II software and
the relative amount of co-localisation quantified in a 3D pixel-by-pixel manner using Imaris
Colocalisation software (Chapter 2.24). These images revealed (Figure 6.2) that 52.4±6.74
% of EGFP-munc 18-1 colocalised with 13.7±2.09 % of native syntaxin la, located
throughout the cells. There was also a large fraction (47.6±8.83 %) of EGFP-munc 18-1 not
co-localised with the syntaxin la, presumably because endogenous muncl8-l interacted with
the endogenous syntaxin la, and the overexpression of EGFP-munc 18-1 resulted in an
excess of EGFP-munc 18-1 over syntaxin la within the cell.
6.2.2 FRET/FLIM of EGFP-munc18-1 and endogenous syntaxin 1a in AtT-20
cells
Since the preceding analysis revealed co-localisation of exogenous EGFP-munc 18-1 and
endogenous syntaxin la in AtT-20 cells, FLIM was used to quantify FRET in order to
determine whether the proteins were interacting, by measuring the fluorescent lifetime of the
EGFP-muncl8-l in the presence and absence of immunostained native syntaxin la. If the
proteins were interacting a decrease in the fluorescence lifetime of the EGFP-munc 18-1
should be seen compared to non-immunostained control samples. Imaging was performed
(Chapter 2.25), but no FRET was detected. There were several possible reasons for this, for
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Figure 6.1: AtT20 cells transfected with EGFP-munc18-1 and immuno-stained for
endogenous syntaxin 1a
Paraformaldehyde fixed AtT20 cells were imaged by CLSM followed data deconvolution using
Huygens II software. EGFP-muncl8-l is shown in green and native syntaxin la is shown in red
A: middle slice of the z-stack image
B: orthoslicer view of the image stack showing the middle slice and looking at the image in XY, YZ
and XZ side views
C: 3D reconstruction of the image stack with a 10 gM grid; see attached CD for accompanying movie
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Figure 6.2: AtT20 cells transfected with EGFP-munc18-1 and immuno-stained for
endogenous syntaxin 1a
Colocalisation analysis of the AtT20 cell transfected with EGFP-muncl8-l and immuno-stained for
endogenous syntaxin la shown in figure 6.1. Quantification was on a 3D pixel-by-pixel basis, using
Imaris Colocalisation software, where pixels containing both EGFP-muncl8-l and native syntaxin
were extracted and displayed.
A: middle slice of the image z-stack
B: orthoslicer view of the image stack
C: 3D reconstruction of the image stack with a 10 pM grid, see accompanying CD for movie
D: Histogram of the amount of both EGFP-muncl8-l (52.4±6.74 %) and endogenous syntaxin la
(13.7x2.09 %) colocalising with each other
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example, Alexa546 became photo-bleached quickly resulting in a low number of photons
being transferred, making it difficult to acquire FLIM data. Furthermore in a recent
publication (Rickman and Davletov 2005) it was shown that the monoclonal antibody HPC-1
does not recognise syntaxin la when it is in complex with muncl8-l, therefore no FRET will
occur between the antibody-conjugated fluorophore and the EGFP fused to munc 18-1.
Since, no FRET could be detected, and due to the pronounced photo-bleaching when using
immuno-stained syntaxin la, it was decided to cotransfect fluorescently-labelled munc 18-1
with ECFP-syntaxin la. In addition, EGFP is a poor FRET acceptor for ECFP fluorescence
resonance energy, so the EGFP was replaced by EYFP as detailed in Chapter 4.9.2. It was
also decided to investigate the interaction between these proteins in HEK293 cells instead of
AtT20 cells so that the interactions could be investigated without an endogenous protein
background, and because HEK293s have a high transfection efficiency.
6.3 HEK293 cells transfected with ECFP-syntaxin 1a, EYFP-munc18-1 or
EYFP-munc18-1R39c
HEK293 cells were plated out on glass coverslips in the same way as the AtT20 cells and
were transfected after 24h with lpg DNA encoding, ECFP-syntaxin la, EYFP-muncl8-l or
EYFP-muncl 8-1r39c, using Lipofeclamine 2000 (Chapter 2.22). Following transfection the
cells were incubated for 48 h before fixing with 4 % (w/v) buffered paraformaldehyde and
mounting in Mowiol (Chapter 2.22.1), then stored at 4 °C before CLSM analysis.
The subcellular distribution of each of the transfected consliucts was investigated, and it was
found that ECFP-syntaxin la was localised throughout the cell and on the plasma membrane
(Figure 6.3), whereas the EYFP-muncl8-1 and EYFP-muncl8-1R39C were distributed
throughout the cell with a large fraction in the cytoplasm.
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Figure 6.3: HEK293 cells transfected either with EYFP-munc18-1 or with
ECFP-syntaxin 1a
Paraformaldehyde-fixed HEK293 cells were imaged by CLSM and deconvoluted using Huygens 11
software
A: middle slice of an image stack of a HEK293 cell transfected with EYFP-muncl8-l
B: orthoslicer view of a HEK293 cell transfected with EYFP-muncl8-l
C: middle slice from an image stack of a HEK293 cell transfected with ECFP-syntaxin la
D: orthoslicer view ofa HEK293 cell transfected with ECFP-syntaxin la
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6.3.1 HEK293 cells cotransfected with ECFP-syntaxin 1a and either EYFP-
munc18-1 or EYFP-munc18-1R39C
For co-transfected cells, ECFP-syntaxin la was transfected together with either EYFP-
muncl8-l or EYFP-muncl8-lR39c, with 0.5 |ig of each of the constructs per well. Following
transfection images were acquired using a multi-tracking, sequential scanning protocol. The
image data were deconvolved (Chapter 2.24) followed by 3D reconstruction.
In HEK293 cells cotransfected with ECFP-syntaxin la and EYFP-muncl8-l (Figure 6.4)
both of the proteins were seen in puncta on the plasma membrane, suggesting that their
interaction may cause redistribution from the predominantly intracellular location that each
exhibited when expressed on its own.
In contrast, however, ECFP-syntaxin la and EYFP-muncl8-lR39c proteins appeared to be
located in intracellular structures (Figure 6.5) implying that the presence of the R39C
mutation in muncl8-l resulted in the intracellular trapping of both proteins. Since ECFP-
syntaxin la and the EYFP-muncl8-ls had overlapping distributions within the HEK293 cells
this was quantified by colocalisation analysis.
6.3.2 Colocalisation analysis of HEK293 cells cotransfected with ECFP-
syntaxin la and either EYFP-munc18-1 or EYFP- munc18-1R39c
The images for co-localisation analysis were acquired by 3D pixel-by-pixel colocalisation of
deconvoluted, CLSM data (Chapter 2.24) and the amount of syntaxin 1 a colocalising with
the different muncl8 1 variants was quantified, since the syntaxin la is constant throughout
all the experiments performed. The co-localisation analysis (Figure 6.6) revealed that
52±8.81 % of the ECFP-syntaxin la co-localised with the EYFP-munc 18-1. Co-localisation
data in isolation indicated the percentage of each protein interacting with each other, but did
not indicate where in the cells the proteins were colocalising, so as well as obtaining whole-
cell data; colocalisation was examined in each individual section throughout the cell.
However problems with this method of analysis became apparent, where during image
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Figure 6.4: HEK293 cell cotransfected with ECFP-syntaxin 1a and EYFP-munc18-1
Paraformaldehyde-fixed HEK293 cells were imaged by CLSM followed by deconvolution using
Huygens II software. ECFP-syntaxin la is displayed in blue and EYFP-muncl8-l is shown in yellow
A: middle slice through the image stack
B: orthoslicer view
C: 3D reconstruction of the image stack, with a 10 pM see accompanying CD for movie
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Figure 6.5: HEK293 cell cotransfected with ECFP-syntaxin 1a and EYFP-munc18-1R39C
HEK293 cells were fixed in paraformaldehyde before being imaged by CLSM followed by
deconvolution using Huygens II software. ECFP-syntaxin la is shown in blue and EYFP-muncl8-lR39C
in yellow.
A: middle slice of the image stack
B: orthoslicer view of the image stack
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Figure 6.6: Colocalisation analysis of a HEK293 cell cotransfected with ECFP-
syntaxin 1a and EYFP-munc18-1
Colocalisation was quantified in a 3D pixel-by pixel manner using Imaris Colocalisation software
A: colocalisation between ECFP-syntaxin la and EYFP-muncl8-l in the middle section of the image
stack. The red line illustrates how the lines were drawn to investigate where the colocalisation was
localised within the cell
B: orthoslicer view of the colocalisation between ECFP-syntaxin la and EYFP-muncl8-l
C: 3D reconstruction of the image showing all the pixels in which colocalisation was dectected with
a 10 pM grid, see accompanying CD for the movie
D: plot of the distribution of colocalisation between the two proteins, within a line drawn through the
middle section of the image stack covering two membranes and the cytoplasm (see Figure 6.6A).
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acquisition the fluorescent proteins became bleached toward the top of the cell resulting in a
reduction in the signal obtained, so that in a plot of colocalisation against confocal section
the colocalisation tailed off, skewing the results. To avoid this problem another method was
used to quantify the spatial distribution of the colocalisation within the cell. The middle 'z'
section of the extracted colocalisation image was chosen, and four straight lines were drawn
randomly through the cell, cutting membranes but avoiding the nucleus (Figure 6.6A). The
software Zeiss LSM image analyser used creates a plot of intensity vs distance (Figure 6.6D)
and a table containing the relative amount of colocalisation in a scale of 0-255 fluorescence
intensity units at corresponding points on the line. The tabulated data was then taken and
normalised to the background of the individual cell in Microsoft excel, then grouped as
either plasma membrane, by taking the first and last 60 data points (approximately 1pm)
from where the signal starts and ends respectively, or intracellular (cytoplasmic) which
included all the other data points in between. A ratio of colocalisation on the plasma
membrane and intracellular was calculated by dividing the mean colocalisation intensity
value for the plasma membrane points by the median of the intracellular points. A
distribution ratio >1 showed more colocalisation on the plasma membrane than inside the
cell and a ratio less than <1 showed more colocalisation within the cell than on the plasma
membrane. This analysis produced a ratio of 5.73+1.3 for the wild-type proteins confirming
that colocalisation of ECFP-syntaxin la and EYFP-munc 18-1 occurs mainly on the plasma
membrane, suggesting that both syntaxin la and muncl8-l are required for the proper
targeting of these proteins to the plasma membrane.
When cells cotransfected with ECFP-syntaxin la and EYFP-munc 18- 1r39c were analysed in
a similar way (Figure 6.7), ECFP-syntaxin la was found to be extensively colocalised (53.7
±11.2 %) with EYFP-munc 18-1R39C. However, when the colocalisation was investigated as
above, there was a ratio of 0.94 ± 0.14 suggesting that the proteins were not properly
targeted to the plasma membrane of the cells (Figure 6.7D).
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Figure 6.7: Colocalisation analysis in HEK293 cell cotransfected with ECFP-syntaxin 1a
and EYFP-munc18-1R39C
Colocalisation was quantified in a 3D pixel-by-pixel manner using Imaris Colocalisation software
where pixels containing both ECFP-syntaxin la and EYFP-muncl8-lR39C were extracted.
A: colocalisation between ECFP-syntaxin la and EYFP-muncl8-lR39C in the middle slice of the
Image stack. The red line illustrates where the lines were drawn through the images to investigate the
distribution of the colocalisation.
B: orthoslicer view of the colocalisation between ECFP-syntaxin la and EYFP-muncl8-lR39C
C: 3D reconstruction of the pixels in the image which had colocalisation between ECFP-syntaxin la and
EYFP-muncl8-lR39C with a 10 pM grid, see accompanying CD for movie.
D: plot of the distribution of colocalisation between the two proteins, within a line drawn through the
middle section of the image stack covering two membranes and the cytoplasm.
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Control experiments were performed in which ECFP-syntaxin la was transfected along with
EYFP to ensure that the fluorescent proteins themselves did not interact, since it has been
reported that EGFP can form dimers (Zacharias 2002). These experiments confirmed that
the EYFP on its own did not localise with the ECFP-syntaxin la suggesting that syntaxin la
and muncl8-l specifically co-localise.
6.4 FRET and FLIM analyses of ECFP-syntaxin 1a and EYFP-munc18-1 or
EYFP-munc18-1R39c transfected HEK293 cells
In these experiments ECFP was used as the donor fluorophore and EYFP as the acceptor.
First, the fluorescence lifetime of the ECFP-syntaxin la alone was determined, which gave a
weighted mean lifetime of 2.1 ±0.2 ns, which was slightly longer than previously reported
(Duncan, Bergmann et al. 2004), possibly as a result of the ECFP being attached to the
syntaxin la. The fluorescence decay for ECFP fused to syntaxin la was found to be fit by a
bi-exponential function as previously described (Duncan, Bergmann et al. 2004), in non-
FRET and FRET systems. All data here are presented as the weighted mean of the two
(FRET or non-FRET) components.
First, FRET was investigated between ECFP-syntaxin la and EYFP-muncl8-l (Figure 6.8).
Three distinct populations of ECFP, with different fluorescence lifetimes, were detected.
The data were best fit by a triple-Gaussian frequency distribution plot describing the whole
FLIM image. A population with long fluorescence lifetime was found in the region of the
cells where there was no colocalisation. This lifetime was identical to that of ECFP-syntaxin
la alone, indicating that no FRET occurred. Although FRET was not detected this does not
necessarily mean that the proteins are not interacting, simply that the two fluorophores are
too far apart or in an unfavourable orientation for FRET to occur. The fluorescence lifetimes
of the other two populations were shorter, as a result of FRET. These were located
exclusively on the plasma membrane (0.9±0.05 ns - 'short') and on both perinuclear
structures reminiscent of Golgi membranes and the plasma membrane (1,4±0.1 ns -
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Figure 6.8: HEK293 cells cotransfected with ECFP-syntaxin 1a and EYFP-munc18-1,
with ECFP-syntaxin 1a and pEYFP or with ECFP-syntaxin 1a and EYFP-munc18-1R39C
FLIM data were acquired on parafolmaldehyde fixed HEK293 cells
A: FLIM map of HEK293 cell cotransfected with ECFP-syntaxin la and EYFP-muncl8-l
B: FLIM map ofHEK293 cell cotransfected with ECFP-syntaxin la and pEYFP
C: FLIM map of HEK.293 cell cotransfected with ECFP-syntaxin la and EYFP-muncl8-lR39C
D: Frequency distribution plot of ECFP lifetimes measured for HEK293 cells cotransfected with
ECFP-syntaxin la and EYFP-muncl8-l
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'intermediate'). The presence of two weighted mean lifetimes suggests that the distance
between, or orientation of, the fluorophores is different in the two populations and therefore
that the ECFP-syntaxin la and EYFP-muncl8-l are interacting in different ways or that the
bimolecular complex has two different conformations, that are specific to intracellular
locations. In the conformation with the short lifetime the fluorophores must be closer
together or preferentially orientated, with more efficient energy transfer than in the
conformation with the intermediate lifetime.
A parallel control was performed, as with the co-localisation analysis, in which cells were
transfected with ECFP-syntaxin la and EYFP itself (Figure 6.8B). In these cells no FRET
was detected (weighted mean lifetime = 2.2±0.1 ns), confirming that the syntaxin la -
muncl8-l interaction is specific.
When FRET between ECFP-syntaxin la and EYFP-muncl8-lR39c was investigated, no
FRET was detected (mean lifetime 2.2±0.1 ns; Figure 6.8C), suggesting that if these proteins
were interacting, their conformation was such that the fluorophores were not close enough
for energy transfer to occur (> ~6 nm in this system), or else that their dipoles were not in a
favourable mutual orientation.
6.4.1 FRET and FLIM analysis of ECFP-syntaxin 1a and EYFP-munc18-1 or
EYFP-munc18-1R39c in the presence of Phorbol Ester
Previous studies (Barclay, Craig et al. 2003) have shown that when muncl8-l is
phosphorylated in vitro by PKC its interaction with syntaxin la is weakened and in bovine
adrenal chromaffin cells exocytosis has been shown to be regulated by phorbol
ester/diacylglycerol-mediated PKC phosphorylation ofmuncl8-l, which can only occur
when muncl8-l is free of syntaxin la (Fujita, Sasaki et al. 1996; Rickman and Davletov
2005). Furthermore, experiments in this laboratory with rat phaeochromocytoma (PC 12)
cells suggested (J. Greaves, personal communication) that endogenous syntaxin la was
translocated to the plasma membrane in response to treatment of the cells with phorbol ester.
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To investigate the role of phosphorylation in the interaction between muncl8-l and syntaxin
la in cells we employed FLIM. This was accomplished by incubating the transfected cells
with 100 nM PMA for 15 mins to activate PKC and hence phosphorylate muncl8-l, before
fixing and mounting them in the usual way (Duncan, Betz et al. 1999).
In cells that had been transfected with ECFP-syntaxin la and EYFP-muncl8-l (Figure 6.9A)
treatment with PMA resulted in a change in the fluorescence lifetimes. The plasma
membrane-located population with the short fluorescence lifetime (highest FRET efficiency)
disappeared, and was replaced by a population of intermediate fluorescence lifetime
(1.5±0.05 ns), equal to that observed predominantly in internal locations in untreated cells.
This corresponded to a reduction in FRET efficiency, an increase in the donor lifetime and
hence a change in the distance and/or orientation of the fluorophores and was confirmed by
the frequency distribution plot of the entire image. This suggested that the phosphorylated
form of muncl8-l still interacts with syntaxin la, but had prevented the formation of the
conformation that brought the fluorophores the closest together.
Interestingly, when the PMA treatment was repeated in cells transfected with ECFP-syntaxin
la and EYFP-muncl8-lR39C (Figure 6.9B), FRET, which was undetectable before the
addition of PMA, could now be detected throughout the cell, with the same efficiency as in
the population of intermediate fluorescence lifetime (1.6±0.06 ns) seen for ECFP-syntaxin la
and EYFP-muncl8-l. This suggested that the phosphorylated form of muncl8-lR39c
interacts with syntaxin la in a way that brings the fluorophores closer together than in the
absence of the PMA. This implied that in the absence of the PMA, the ECFP-syntaxin la
and the EYFP-muncl8-lR3gc may still be interacting with each other but in a conformation or
orientation where the fluorophores are too far apart, or aligned in an unfavourable manner,
for FRET to occur, but when the munc 18-1 R39c is phosphorylated the proteins interact with
an altered conformation. Furthermore, although the R39 residue of munc 18-1 is essential for
the conformation of muncl8-l and for its interaction with syntaxin la (Misura, Scheller et al.
2000; Fisher, Pevsner et al. 2001), our FLIM data suggests that PKC phosphorylation of
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Figure 6.9: HEK293 cells cotransfected either with ECFP-syntaxin 1a and EYFP-
munc18-1 or with ECFP-syntaxin 1a and EYFP-munc18-1R39C
FLIM data were acquired from HEK293 cells that had been treated with 100 nM PMA before being
fixed in paraformaldehyde.
A: FLIM map of a HEK293 cell cotransfected with ECFP-syntaxin la and EYFP-muncl8-l
B: FLIM map of a HEK293 cell cotransfected with ECFP-syntaxin la and EYFP-muncl8-lR39C
C: Frequency distribution plot of the different ECFP lifetimes measured, revealing the short,
intermediate and non-FRET lifetime populations
180
muncl8-l bypasses the requirement for R39 in the syntaxin la-muncl8-l complex; in
other words, it rescues the R39C mutant form ofmuncl8-l.
Parallel controls were set up to check that the changes in the fluorescence lifetime of the
ECFP-syntaxin 1 a were not a direct effect of adding the PMA. Cells transfected with ECFP-
syntaxinla alone were treated with PMA and the fluorescence lifetime of the ECFP-syntaxin
la measured. It was found to be the same as in the absence of PMA. HEK293 cells
transfected with ECFP-syntaxin la and EYFP were also treated with PMA, which again had
no effect on the lifetime of the ECFP-syntaxin la. Therefore the changes in the fluorescence
lifetimes detected on treatment with PMA were the result of changes in conformation of the
complex formed by the two proteins, altering the distance between the fluorophores and
hence the efficiency of FRET. In other control experiments, done to confirm that the effect
seen due to the addition of phorbol ester was mediated via the activation of PKC, the cells
were treated with an inactive phorbol ester, -phorbol 4a-myristoyl acetate (4a-PMA), (100
nM) for 15 minutes prior to fixing as before. This had no effect on the fluorescent lifetimes
measured for ECFP-syntaxin la in the presence on either EYFP-muncl 8-1 or EYFP-
muncl8-lRw, suggesting that the phorbol ester effect seen is specific.
6.5 FRET and TLIM analycce of cells cotransfected with ECFP-syntaxin 1a
and either EYFP-munc18-1s306E:S3i3E or EYFP-munc18-lR39o:s306E:s3i3E
To further investigate whether the changes in fluorescence lifetime produced by PMA
treatment of cells was due to phosphorylation of muncl8-l and muncl8-lR39C on Serines 306
and 313, as previously reported (Barclay, Craig et al. 2003), phosphomimetic mutants, made
by site-directed mutagenesis, (kind gift ofDr Rory Duncan) were studied. The mutations
changed these serines into glutamic acids, in which the negative charge mimics the effect of
phosphorylation of EYFP-muncl 8-1 and EYFP-muncl 8-lR39c. The muncl8-lS306E:S3i3E
phosphomimetic (double mutant) has previously been shown (Barclay, Craig et al. 2003) to
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have weakened affinity for syntaxin 1 a in vitro, comparable with that of phosphorylated
muncl8-l. Its expression also modified the kinetics of catecholamine release from bovine
adrenal chromaffin cells in a similar, but not identical way to phorbol ester treatment of the
cells.
FLIM data for HEK293 cells cotransfected with ECFP-syntaxin la and EYFP-muncl8-
ls306E:s3i3E (Figure 6.10A) were generated in the same way as above and showed that with the
phosphomimetic muncl8-l mutant, the shortest lifetime (plasma membrane) population was
not detectable, however the intermediate (predominantly non-plasma membrane) lifetime
population (1.7±0.06 ns) was found uniformly throughout the cells. This gives support to the
idea that the phosphorylation ofmuncl8-l is responsible for the reduction in the observed
FRET efficiency, presumably through a change in the conformation of the syntaxin la -
muncl8-l complex.
Similar experiments were performed with a phosphomimetic mutant of EYFP-muncl8-lR39C.
FLIM data for HEK293 cells transfected with ECFP-syntaxin la and EYFP-muncl8-
1r39C:S306E:S313e (triple mutant, Figure 6.10B) showed levels of FRET (1.6±0.07 ns) identical
to those seen in PMA-treated cells expressing EYFP-muncl8-lR39C and in cells expressing
the phosphomimetic mutant.
The observation that PKC-directed phosphorylation of muncl8-l on serines 306 and 313
results in a reduction of FRET between the two fluorophores implies that there is a change in
the conformation of the syntaxin la - muncl8-l complex that results either in an increase in
the interdipole distance or in an unfavourable dipole orientation. Significantly, this effect is
restricted to muncl8-l/syntaxin la resident on the plasma membrane.
Controls were also performed in which the cells were treated either with 100 nM PMA or
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Figure 6.10: HEK293 cells cotransfected either with ECFP-syntaxin 1a and EYFP-munc18-
1s306E:S3i3Eorwith ECFP-syntaxin 1a and EYFPmunc18-1R39C:S306E:S313E
FLIM data were acquired on paraformaldehyde fixed HEK293 cells
A: FLIM map of HEK293 cell cotransfected with ECFP-syntaxin la and EYFP-muncl8-lS306ES313E
B: FLIM map of HEK293 cell cotransfected with ECFP-syntaxin la and EYFP-muncl8-lR39CS306ES313E
C: Frequency distribution plot of the global analysis of the ECFP fluorescent lifetimes measured
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6.6 Colocalisation analysis of HEK293 cells cotransfected with ECFP-
syntaxin 1a and either EYFP-munc18-1 or EYFP-munc18-1R39c treated
with 100 nM PMA
Since the effects of muncl8-l phosphorylation appeared to be restricted to the plasma
membrane of the cells, it was investigated whether phosphorylation had any effect on
colocalisation of the proteins.
HEK293 cells transfected with ECFP-syntaxin la and EYFP-muncl8-l were treated with
100 nM PMA for 15 mins, then fixed and mounted (Chapter 2.22.1). Laser scanning
confocal microscopy was used to generate image stacks, which were deconvolved and
reconstructed as before (Figure 6.11), showing that both ECFP-syntaxin la and EYFP-
muncl8-l were on the plasma membrane. 3D pixel-by-pixel colocalisation analysis was
performed (Figure 6.12) on these images revealing that 39.7± 11.8% of the ECFP-syntaxin
la colocalised with the EYFP-muncl8-l. When the spatial distribution of the colocalisation
was investigated a ratio of 4.73±1.73 was found suggesting there was more colocalisation on
the plasma membrane of the cell than in the cytoplasm. These results were similar to those
obtained with untreated cells.
Interestingly, when the same analysis was done on cells cotransfected with ECFP-syntaxin
la and EYFP-munclS 1 Kjyi. and treated with PMA, in the reconstructed images (Figure
6.13), a fraction of both proteins appeared to be on the plasma membrane and therefore had
reached their correct intracellular destination. Colocalisation analysis (Figure 6.14) revealed
that 44.6±9.7 % of the ECFP-syntaxin la colocalised with the EYFP-muncl8-lR39c, and, in
contrast to untreated cells, when the location of the colocalisation was quantified the
distribution ratio was 4.44+1.64, revealing that there was more colocalisation on the plasma
membrane than in the cytoplasm. Control experiments were performed in which the cells
were treated with 100 nM 4a-PMA instead of PMA to check that the effects seen were
specifically PMA-mediated (Figure 6.15 & 6.16). In cells cotransfected with ECFP-syntaxin
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Figure 6.11: IIEK293 coll cotransfucted with ECFP-syntaxin 1a and EYFP-munc18-1
HEK293 cell'; wore treated with 10nM PMA before being fixed in paraformaldehyde and imaged
using CLSM followed by deconvolution with Huygens II software. The ECFP-syntaxin 1 a is
shown in blue and EYFP-muncl8-l in yellow
A: middle slice through the image stack
B: orthoslicer view of the image stack
C: 3D reconstruction of image stack with a lOpM grid; see accompanying CD for movie
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Figure 6.12: HEK293 cell cotransfected with ECFP-syntaxin 1a and EYFP-munc18-1
Colocalisation was quantified on a 3D pixel-by-pixel basis, using Imaris Colocalisation software.
HEK293 cells were treated with 100 nM PMA before being fixed in paraformaldehyde
A: middle slice of an image stack containing an example of a line drawn for investigating the
distribution of colocalisation within in the cell.
B: orthoslicer view of image stack
C: 3D reconstruction of image stack with a 10 pM grid, see accompanying CD for movie




Figure 6.13: HEK293 cell cotransfected with ECFP-syntaxin 1a and EYFP-munc1B-lR39C
HEK293 cells were treated with 100 nM PMA before being fixed in paraformaldehyde and imaged by
CLSM followed by deconvolution with Huygens II software. ECFP-syntaxin la is shown in blue and
EYFP-muncl 8-1R39C in yellow
A: middle slice of an image stack
B: orthoslicer view of the image stack
C: 3D reconstruction of image stack with a 10 pM grid ; see accompanying CD movie
187
A B
Figure 6.14: HEK293 cell cotransfected with ECFP-syntaxin 1a and EYFP-munc18-1R39C
Colocalisation in the cell shown in Figure 6.13 was quantified on a 3D pixel-by-pixel basis that had
been treated with 100 nM PMA before being fixed in paraformaldehyde
A: middle slice of an image stack with an example of how the lines were drawn to investigate the
distribution of the colocalisation.
B: orthoslicer view of the image stack
C: 3D reconstruction of the image stack with a 10 pM grid; see accompanying CD for movie
D: plot of colocalisation intensity measured on a line drawn (see Figure 6.14A) through the middle
section of the colocalised image stack.
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Figure 6.15: HEK293 cell cotransfected with ECFP-syntaxin 1a and EYFP-munc18-1
HEK293 cells were treated with 100 nM 4a-PMA for 15min before being fixed and imaged by
CLSM. Image data were deconvolved using Huygens II software. ECFP-syntaxin la is displayed in
blue and EYFP-munc 18-1 in yellow.
A: middle section an image stack
B: orthoslicer view of the image stack















Figure 6.16: HEK293 cell cotransfected with ECFP-syntaxin 1a and EYFP-munc18-1
3D pixel-by-pixel colocalisation analysis was done on HEK293 cell transfected and treated with
I OnM 4a-PMA for 15min prior to fixing shown in Figure 6.15.
A: middle section of the colocalisation image stack containing an example of the lines drawn to
investigate the distribution of the colocalisation
B: orthoslicer view of the colocalisation image
C: 3D reconstruction of the colocalised pixels in the image stack with a 10 pM grid, see
accompanying CD for movie.
















la and EYFP-muncl8-l there was 38.3±3.9 % colocalisation of the syntaxin la with the
muncl8-l and this colocalisation had a distribution ratio of 2.37±0.81, suggesting that most
of the proteins were colocalising on the plasma membrane as in untreated cells.
When cells cotransfected with ECFP-syntaxin la and EYFP-muncl8-lR39c were treated with
100 nM 4a-PMA (Figure 6.17 &6.18), 48.9±9.5 % of the syntaxin la colocalised with the
muncl8-lR39c and the distribution ratio was 0.48±0.04, so most of the protein complex was
located intracellularly, as was seen in untreated cells.
These results suggested that phosphorylation of muncl8-l on serines 306 and 313 bypasses
the requirement for interactions involving R39, and therefore rescues the R39C mutation,
allowing proper targeting of the syntaxin 1 a - muncl8-l complex to the plasma membrane.
6.7 Colocalisation analysis of HEK293 cells cotransfected with ECFP-
syntaxin 1a and either EYFP-munc18-1S306E:s3i3Eor EYFP-munc18-
1 R39C:S306E:S313E
To further understand the role of phosphorylation on the syntaxin la - muncl8-l complex,
the colocalisation of ECFP-syntaxin la and the phosphomimetic mutants was investigated.
HFK293 cells were cotransfected with either, ECFP-syntaxin la and EYFP-muncl8-
ls306E:S3i3Eor ECFP-syntaxin la and EYFP-muncl8-lR39C:s306E:S3i3Ein the same way as before
(Chapter 6.2) then imaged using CLSM.
In cells cotransfected with ECFP-syntaxin la and EYFP-muncl 8-1S306E:S313e (Figure 6.19) the
proteins were found to be both cytoplasmic and on the plasma membrane. The same was
seen in cells cotransfected with ECFP-syntaxin la and EYFP-muncl8- 1R39C:S306E:S313e(Figure
6.20).
The amount of colocalisation between the proteins was quantified in a 3D pixel-by-pixel
manner using Imaris colocalisation software and the spatial distribution of the colocalisation




Figure 6.17: HEK293 cell cotransfected with ECFP-syntaxin 1a and EYFP-munc18-1R39C
Cells were treated with 100 nM 4a-PMA for 15min before fixing and imaging by CLSM. The image
data were then deconvolved using Huygens II software. ECFP-syntaxin la is displayed in blue and
EYFP-muncl8-lR39C in yellow
A: middle section of a cell image stack
B: orthoslicer view of the image stack
C: 3D reconstruction of the image stack with a 10 pM grid, see accompanying CD for movie.
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Figure 6.18: HEK293 cell cotransfected with ECFP-syntaxin 1a and EYFP-munc18-1R39C
Colocalisation analysis was performed on a 3D pixel-by-pixel basis using Imaris colocalisation
software on cells treated with 4a-PMA for I5min before fixation.
A: middle section of the colocalisation image stack containing an example of the lines drawn in the
investigation of the distribution of the colocalisation.
B: orthoslicer view of the colocalisation image stack
C: 3D reconstruction of the colocalised pixels of the image stack with a 10 pM grid, see
accompanying CD for movie.
D: plot of colocalisation intensity measured on a line drawn through the middle section of the
colocalised image stack.
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Figure 6.19: HEK293 cell cotransfected with ECFP-syntaxin 1a and
EYFP-munc18-1 S306E:S313E
Transfected HEK293 cells were fixed in 4 % (w/v) paraformaldehyde then imaged using CLSM
followed by deconvolution using Huygens II software. The ECFP-syntaxin 1 a is shown in blue and
the EYFP-muncl8-lS306E.S313E in yellow
A: middle section of the image stack
B: orthoslicer view of the confocal image stack
C: 3D reconstruction of the deconvolved image stack with a 10 pM grid, see accompanying CD for
movie.
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Figure 6.20: HEK293 ceil cotransfected with ECFP-syntaxin 1a and
EYFP-munc18-1 R39C:S306E:S313E
Transfected HEK293 cells were fixed in 4 % (w/v) paraformaldehyde and imaged using CLSM
followed by deconvolution using Huygens II software. ECFP-syntaxin la is displayed in blue and
EYFP-muncl8-lR39C:S306E:S3i3E in yellow.
A: middle section through a confocal image stack
B: orthoslicer view of the confocal image stack
C: 3D reconstruction of the confocal image stack with a 10 pM grid, see accompanying CD for movie.
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In HEK293 cells cotransfected with ECFP-syntaxin la and EYFP-muncl8-lS306E:S3i3E>
42±4.81 % of the ECFP-syntaxin la colocalised with EYFP-muncl8-lS306E:S3i3E, which is not
significantly different from the colocalisation seen with wild-type proteins (Figure 6.21).
The distribution of the colocalisation in the cell was also investigated (Chapter 6.3.2); the
distribution ratio was 1.53±0.64 % suggesting that slightly more of the protein complex was
found on the plasma membrane than intracellularly. This is, however, different to wild-type
proteins in cells treated with PMA, in which a much higher percentage of the protein is
localised to the plasma membrane than in the cytoplasm. A possible reason for this
difference is a folding problem with the phosphomimetic mutant, such that the presence of
the glutamic acids at positions 306 and 313 may result in inefficient folding of a fraction of
the muncl8-l, resulting in the formation of a syntaxin la - muncl8-l bimolecular complex
that is trapped intracellularly; where the muncl8-lS306E:S3i3E has folded correctly the syntaxin
la- muncl8-lS306E:s3i3Ecomplex is correctly targeted to the plasma membrane. This is in
contrast to phosphorylation of wild-type muncl8-l, which obviously must occur following
folding.
In HEK293 cells cotransfected with ECFP-syntaxin la and EYFP-muncl8-lR39C:S306E:S3i3Ethe
colocalisation analysis revealed (Figure 6.22) that 53.2±7.04 % of the ECFP-syntaxin la
colocalised with the EYFP-muncl8-lR39C;S306E:S3i3E which is not significantly different from
the colocalisation seen in cells transfected with wild-type proteins. When the distribution of
the colocalised proteins was investigated as before, the distribution ratio was 1.85±0.53 %,
revealing that slightly more of the complex was localised on the plasma membrane than
intracellularly. Although this result differs from that obtained in cells cotransfected with
ECFP-syntaxin la and EYFP-muncl8-lR39C, it is also different to the result obtained in cells
cotransfected with ECFP-syntaxin la and EYFP-muncl8-lR39C treated with 100 nM PMA, in
which trafficking of the complex to the plasma membrane is restored. Again the reason for a
difference in these results could be due to the mis-folding of some of the munc 18-1
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Figure: 6.21: HEK293 cell transfected with ECFP-syntaxin 1a and
EYFP-munc18-1S306E:S313E
3D pixel-by-pixel colocalisation analysis was carried out using Imaris imaging software on the cell
shown in Figure 6.20
A: middle section of the colocalisation image stack with a example of the lines drawn to investigate
the distribution of the colocalisation
B: orthoslicer view of the image stack
C: 3D reconstruction of the colocalised pixels with a 10 pM grid, see accompanying CD for movie.




















Figure 6.22: HEK293 cell transfected with ECFP-syntaxin 1a and EYFP-munc18-
1R39C:S306E:S313E
Colocalisation analysis was performed on a 3D pixel-by-pixel basid using Imaris colocalisation
software
A: middle section of the image slice with an example of the lines drawn to investigate the
distribution of the colocalisation within the cell
B: orthoslicer view of the colocalisation image stack
C: 3D reconstruction of the colocalised pixels with a 10 pM grid, see accompanying CD for movie.
D: A plot of the amount of colocalisation found in a line drawn through the middle section of the
colocalisation image stack
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the glutamic acids do not accurately mimic the electrostatics of P042" groups therefore do not
rescue the R39C mutation as well as PKC phosphorylation does.
Similar experiments were done with cells treated with 100 nM 4a-PMA for 15 mins prior to
fixing, which had no effect on the amount and distribution of the colocalisation calculated.
In cells cotransfected with ECFP-syntaxin la and EYFP-muncl 8-1S306E:S313e and treated with
4a-PMA, 55.2±5.15 % of the ECFP-syntaxin la was found to colocalise with the EYFP-
muncl8-lS306E:S3i3Ephosphomimetic mutant with a ratio of 0.95±0.33, both of which are not
significantly different to the results obtained in untreated cells. With cells cotransfected with
ECFP-syntaxin la and EYFP-muncl8- 1r39C:s306E:S313etreated with 4a-PMA, 56.6±6.9 % of
the ECFP-syntaxin la colocalised with the EYFP-muncl8-1r39C:S306E:S313e with a ratio of
1.25±0.19 and therefore not significantly different to the results obtained with untreated
cells.
6.8 Summary
This chapter demonstrates that both syntaxin la and muncl8-l had to be co-expressed in
cells together in order for the bimolecular complex to be properly targeted. These proteins,
when expressed together, were found to colocalise specifically at the plasma membrane;
approximately 50 % of syntaxin la colocalises with muncl8-l, with a plasma
membrane.intracellular colocalisation ratio >3, (Figure 6.23). Colocalisation analysis
however, does not by itself reveal whether two proteins are interacting. For this TCSPC-
FLIM was employed to investigate specifically the syntaxin la - muncl8-l interaction in
HEK293 cells.
In cells cotransfected with ECFP-syntaxin la and EYFP-muncl8-1, FLIM data showed the
presence of three different FCFP-syntaxin la populations; a long-lifetime, non FRET
population, which corresponded to regions of the cell in which no colocalisation was
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Figure 6.23: Colocalisation of syntaxin 1a with the different munc18 variantss
A: Histogram of the total colocalisation of ECFP-syntaxin with the various EYFP-muncl8-ls
including all treatments used (n = 3 for each group)
B: Histogram of colocalisation distribution ratios (plasma membrane/cytoplasmic intensities) (n




population, in which the fluorophores are closest together, was localised exclusively to the
plasma membrane of the cell and the intermediate lifetime population was found mainly in
intracellular structures with some located to the plasma membrane. The presence of these
two populations, with different FRET lifetimes, is suggestive of two distinct conformations
of the syntaxin la - muncl8-l complex that are spatially restricted within the cell.
When the effect of muncl8-l PKC phosphorylation on serines 306 and 313 was investigated
by incubating the cells with PMA, TCSPC-FLIM revealed that the population with the
shortest FLIM lifetime had disappeared from the plasma membrane and was replaced by one
with intermediate lifetime. This suggested that the phosphorylation of muncl8-l resulted in
a change in the conformation of the syntaxin la -muncl8-l complex, altering the proximity
of the fluorophores.
When the role of R39 was investigated by use of the muncl8-lR39c mutant, similar amounts
of syntaxin la were found to localise with muncl8-lR39c (figure 6.23), however the proteins
were mainly trapped in intracellular structures. TCSPC-FLIM analysis revealed only the
presence of the non-FRET population, indicating that if the proteins were interacting they
were doing so in a way that the fluorophores were either too far apart or in an unfavourable
orientation for FRET to occur.
Interestingly, when these cells were treated with PMA the population of intermediate FRET
lifetime could be detected. Furthermore, when the spatial distribution of the colocalisation
between ECFP-syntaxin la and EYFP-muncl8-lR39C was investigated in the presence of
PMA the proteins were found to colocalise largely on the plasma membrane (Figure 6.23).
These results implied that when R39 is mutated to a cysteine it results in an altered
conformation of the syntaxin la - muncl8-l complex that is not trafficked correctly to the
plasma membrane, but phosphorylation ofmuncl8-l causes a conformational change, so that
interactions involving R39 are not required and therefore the complex can be properly
targeted.
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To confirm that the effects seen were indeed due to phosphorylation of muncl8-l on Ser306
and Ser313, phosphomimetic mutants were made in which these serines were mutated to
glutamic acids. TCSPC-FLIM analysis of cells cotransfected with either, ECFP-syntaxin la
and EYFP-muncl8-lS3o6E:S3i3Eor ECFP-syntaxin la and EYFP-muncl8-lR39c:s306E:S3i3E
revealed the presence only of the population of intermediate lifetime and not that with the
shortest FLIM lifetime, suggesting that phosphorylation on Ser306 and Ser313 is capable of
altering the syntaxin la - muncl8-l complex conformation.
When the localisation of the ECFP-syntaxin la - EYFP-muncl8-lS306E:S3i3Ecomplex was
investigated, differences were seen from the phosphorylated wild-type proteins. This
complex was found slightly more on the plasma membrane than intracellularly, rather than
being predominantly on the plasma membrane like the wild-type protein complex. In cells
cotransfected with ECFP-syntaxin la and EYFP-muncl 8-1r39C:s306E:S313e> the complex was
also found in larger amounts on the plasma membrane than inside the cell, which was
different to the localisation of the complex, both in cells cotransfected with ECFP-syntaxin
la and EYFP-muncl8- 1R39C, where the complex is trapped intracellularly, and in these cells
after treatment with PMA, in which the complex is found predominantly on the plasma
membrane. A reason for the differences in the spatial distribution of the phosphomimetic
mutants could be due to the effect of the glutamic acid substitution on the folding of
muncl8-l, so that a fraction of muncl8-l is mis-folded the syntaxin la- muncl8-l complex
is trapped intracellularly, but when the muncl8-l folds folds properly, the complex is
correctly targeted to the plasma membrane, this seems plausible since PKC phophorylation
of muncl8-l can only occur following folding, and the presence of the negatively charged





7.1 Discussion and Future Work
Muncl8-1 and its homologues, known as the Secl/muncl8 (SM) proteins are believed to be
key regulators of membrane fusion steps throughout the secretory pathway, and to have both
positive and negative regulatory roles in exocytosis. Many SM proteins share a common
feature of interacting with their corresponding syntaxin homologue, leading to the suggestion
that SM proteins may function by acting as a chaperone for their cognate syntaxin. This idea
was strongly supported by studies in the yeast S.cerevisiae lacking the muncl8 orthologue,
Vps45p, where its syntaxin binding partner, Tlg2p was severely down-regulated through
rapid proteasomal degradation (Bryant and James 2001). However the yeast muncl8
homologue Seclp does not bind to monomeric Ssolp, a syntaxin homologue, although it
does bind to a ternary complex containing homologues of VAMP and SNAP-25 (Carr, Grote
et al. 1999). In addition, in PC12 cells syntaxin is unable to leave the Golgi in the absence of
muncl8 (Rowe, Calegari et al. 2001) and a recent reanalysis of the muncl8-l null mutant
mouse revealed that syntaxin la levels were reduced by up to 70% (Toonen, de Vries et al.
2005), providing a simple explanation for the reduction in neurotransmission seen.
Therefore, muncl8-l may function by transporting newly synthesised syntaxin la, in an
inhibited state, to sites of exocytosis, where the syntaxin la -muncl8-l complex dissociates,
allowing SNARE complex formation and eventually exocytosis (Rickman and Davletov
2005). Such a role could explain both the positive and negative effects seen in the various
SM protein mutants. However, this leads to a further question: how is syntaxin la released
from its tight complex with muncl8-l?
To date several possible candidates for the dissociation of the syntaxin la -muncl8-l
complex have been investigated; UNC13/muncl3 proteins, Rab and Rab effectors, Tomosyn,
muncl8-l phosphorylation and, more recently, arachidonic acid and Mintl (Okamoto and
Sudhof 1997; Biederer and Sudhof 2000; Rickman, Hu et al. 2005). The work reported in
this thesis focussed on the effects of phosphorylation by PKC, which has been shown to
stimulate Ca2+-dependent exocytosis in various types of secretory cell. PKC was found to
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phosphorylate free muncl8-l on Ser306and Ser313 in vitro, with a reduction in its affinity
for syntaxin la, although muncl8-l was not phosphorylated when in complex with syntaxin
la (Fujita, Sasaki et al. 1996). In this study however, the detergent CHAPS, which is
capable of dissociating the syntaxin la - muncl8-l complex, was included in the reaction
buffer (Rickman, Hu et al. 2005).
In rat brain synaptic terminals muncl8-l is almost completely dephosphorylated and
inhibition of protein phosphatases results in a 250 % increase in phosphorylation, which is
then increased by a further 1500 % on additional, direct PKC activation by phorbol esters (de
Vries, Geijtenbeek et al. 2000). Also, phosphorylation of muncl8-l increased by 50 %, in a
Ca2+-dependent manner, within 5 seconds of K+-evoked depolarisation, and activation of
endogenous PKC in nerve terminals inhibited the interaction of muncl8-l with syntaxin la
by 50 % (de Vries, Geijtenbeek et al. 2000).
In intact bovine chromaffin cells muncl8-l has been shown to be phosphorylated in response
to treatment with phorbol ester or histamine and in permeabilised bovine chromaffin cells in
response to elevation of [Ca2+], altering the release kinetics of exocytosis. These results
were mimicked in chromaffin cells overexpressing a muncl8-l phosphomimetic mutant in
which both Ser306 and Ser313 were mutated to glutamates (Barclay, Craig et al. 2003;
Craig, Evans et al. 2003).
In this thesis the role of muncl8-l phosphorylation in the dimeric syntaxin la - muncl8-l
complex was investigated by expressing fluorescent fusion proteins and various muncl8-l
mutants in HEK293 cells, which were chosen since they do not contain endogenous muncl8-
1, syntaxin la or several other exocytotic proteins. Initial binding experiments were
performed in vitro, comparing the relative binding affinities of wild-type syntaxin la and
muncl8-l with those of N-terminally fluorescence-tagged syntaxin la and muncl8-l, and it
was concluded that the attachment of the fluorescent proteins had no significant effect on
their interaction. HEK293 cells were then cotransfected with ECFP-syntaxin and either
EYFP-muncl8-l or the muncl8-l mutant, EYFP-muncl8-lR39C. R39 is thought to be an
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important residue in munc 18-1-syntaxin interactions, since it not only makes electrostatic
contacts with syntaxin la, but also coordinates intra-molecular interactions with other amino
acids within each of the domains ofmuncl8-l, suggesting that it is essential for stabilising
both muncl8-l and the syntaxin la - muncl8-l complex structures. When R39 is mutated
to cysteine all of these contacts are lost, and overexpression of this mutant in bovine
chromaffin cells was reported to alter granule release kinetics (Fisher, Pevsner et al. 2001).
In recent work with PC 12, cells, however, no such effect was found (Schutz, Zilly et al.
2005). In this context, the possibility that syntaxin la is extensively localised in cholesterol-
rich rafts (Salaun, Gould et al. 2005) may be relevant, as the amperometric studies of Fisher
et al were performed in digitonin-permeabilized chromaffin cells, and the permeabilization
process itself may have altered the distribution of syntaxin, thereby altering the release
kinetics.
In these transfectants most of the proteins were localised intracellularly, with some of the
ECFP-syntaxin la found on the plasma membrane. However, when HEK293 cells were
cotransfected with ECFP-syntaxin la and EYFP-muncl8-l they were found to colocalise
predominantly on the plasma membrane supporting the data from PC 12 cells (Rowe,
Calegari et al. 2001) and yeast (Bryant and James 2001), which suggested that muncl8-l has
to be present for the correct plasma membrane targeting of syntaxin la. Interestingly, in
HEK293 cells cotransfected with ECFP-syntaxin la and EYFP-muncl8-lR39c both proteins
were found to be trapped on intracellular structures and not properly targeted to the plasma
membrane, suggesting that the predominant effect of the muncl8-lR39c mutation is on
targeting. This is in agreement with a recent report on the effect of the R39C mutation in
PC12 cells (Schutz, Zilly et al. 2005). These workers also studied another muncl8-l variant,
D34N, which binds negligibly to syntaxin la; paradoxically, while muncl8-lR39c inhibited
exocytosis in PC12 cells, muncl8-lD34N was found to be stimulatory. This was attributed to
its strong interaction with Mintl, which has been reported to form a trimeric complex with
munc!8 and syntaxin (Okamoto and Sudhof 1997).
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These data strongly suggest an interaction between the two proteins, but since colocalisation
of proteins does not necessarily prove their direct interaction, TCSPC-FLIM was used. This
revealed the presence in HEK293 cells cotransfected with ECFP-syntaxin la and EYFP-
muncl8-l of three ECFP-syntaxin la populations with distinct fluorescence lifetimes; a
long-lifetime, non-FRET population in regions of the cells where no colocalisation was
detected and two others, of short and intermediate FRET lifetimes. The population of
highest FRET efficiency (short fluorescent lifetime) was detected exclusively on the plasma
membrane and the population of lower FRET efficiency (intermediate fluorescent lifetime)
was detected both on the plasma membrane and in intracellular structures. The finding of
two FLIM lifetimes suggests two distinct conformational states of the bimolecular syntaxin
1 a - munc 18-1 complex; one in which the fluorophores are closer together or in a more
favourable orientation, having a higher FRET efficiency, a shorter fluorescence lifetime and
therefore probably a tighter interaction, than in the other conformation, because FRET is a
direct measurement of the interdipole distance between the two fluorophores. In HEK293
cells cotransfected with ECFP-syntaxin la and EYFP-muncl8-lR39C only the non-FRET
lifetime was detected suggesting that if the proteins were interacting they were doing so in a
conformation in which the fluorophores were too far apart (>6nm in this system) or in a
unfavourable orientation for FRET to occur.
Next, the effect of munc 18-1 phosphorylation was investigated by treating the cells with
phorbol ester before fixing. Analysis of colocalisation between ECFP-syntaxin la and
EYFP-muncl8-l showed that the proteins were found mainly on the plasma membrane of
the cells, with no significant difference in distribution from untreated cells. However, the
FLIM data revealed that the population of shortest fluorescence lifetime, residing exclusively
on the plasma membrane in untreated cells, had disappeared and been replaced by population
with the intermediate fluorescence lifetime, suggesting that the phosphorylation of munc 18-1
had altered the conformation of the syntaxin la - munc 18-1 complex so that the two
fluorophores were further apart. Interestingly, when FLIM data was acquired from HEK293
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cells cotransfected with ECFP-syntaxin la and EYFP-muncl8-lR39c and then treated with
PMA, the intermediate FRET lifetime was also detectable, implying that the phosphorylation
ofmuncl8-l altered the conformation of the muncl8-lR39c and/or the ECFP-syntaxin la -
EYFP-muncl8-lR39c complex so that the fluorophores were now able to participate in FRET.
Furthermore, colocalisation analysis showed that the complex was predominantly on the
plasma membrane, so its proper targeting had been restored by phosphorylation of EYFP-
muncl8-lR39C- This suggests that if R39 is mutated to cysteine the conformation of muncl8
and/or of the syntaxin la - muncl8-l complex is destabilized and that as a result it is no
longer properly targeted; but that this is rescued by phosphorylation of muncl8-l.
To confirm that the changes seen on addition of phorbol ester were indeed due to
phosphorylation of muncl8-l the experiments were repeated using phosphomimetic mutants,
in which Ser306and Ser313 were mutated to glutamates. FFIM data from cells
cotransfected with ECFP-syntaxin la and either EYFP-muncl8-lS3o6E:S3i3EOr EYFP-muncl8-
1r39C:S306E:S313e revealed the presence of a complex of intermediate fluorescence lifetime
throughout the cells, suggesting that the negative charge on Ser306 and Ser313, arising either
from phosphorylation or from mutation to glutamate, in muncl8-l is sufficient to change the
conformation of the dimeric complex so that the fluorophores are further apart than when the
shortest lifetime was detected. When colocalisation analysis was performed on these cells in
both cases the syntaxin la - muncl8-l complex was found in roughly equal amounts on the
plasma membrane and inside the cell, with slightly more on the plasma membrane, which
was different from results obtained from cells cotransfected with wild-type proteins, either in
the presence or the absence of phorbol ester, and from cells cotransfected with ECFP-
syntaxin la and EYFP-muncl8-lR39C after treatment with phorbol ester. One possible
explanation for this is that the phosphorylation of muncl8-l necessarily occurs post-
translationally and after the protein has folded, while in contrast, the substitution of
negatively charged glutamates for serines in positions 306 and 313 may affect the folding
efficiency of the overexpressed muncl8-l. Thus, if the phosphomimetic muncl8-ls fold
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correctly then the dimeric complex is targeted correctly to the plasma membrane, and if not
then the complex is trapped intracellularly. Alternatively it is possible that the serine-to-
glutamate substitution does not fully mimic the effect of phosphorylation.
Taken together these data suggest that the syntaxin la - muncl8-l complex can exist in two
conformations that are spatially restricted within the cell (Figure 7.1) and that these
conformations can be modulated by PKC-catalysed phosphorylation ofmuncl8-l; the
consequent conformational changes are reflected in the FLIM signal. In untreated cells the
complex of shortest fluorescence lifetime, and presumably tightest interaction, was located
exclusively on the plasma membrane, with the weaker complex, of intermediate fluorescent
lifetime, located both on the plasma membrane and intracellularly. Upon PMA treatment,
resulting in PKC activation and hence enhanced muncl8-l phosphorylation, the plasma
membrane population of shortest fluorescence lifetime was replaced by one of intermediate
fluorescence lifetime. This suggests that the fluorescence lifetime of ECFP-syntaxin la in
complex with muncl8-l is indicative of the phosphorylation state of muncl8-l. Therefore,
the shortest fluorescent lifetime corresponds to the population of the complex containing
non-phosphorylated muncl8-l and the intermediate fluorescent lifetime corresponds to
syntaxin la-muncl8-l complexes containingphosphorylated muncl8-1. This suggests that
phosphorylation of muncl8-1 is required for the targeting of the syntaxin la - muncl8-1
complex to the plasma membrane, but that upon reaching the plasma membrane, muncl8-1
is dephosphorylated, resulting in the appearance of the tightest complex, which holds
syntaxin la in an inactive conformation until it is dissociated by some other factor, possibly
arachidonic acid (Rickman and Davletov 2005), allowing exocytosis to proceed. This theory
is further supported by the data obtained from cells overexpressing ECFP-syntaxin la and
EYFP-muncl8-lR39c, in which the proteins either do not interact or are in a conformation
that prevents the correct targeting of the complex; however upon phosphorylation of
muncl8-1 the conformation of the complex changes so that the requirement for R39 in




















Figure 7.1: The targeting of the munc18-1 - syntaxin 1a complex in cells
Phosphorylated muncl8-l and syntaxin la form a complex in the Golgi apparatus. The bimolecular
complex is then transported to the plasma membrane, where the muncl 8-1 is dephosphorylated. The
complex remains on the plasma membrane until upon activation it is dissociated by some factor
allowing syntaxin la to participate in SNARE complex formation and exocytosis to occur.
The muncl8-lR39C - syntaxin la complex remains trapped in the Golgi, where no FRET can be
detected between the fluorophores. Upon phosphorylation, FRET is measured and the complex is
properly targeted to the plasma membrane
210
proper targeting to the plasma membrane. Again this hypothesis is supported by the data
seen with the phosphomimetic variants, in which the presence of glutamates at positions 306
and 313 is sufficient to alter the conformation of the complex so as to give the intermediate
fluorescence lifetime and partially to rescue trafficking to the plasma membrane.
To further test this hypothesis and to confirm the role ofmuncl8-l phosphorylation in
exocytosis these experiments should be repeated using a non-phosphorylatable muncl8-l
mutant, created by mutating Ser306 and Ser313 to alanines. If this hypothesis is correct then
the complex of muncl8-lS306A:S3i3A with syntaxin la would be trapped intracellularly and
exhibit the shortest fluorescence lifetime inside the cell. In addition the phosphorylation
state ofmuncl8-l could be investigated using antibodies specific for phosphorylated
muncl8-l, raised against phosphorylated munc 18-1-derived peptides. This would reveal
whether the complex of intermediate fluorescence lifetime is phosphorylated, and the
complex with the shortest lifetime is dephosphorylated. A further prediction, which could be
tested in vitro, is that the phosphorylated, bimolecular syntaxin la - munc 18-1 complex can
be dephosphorylated.
The recent demonstration (Schutz, Zilly et al. 2005) that Mintl may be directly involved in
syntaxin la - muncl8-l complex formation suggests that an investigation of the effect of
muncl8 phosphorylation on its interactions with Mintl is necessary. Finally, it is not
known how trafficking of the bimolecular complex is carried out, and it remains to be








1.1 Electrophoretic separation and detection of proteins solutions
2.1.1 SDS-PAGE separating gel
component ml
30:0.8 % (w/v) acrylamide/bis-acrylamide 2.0
1.5 M Tris-HCl, 8 mM EDTA, 0.4 % SDS pH8.8 1.5
H20 1.5
3 % Polyacrylamide, ImM NaN3, 1 mM NaF 1.0
TEMED 0.006
10 % (w/v) ammonium persulfate 0.06
1.1.1 SDS-PAGE stacking gel
component ml
30:0.8% (w/v) acrylamide/bis-acrylamide 0.6
0.5 M Tris-HCl, 8 mM EDTA, 0.4 % SDS, pH6.5 1.0
H20 1.7
3 % Polyacrylamide, 1 mM NaN3, 1 mM NaF 0.65
TEMED 0.006
10 % (w/v) ammonium persulfate 0.06
1.1.2 1 X SDS sample buffer
50 mM Tris-HCl pH6.5, 5 % (w/v) SDS, 10 % (w/v) glycerol, 10 mM DTT, 50
bromophenol blue
1.1.3 Electrophoresis running buffer
0.05 M Tris-base, 0.384 M Glycine, 0.1 % SDS, 0.2 mM EDTA
214
1.2 Coomassie Blue R Staining
1.2.1 Fixing solution
50 % (v/v) methanol, 10 % (v/v) acetic acid
1.2.2 Coomassie Blue R Stain
0.25 % (w/v) Coomassie Brilliant Blue R dissolved in 50 % (v/v) methanol
10 % (v/v) acetic acid
1.2.3 Destaining solution
10 % (v/v) methanol, 7 % (v/v) acetic acid
1.3 Silver staining solutions
1.3.1 Solution A
dissolve 0.4 g AgN03 in 2 ml of H20
1.3.2 Solution B
mix 21 ml 0.36 % NaOH with 1.4 ml 14.8 M NH4OH make up to 100 ml
1.3.3 Solution C
solution A added dropwise to solution B with vigorous stirring
1.3.4 Solution D
mix 2.5 ml 1 % acetic acid with 0.25 ml formaldehyde (38 % stock) and make up to 500 ml
with H20
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1.4 Western blotting solutions
1.4.1 Transfer Buffer
20 mM Na2HP04, 20 % (v/v) methanol, 0.02 % (w/v) SDS
1.4.2 Tris buffered saline (TBS)
0.01 M Tris-HCl pH7.5, 0.15 M NaCl
1.4.3 TBST
0.01 M Tris-HCl pH7.5, 0.15 M NaCl, 0.5 % (v/v) Tween 20
1.4.4 Primary antibody solution
TBS, 0.1 % (v/v) NaN3, 1 % (v/v) BSA, 10 % (v/v) Calf Serum, 0.05 % (v/v) Tween 20
1.4.5 ECL solution 1
1.0 ml stock luminol (250 mM in DMSO), 0,44 ml stock p-coumaric acid (90 mM in
DMSO), 10 ml 1 M Tris-HCl pH8.5 made up to 100 ml with HzO
1.4.6 ECL solution 2
64 pi 30 % H202, 10 ml 1 M Tris-HCl pH8.5 made up to 100 ml with H20
1.5 Purification of oligohistidine-tagged protein solutions
1.5.1 HiTrap affinity column solutions
1.5.1.1 Wash buffer
0.02 M phosphate, 0.5 M NaCl pH7.4
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1.5.1.2 Elution buffer
0.02 M phosphate, 0.5 M NaCl, 50-500 mM Imadazole pH7.4
1.5.2 BD Talon™ resin solutions
1.5.2.1 Wash buffer
50 mM phosphate, 300 mM NaCl pH7.0
1.5.2.2 Elution buffer
50 mM NaH2P04, 300 mM NaCl, 50-500 mM imadazole pH7.0
1.5.3 Ni-NTA Superflow columns solutions
1.5.3.1 Lysis buffer
50 mM NaH2P04, 300 mM NaCl, 10 mM Imadazole, pH8.0
1.5.3.2 Wash buffer
50 mM NaH2P04, 300 mM NaCl, 20 mM Imadazole, 0.5 % Triton X-100, pH8.0
1.5.3.3 Elution buffer
50 mM NaH2P04, 300 mM NaCl, 250 mM Imadazole, pH8.0
1.6 Purification of GST-tagged proteins solutions
1.6.1 Wash buffer
PBS, 5 mM DTT, 0.1 % Triton X-100 pH7.5
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1.7 Bradford method solutions
1.7.1 Bradfords reagent
50 mg Coomassie blue G250 dissolved in 25 ml 95 % (v/v) ethanol, 50 ml 85 % (v/v)
phosphoric acid was added and then made up to 500 ml with H20
1.8 Lowry method solutions
1.8.1 Solution A
200 mM Na2C03, 100 mM NaOH, 7 mM sodium tartate, 1 % (w/v) SDS
1.8.2 Solution B
4 % (w/v) CuS04.5H20
1.8.3 Solution C
100 pi solution B added to 10 ml solution A
1.8.4 Solution D
1:1 dilution H20:Folin reagent
1.9 Solubilisation and refolding of insoluble fusion proteins solutions using
non detergent sulforbutane
1.9.1 Solubilising solution
50 mM HEPES-NaOH pH 7.5, 6 M guanidine HCl, 25 mM DTT
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1.9.2 Inclusion body wash buffer
50 mM Tris, 1 mM EDTA, 100 mM NaCl, 2 M Urea, 1 % Triton X-100
1.9.3 Refolding buffer
50 mM HEPES pH7.5, 0.2 M NaCl, 1 mM DTT, 1 M NDSN256
1.9.4 Phosphate buffer
50 mM sodium phosphate, 300 mM NaCl pH7.0
1.10 Solubilising and refolding of insoluble GST-fusion proteins using Q-
Sepharose
1.10.1 Buffer A
50 mM Tris-HCl pH8, 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 1 mM phenylmethyl
sulfonyl fluoride, 10 % glycerol
1.10.2 High salt buffer A
50 mM Tris-HCl pH8, 1 mM EDTA, 1 mM DTT, 1 mM phenylmethyl sulfonyl fluoride, 10
% glycerol, 250-750 mM NaCl
1.11 Binding experiment solutions
1.11.1 Binding/wash buffer





2.2 Munc18-1 variants sequencing primers
2.2.1 Forward sequencing primers
T7: 5'-TAA TAC GAC TCA CTA TAG GG-3'
Muncl8-1 Forward 1: 5'-AAC GAG AAG CGC GAT CAC AT-3'
Muncl8-1 Forward 2: 5'-AGT ACA AGG ACA ATG CCT TG-3'
Muncl8-1 Forward 3: 5'-AGA AGA CAG TGA GAT CAT CA-3'
EGFP Forward 1: 5'-CTG CTG CCC GAC AAC CAC TA-3'
EGFP - Muncl8-1 junction: 5'-GAC GGC AGC GTG CAG CTC GC-3'
Muncl8-1 - Vector junction: 5'-GGG GAG TAC CGC AGC GGT CC-3'
M13 uni (-43): 5'-AGG GTT TTC CCA GTC ACG ACG TT-3'
2.2.2 Reverse sequencing primers
T7 Reverse: 5'-CTA GTT ATT GCT CAG CGG T
Muncl8-1 Reverse 1: 5'-TTT GTA TCC AGT TTG TCT TC-3'
Muncl8-1 Reverse 2: 5'-ATG TTG GTG ATG ATC TCA CT-3'
Muncl8-1 Reverse 3: 5'-TTG CTA GAG GAA AAG TCC TT-3'
EGFP Reverse 1: 5'-ATG CCG TTC TTC TGC TTG TC-3'
Muncl8-1 - EGFP junction: 5'-GCT CTC GGG GCT TGT TGA TGA TA-3'
Ml3 rev (-49): 5'- GAG CGG ATA ACA ATT TCA CAC AGG-3'
2.3 Syntaxin 1a variants sequencing primers
2.3.1 Forward sequencing primers
T7: 5'-TAA TAC GAC TCA CTA TAG GG-3'
Syntaxin la - Vector junction: 5'-AGA GCC AGG GGG AGA TGA TT-3'
GST - ECFP junction: 5'-TCT TGA TGT TGT TTT ATA CA-3'
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ECFP - Syntaxin la junction: 5'-GAC GGC AGC GTG CAG CTC GC-3'
2.3.2 Reverse sequencing primers
Syntaxin la - Vector junction: 5'- GGT TCG GGG AGG CCA GGA TG-3'
Reverse: 5'-AAC GCA ATT AAT GTG AGT TA-3'
Syntaxin la- ECFP junction: 5'-TCA GCA ATC TTG TCA ATA AA-3'





3.1 Derivation of the equation describing the Dixon Plot (Dixon 1953)
Consider a protein, P, that binds a ligand, L and a competitor, I, at the same binding site.







Denoting the total concentrations of protein, ligand and inhibitor as PT, LT and IT, and
assuming IT»PT but that LT ~ PT
PT = [P] + [PL] + [PI]




= Kd[PL] + + Kd[PL][I]
Lt - [PL] (Lt - [PL])K,
This can be expanded to give the expression
PtLt - Pt[PL] = KJPL] + Lt[PL] - [PL]2 + [PL][I]K̂,
If [PL] is replaced by B, the concentration of bound ligand, and PT by Bmax, the concentration
bound at saturation; and if the term [PL]2 is neglected because it is small, this expression
simplifies to:
Lt.B = B(Kd + B + Lt +[I]^)T max v D max T L J -/
g _ P max T
L_ + B + KD + [1]^T max D L J y
AV ,
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